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“We no longer think of chairs as technology; we just think of them as chairs. But there was a 
time when we hadn't worked out how many legs chairs should have, how tall they should be, 
and they would often 'crash' when we tried to use them.” 
Douglas Adams 
 The Sunday Times, August 29th 1999
  
ABSTRACT 
The last decade has seen a rapid increase in the manufacture and use of nanomaterials, a 
development which should be met with appropriate safety assessment strategies in order to 
ensure the sustainable development of nanotechnology. With decreasing size, the percentage 
of atoms found at the surface of a given material increases substantially, leading to an increase 
in surface phenomena and acquisition of novel properties. These new traits can be appealing 
for industrial purposes, however, they can also enhance the intrinsic toxicity of the materials 
as compared to their bulk counterparts. Currently, nanotoxicology faces several challenges 
related to the multitude of materials that need to be tested, the possible interactions of the 
nanomaterials with the conventional toxicology assays and the potential emergence of novel 
nano-specific properties. Despite numerous research efforts being made in the last decade to 
evaluate the toxicity of nanomaterials, most of these studies fall short of several aspects, such 
as appropriate particle characterization, cellular uptake, relevant doses and exposure duration. 
The aim of this thesis was to use in vitro models to address some of the challenges in 
nanotoxicology in order to improve our understanding of the interactions between 
nanomaterials and biological systems. In Paper I we demonstrated that we can use the 
ToxTracker assay, which consists of reporter stem cells, to screen and predict the genotoxicity 
of metal oxide nanoparticles and at the same time obtain information about their mechanism of 
toxicity. In Paper II we used a panel of thoroughly characterized silver nanoparticles to address 
the issue of size-dependent toxicity in human lung cells. Our results showed that small (10 nm) 
particles were more cytotoxic than larger particles (˃40 nm) after acute exposure (24 hours), 
and that could be related to a ‘Trojan horse’ effect by which the particulate form facilitates the 
cellular uptake of metal, with subsequent release of toxic metal ions. In Paper III we selected 
two of the silver nanoparticles tested in Paper II and evaluated the effects following low-dose, 
long-term (6 week) exposure to human lung cells. By using both conventional assays and 
systems toxicology approaches (RNA-sequencing, genome wide DNA-methylation) we 
identified that chronic exposure to low doses of silver nanoparticles induced a cancer-like 
phenotype and had immunosuppressive effects in human lung cells. In Paper IV we explored 
the effects of antioxidant cerium oxide nanoparticles, which allegedly have promising 
therapeutic potential, in neural stem cells. On one hand, we showed that pretreatment with 
cerium oxide nanoparticles provided a temporary neuroprotective effect when cells were 
challenged with an oxidative stress inducer. On the other hand, by using both 
immunofluorescence and RNA-sequencing we revealed that the same antioxidant properties 
can have detrimental effects by suppressing neuronal differentiation, in which reactive oxygen 
species play an important role as signaling molecules. In all, our studies show that by using 
well-characterized nanomaterials together with appropriate experimental setups, and a 
combination of traditional toxicological assays with novel tools such as ‘omics’, we can 
improve our understanding of the toxicity of nanomaterials and by these means contribute to 
the sustainable development of nanotechnology.  
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 INTRODUCTION 
 PARTICLE TOXICOLOGY VERSUS NANOTOXICOLOGY 
1.1.1 Lessons learnt from the past 
Exposure to (nano)particles has occurred in parallel with human evolution and as a result the 
lungs have developed mechanisms to cope with particle exposure, e.g. phagocytosis followed 
by mucociliary clearance (Oberdörster et al., 2005). However, since the dawn of the industrial 
revolution the anthropogenic exposure to particles has increased drastically (Oberdörster et al., 
2005). The relationship between exposure to particles and lung diseases has been described as 
early as the 15th century, when workers in metal mines were ‘reported’ to have ‘breathing 
problems’, which are now believed to have been early accounts of silicosis (Donaldson and 
Seaton, 2012). From a historical perspective, there are three major culprits for the pathologies 
related to occupational exposure to particles, namely crystalline silica (quartz), asbestos and 
coal.   
Quartz dust is highly reactive, induces inflammation, genotoxicity and has been found to be 
carcinogenic in humans following inhalational exposure, hence classified by the International 
Agency for Research on Cancer (IARC) as a Class 1 carcinogen (IARC, 2012, 100C). Asbestos 
is a composite silicate fiber also classified as a Class 1 carcinogen (IARC, 2012, 100C). 
Exposure to asbestos has been correlated to a specific type of cancer of the pleura, namely 
mesothelioma. Research on asbestos laid the foundation for the fibre pathogenicity paradigm 
which states that long, thin and biopersistent fibers are highly pathogenic and induce chronic 
inflammation due to, among other factors, ‘frustrated phagocytosis’. Basically, macrophages 
are unable to completely engulf the long thin fibers which results in inflammatory processes 
(Donaldson and Poland, 2012). Coal dust consists of a mixture of carbon, quartz and silicates 
that upon inhalation can lead to pneumoconicosis, a risk factor for lung fibrosis (Donaldson 
and Seaton, 2012). However, the relationship between coal dust and lung cancer is unclear and 
coal dust has yet to be classified as carcinogenic to humans (Class 3) (IARC, 1997, 68).    
Apart from occupational exposure, humans are exposed to particles derived from 
anthropogenic sources such as diesel and engine exhaust particles as well as outdoor and indoor 
air particles. Diesel exhaust particles consist of a carbonaceous particle core on which a variety 
of substances are adsorbed, such as gases, poly-aromatic hydrocarbons and metals (Wichmann, 
2007), and have been classified as carcinogenic to human (Class 1) (IARC, 2013, 105). In 
addition, outdoor air pollution and particulate matter in outdoor air pollution have been recently 
classified as carcinogens (Class 1) (IARC, 2016, 109). Besides the carcinogenic effect, air 
pollution is correlated with cardiovascular effects such as atherosclerosis and stroke (Brook, 
2008).  
The steep development of nanotechnology is deemed to increase the exposure to (nano) 
particles even more (Oberdörster et al., 2005). In a visionary editorial published in 2004 and 
entitled ‘Nanotoxicology: A new frontier in particle toxicology relevant to both the workplace 
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and general environment and to consumer safety’ Ken Donaldson and colleagues addressed for 
the first time the potential toxicological implications of nanotechnology (Donaldson et al., 
2004). The authors mentioned issues such as size, surface reactivity and biodistribution, that 
could be of potential concern for the toxicity of nanoparticles, and postulated that 
nanotoxicology would be critical for the sustainable development of nanotechnology 
(Donaldson et al., 2004). It should be noted, however, that nanotoxicology is not a new 
discipline but is rather an emerging field grounded in particle and ultrafine particle toxicology 
(Oberdörster et al., 2005).    
Well-established paradigms and previous studies on particles and fibers should and are indeed 
revisited now in nanotoxicology research. As an example, among all nanomaterials, carbon 
nanotubes (CNTs) raised a great deal of concern due to their likelihood of fitting in the fiber 
pathogenicity paradigm. Indeed, some CNTs, i.e. the long, and stiff CNTs share similar 
properties and in vivo outcomes with asbestos fibers (Donaldson et al., 2013). A type of multi-
walled carbon nanotubes (MWCNTs), namely Mitsui MWCNT-7 was classified as Class 2B 
(possibly carcinogenic to humans) in absence of human cancer data (Grosse et al., 2014). This 
is an instance where lessons have been learnt from the past in the sense that now the aim is to 
predict the human toxicity of engineered nanomaterials before they are being produced in large 
enough quantities, and before considerable human exposure and subsequent health effects 
occur (Donaldson and Seaton, 2012). 
1.1.2 Definitions  
From a regulatory perspective, the current definition of nanomaterials at the European Union 
level is based on the EU Commission recommendation 2011/696/EU and is expected to be 
reviewed by the end of 2016.  
“A natural, incidental or manufactured material containing particles, in an 
unbound state or as an aggregate or as an agglomerate and where, for 50 % or 
more of the particles in the number size distribution, one or more external 
dimensions is in the size range 1 nm - 100 nm.  
In specific cases and where warranted by concerns for the environment, health, 
safety or competitiveness the number size distribution threshold of 50 % may be 
replaced by a threshold between 1 and 50 %. 
By derogation from the above, fullerenes, graphene flakes and single wall carbon 
nanotubes with one or more external dimensions below 1 nm should be 
considered as nanomaterials” (EU commission, 2011) 
As discussed in the Joint Research Center follow-up documents, the size range together with 
the percentage threshold were bound to aid regulatory processes and were not set out of 
scientific reasons (Hubert, 2015). Indeed, there is no biologically/toxicologically sound reason 
for a rigid 1 – 100 nm threshold.  
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1.1.3 Novel (nano-specific) effects 
The issue of size was predicted to be of concern even from the first account of nanotoxicology 
(Donaldson et al., 2004). For nanomaterials the surface to volume ratio as well as the 
percentage of atoms found at the surface are significantly higher as compared to the bulk form 
(Figure 1, left) leading to an increase in surface phenomena (Figure 1, right). This is in turn 
correlated with an increased reactivity and a potentially enhanced toxicity (Auffan et al., 2009). 
However, it is not to be generalized that all nano-sized particles imply an increased toxicity 
compared to the bulk form. (Auffan et al., 2009).  
The question of nano-specific modes of toxicity has long been under scrutiny. In a recent 
review, Donaldson and Poland put forward a sound argument that nanomaterials have no new 
modes of action compared to conventional particles, but rather bear a gradual magnification of 
the intrinsic hazard (Donaldson and Poland, 2013). Despite proximal events such as particle 
uptake and biodistribution being to some extent novel, the final pathways of toxicity, i.e. 
oxidative stress, inflammation and genotoxicity, overlap between nanoparticles and 
conventional particles (Donaldson and Poland, 2013).  
Some accounts of mechanisms of toxicity for nanoparticles have been published but it is 
unclear how nano-specific they are. For example, the proton sponge effect is elicited by cationic 
particles that upon entry to the lysosomal compartment sequester protons from the proton 
pumps, ultimately leading to lysosomal swelling and rupture as a result of the accumulation of 
Cl- and H2O molecules (Nel et al., 2009). Another example is the ‘Trojan horse’ mechanism 
by which partially soluble metal nanoparticles are taken up via endocytosis, followed by the 
release of metal ions inside the cells, thereby increasing intracellular bioavailability of toxic 
metals (Limbach et al., 2007).  
Finally, there are formulated concerns that nanoparticles are in the size range of sub-cellular 
structures and therefore the ‘matching of scales’ could imply novel interactions (Hubbs et al., 
2013, Maynard et al., 2011). Several studies have indicated that nanomaterials can interact with 
Figure 1. Surface to volume ratio and surface phenomena at the nanolevel 
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cytoskeletal structures. For instance, carbon nanotubes induce actin reorganization (Holt et al., 
2010) and disrupt the mitotic spindle with subsequent aneuploidy (Sargent et al., 2012). 
1.1.4 Challenges in nanotoxicology 
An important challenge in nanotoxicology is represented by the immense diversity of 
nanomaterials that are produced via different methods, with various levels of residual 
impurities, and with different shapes and sizes (Johnston et al., 2013). This makes the selection 
of nanomaterials to be tested challenging if they are to be representative for human exposure. 
Moreover, this advocates the need for increasing the throughput of our current techniques 
allowing for fast screening and hazard ranking of nanomaterials (Nel et al., 2013). In line with 
the ‘Toxicity Testing in the 21st Century’ paradigm, the high-throughput techniques should also 
provide mechanistic insight and allow for pathway-based toxicity testing (Nel et al., 2013), a 
point which was addressed in Paper I.  
In addition, thorough characterization in the relevant medium is mandatory in order to correlate 
certain physico-chemical properties with toxicological outcomes. In most of the cases a 
primary particle characterization is provided by the manufacturer, but this has to be 
complemented with characterization in the relevant physiological fluid, where particles acquire 
their biological identity by e.g. formation of the bio-corona.  
Due to their intrinsic properties, nanomaterials can interfere with conventional toxicological 
assays and detection methods, thereby skewing the results. Nanomaterials can have intrinsic 
fluorescence/absorbance, can adsorb assay reagents or catalyze enzymatic reactions, 
potentially leading to false results. Interactions between nanoparticles and test systems have 
been reported for both carbon-based materials (Monteiro-Riviere et al., 2009) and metal-based 
materials (Kroll et al., 2012). Assessment of interference of nanomaterials with assays should 
be performed on a routine basis for every tested nanomaterial as results cannot be generalized. 
In addition, the use of two or more assays to address similar endpoints could increase the 
reliability of the results.  
A common problem in nanotoxicology studies is the use of very high, unrealistic doses (Krug 
and Wick, 2011). This is partially fueled by the editorial bias towards publishing positive 
results and is detrimental for achieving scientific progress in the field of nanotoxicology (Krug 
and Wick, 2011). If we are to make meaningful progress in understanding the toxicity of 
nanomaterials, relevant doses should be used in both in vivo and in vitro studies. In addition, 
most of the work so far reports on the short-term effects of nanomaterials and more chronic, 
ideally low-dose studies are critical to aid risk assessments endeavors. The use of low-dose 
chronic-exposure to nanoparticles was evaluated in Paper III.  
A review by Krug H. in 2014 entitled “Nanosafety Research – Are We on the Right Track?” 
paints a fairly pessimistic picture of the progress nanosafety research has seen in the previous 
15 years (Krug, 2014). Basically, despite increasing number of publications (over 10 000), 
major knowledge gaps there still exist, which makes it difficult to draw sound conclusions on 
the safety of nanomaterials. Again, a major problem is the use of unrealistic doses that provide 
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mechanistic information but are of questionable use for toxicological assessment. The lack of 
reference materials and appropriate controls are other factors that pose difficulties for reliable 
comparison between studies for risk assessment purposes (Krug, 2014).  
 INHALATIONAL EXPOSURE TO NANOMATERIALS  
Exposure to engineered nanomaterials occurs via inhalation, ingestion and contact with the 
skin. One of the first lines of exposure occurs in occupational settings via inhalation, which 
makes the lung an important target organ. Due to their small size, nanoparticles can penetrate 
and deposit deeper into the lungs, in the alveolar region (Oberdörster et al., 2005) which 
determines the magnitude of the toxic effect.  
Figure 2 depicts the predicted deposition of particles depending on their size according to the 
International Commission on Radiological Protection.  According to the model, both large (1 
– 10 µm) and very small (1 nm) particles are mainly deposited in the upper nasal airways, 
pharynx and larynx, whereas e.g. 20 nm particles have the highest deposition in the alveolar 
area (Oberdörster et al., 2005). In vivo studies in rats showed that 10 nm Ag nanoparticles had 
a higher total lung deposition, a higher predicted alveolar deposition and induced more lung 
inflammation compared to 410 nm Ag nanoparticles (Braakhuis et al., 2014a). 
 
The mechanisms of nanoparticle deposition are governed by diffusion whereas for larger 
particles (or agglomerates) deposition is mediated by inertial impaction, gravitational settling 
and interception (Oberdörster et al., 2005). Depending on the deposition site, particles are 
cleared by different mechanisms. For particles deposited in the alveolar area, macrophage 
clearance is the main mechanism and is followed by gradual movement towards the 
mucociliary escalator, with an estimated retention half-time of 700 days in humans 
Figure 2. Predicted deposition of inhaled particles in the respiratory tract. Reproduced from 



























































(Oberdörster et al., 2005). The total lung macrophage clearance is very efficient for 
microparticles but for nanoparticles only 20% of the particles are cleared this way, which 
allows for interaction of nanoparticles with the epithelial cells and interstitial sites (Oberdörster 
et al., 2005).    
Translocation across the lung-blood barrier for nanoparticles is considered to be in general very 
low but could be relevant considering accumulation during a life-long exposure scenario (Krug, 
2014). Moreover, translocation from the lungs to the secondary organs was reported to be size-
dependent; higher for 15 nm versus 80 nm iridium nanoparticles (Kreyling et al., 2009) and 
higher for 2 nm compared to 40 and 80 nm gold nanoparticles (Sadauskas et al., 2009).  
In addition, studies have shown that particles can translocate from the nose to the brain via the 
olfactory bulb, making the brain an additional target organ following inhalation exposure 
(Oberdörster et al., 2004). For example, Ag nanoparticles were shown to translocate to the 
brain via the olfactory bulb after inhalational exposure in rats (Patchin et al., 2016). This can 
pose toxicological concerns considering that Ag nanoparticles were shown to alter cytoskeletal 
organization in neurons in vitro (Cooper and Spitzer, 2015). Moreover, ultrafine carbon 
particles were reported to reach the brain to a significant extent via sensory nerve endings in 
the respiratory tract (Oberdörster et al., 2004) and MnO nanoparticles were shown to 
translocate to the brain of rats via similar routes and induce inflammatory changes (Elder et al., 
2006).  
A recent study identified combustion-derived magnetite nanoparticles in human brain samples, 
which were believed to originate from olfactory bulb transport (Figure 3), and postulated a 
connection with Alzheimer disease (Maher et al., 2016). Other routes of nanoparticle access to 
the central nervous system apply to nanoparticles that are in the blood stream and imply the 
crossing of the blood-brain barrier which can occur through endothelial tight junctions for 
particles smaller than 6 nm or through transcytosis for larger particles (Cupaioli et al., 2014). 
These routes are, however, more relevant in the light of brain delivery of nanomaterials 
intended for biomedical applications.  
Figure 3. Brain translocation of nanoparticles following inhalation exposure. Picture courtesy of         
Dr. Imad Ahmed in relation to the reference Maher et al., 2016. 
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 HAZARD ASSESSMENT OF NANOMATERIALS 
1.3.1 Physico-chemical properties 
Interaction of nanoparticles with biological systems and subsequent toxicity is closely 
dependent on physico-chemical properties of nanomaterials such as particle, size, shape, 
coating, surface area, crystalline structure and composition, some of which will be introduced 
and discussed below. Considering that even small changes in these properties could result in 
alteration of biological responses, it is crucial to perform a thorough particle characterization 
in parallel with the toxicity assessment (Fadeel et al., 2015).  
 Size  
Size is an aspect that was previously mentioned and that plays an important role for the 
reactivity of the nanomaterials because with decreasing size there is an increase in the 
percentage of atoms found at the surface, which are more reactive than the atoms found inside 
(Auffan et al., 2009). Surface area is also strictly related to the size and increases proportional 
to the decrease in size, for the same mass (Hubbs et al., 2013). Size-dependent toxicity has 
been reported for Ag nanoparticles (Braakhuis et al., 2014a, Wang et al., 2014) and was 
investigated in this thesis (Paper II and III). Since nanoparticles have variable stability in the 
dispersion medium, it is important to distinguish between the primary particle size and the size 
of the particle agglomerates and aggregates in the relevant biological environment. In addition, 
particle agglomeration and sedimentation can influence the uptake (Cho et al., 2011) and 
consequently the toxicity of nanoparticles.   
Size also dictates the uptake mechanisms (Figure 4). When it comes to active uptake pathways, 
particles up to 100 nm can be taken up by pinocytosis, clathrin and caveolin pathways whereas 
larger particles are taken up by phagocytosis and macropinocytosis (Krug and Wick, 2011, 
Kuhn et al., 2014).  
In addition to active mechanisms, diffusion is a passive process which was reported e.g. for 
quantum dots (Wang et al., 2012) and gold nanoparticles (Lin et al., 2010). In general, 
nanoparticles are taken up by a combination of mechanisms, also shown in this thesis (Paper 
II). It is worth noting that the nanoparticle uptake is less well regulated compared to the uptake 
Figure 4. Active uptake mechanisms for (nano)particles 
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of metal ions, which is problematic for particles with intrinsic toxicity as it can lead to an 
increased bioavailability for toxic metals (Krug and Wick, 2011).  
 Shape 
Nanomaterials can be distinguished into low- aspect-ratio nanoparticles (LARN) comprised of 
spherical, cubic, prismatic, helical or pillar shaped materials, and high-aspect-ratio 
nanomaterials (HARN) comprised of nanotubes and nanowires (Colognato, 2012). The 
similarity between HARN and asbestos raised well-grounded concerns about the potential 
toxicity of HARN. Tran et al. established a hypothetical model to predict HARN toxicity which 
was based on the pathogenic fiber paradigm and that covers three main aspects: (i) the HARN 
dimension should be thin enough to allow for deposition in the lower airways; (ii) a high 
enough deposition of HARN is achieved; (iii) biopersistency (Tran et al., 2011). In contrast to 
asbestos fibers, carboxylated single-walled carbon nanotubes (SWCNTs) were reported to 
undergo enzymatic degradation with subsequent reduction of lung inflammation (Kagan et al., 
2010), whereas SWCNTs conjugated with polyethylene glycol were shown to be enzymatically 
degraded in the presence of myeloperoxidase (Bhattacharya et al., 2014). Shape-dependent 
toxicity has been reported for metal nanoparticles such as Ag for which nanowires (1.5 and 8 
µm) were more toxic than nanospheres in A549 cells (Stoehr et al., 2011). In the case of TiO2 
nanomaterials, long (> 15 µm) nanobelts but not short (< 5 µm) nanobelts or nanospheres 
induced inflammasome activation in alveolar macrophages (Hamilton et al., 2009). 
 Surface charge 
The surface charge of a nanoparticle is defined by the zeta potential and is determined by the 
electric potential created between the surface of the particle and the dispersion medium (Cho 
et al., 2012). Considering the electric potential of cellular membranes, the surface charge of 
nanoparticles can influence the interactions between nanomaterials and biological systems and 
by these means modulate the toxicity profile. Fröhlich E. reviewed the issue of surface charge 
and cellular uptake and reported that cationic particles are more likely to disrupt the cell 
membrane and induce toxicity as compared to anionic particles which are more prone to induce 
apoptosis (Fröhlich, 2012). In addition, cationic nanoparticles could induce lysosomal damage 
via the proton sponge effect (Nel et al., 2009) discussed in the previous section (1.1.3). For 
low-soluble metal and metal oxide nanoparticles the zeta potential in acidic conditions was 
correlated with lung inflammation and the authors speculated that a high zeta potential in the 
acidic lysosomal environment could disrupt the lysosomal membrane and lead to inflammation 
(Cho et al., 2012). In biological environments the surface charge of nanomaterials changes due 
to the adsobtion of biomolecules and formation of the bio-corona (Monopoli et al., 2012).  
 Composition  
While size, shape and surface charge play an important role in determining the magnitude of 
the toxic outcome, the chemical composition of the nanomaterials is equally important as it 
defines the intrinsic hazard. According to their composition, nanomaterials can be briefly 
classified in metal based (e.g. Ag, Au, Ni, NiO, SiO2, CeO2), carbon based (e.g. carbon 
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nanotubes, graphene) and polymeric nanoparticles (e.g. dendrimers), all of which can bear 
different coatings and functionalisations. Studies revealed that Cu and Zn based materials have 
the highest acute toxicity both in vitro and in vivo when compared to e.g. Ti and Ce based 
materials (Cho et al., 2010, Lanone et al., 2009).  Purity of the nanomaterials can influence 
toxicity and is often overlooked in toxicity studies. It has been reported that nanomaterials can 
be contaminated with endotoxins or organic residues (Crist et al., 2013).  
 The concept of ‘bio-corona’ 
When introduced into biological environments, nanoparticles gain their biological identity by 
adsorbing biomolecules onto their surface with the formation of the bio-corona, a phenomena 
related to the high free energy at the surface (Monopoli et al., 2012). Depending on the type of 
molecules adsorbed, the nanoparticles can acquire a protein corona, a lipid corona etc. The 
protein corona is a dynamic entity that consists of a so-called ‘hard’ corona (comprised of 
tightly bound molecules) and a ‘soft’ corona (comprised of loosely associated molecules) 
(Figure 5, left) (Docter et al., 2015). The formation of the protein corona is a fast and dynamic 
process; in terms of the protein composition the protein corona undergoes quantitative but not 
qualitative changes over time (Figure 5, right) (Docter et al., 2015, Tenzer et al., 2013). The 
composition of the bio-corona depends on the nanoparticle material, surface properties, size, 
‘exposure’ duration as well as type of biological environment and is reported to differ 
qualitatively and quantitatively from the composition of the biological environment 
(Westmeier et al., 2016).  
 
The bio-corona has implications for the physico-chemical properties of the nanoparticles, by 
influencing particle colloidal stability, as well as for the toxicological outcome. For example, 
the formation of the protein corona was reported to influence the uptake of Ag nanoparticles in 
mouse macrophages (Shannahan et al., 2015) and human embryonic kidney cells (Monteiro-
Riviere et al., 2013) which can in turn modulate their toxicity. The formation of bio-corona 
Figure 5. The structure and dynamics of the protein corona. Reproduced from Docter et al., 2015, 
Chemical Society Reviews, with modifications. 
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was not studied in this thesis, however, it would be of interest to address the effects of e.g. lung 
surfactant corona on the toxicity of nanoparticles in lung cells.  
1.3.2 Conventional endpoints of toxicity 
 Cytotoxicity 
Cytotoxicity is commonly one of the first assessments when performing in vitro toxicity testing 
of compounds of interest, including nanoparticles. There are several cytotoxicity tests available 
and the choice of assay should be made depending on:  
(i) type of endpoint of interest e.g. membrane integrity (LDH assay), mitochondrial 
activity (Alamar Blue assay)  
(ii) type of cell death of interest e.g. necrosis (LDH assay, Trypan blue), apoptosis 
(Annexin V), autophagic cell death  
(iii) possible interference between nanoparticles and the assay, which should be tested 
on a case by case scenario (Kong et al., 2011a) 
A common critique of nanotoxicology studies is the use of very high unrealistic doses that are 
of no relevance for human exposure (Krug, 2014). However, for an initial evaluation of 
cytotoxicity one might need to go up to quite high doses in order to observe cell death and get 
an indication of the cytotoxicity profile. In addition, cytotoxicity assessment is a very crude 
measurement of nanoparticle toxicity but can be useful for ranking purposes or for establishing 
doses for other endpoints.  
 Oxidative stress  
The oxidative stress paradigm is a well-established model for explaining the toxic effects of 
inhaled particles and its suitability can be extended to nanoparticles as well (Nel et al., 2006). 
Nanomaterials can induce oxidative stress via several mechanisms: 
(i) directly, as a result of the presence of reactive groups at the surface (e.g. transition 
metal-based nanoparticles,  transition metal catalysts as residues from the synthesis 
or free radical intermediates at the surface) that can transfer electrons to oxygen 
molecules resulting in superoxide radicals that in turn can enter Fenton reaction or 
undergo dismutation with formation of additional reactive oxygen species (ROS) 
(Nel et al., 2006, Shvedova et al., 2012) 
(ii) following dissolution (in the case of metal nanoparticles) with subsequent release 
of metal ions that can catalyze Fenton and/or Haber-Weiss reactions (Manke et al., 
2013) 
(iii) indirectly, following particle interaction with cellular components such an 
phagosomes, lysosomes and mitochondria (Xia et al., 2006) 
(iv) indirectly, as a result of antioxidant depletion (Manke et al., 2013) 
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According to the hierarchical oxidative stress model depicted in Figure 6, a low increase in 
ROS activates the nuclear factor-erythroid 2-related factor 2 (Nrf2) pathway (by inhibiting the 
suppressor activity of Keap1) which leads to the activation of the antioxidant response element 
(ARE) that in turn upregulates expression of Phase II genes such as glutathione-S-transferases 
and NADPH:quinone oxido-reductase 1 (Nguyen et al., 2009, Nel et al., 2006). This is a 
protective mechanism that can be overwhelmed at higher ROS levels when inflammation and 
eventually cell death occur. Inflammation is believed to be mediated by mitogen-activated 
protein kinase (MAPK) and NF-κB pathways and results in the secretion of cytokines and 
chemokines (Nel et al., 2006). In addition, ROS can directly bind to DNA and induce 
genotoxicity, as discussed below, as well as trigger protein or lipid oxidation with subsequent 
altered cellular functionality (Manke et al., 2013).  
On the other hand, ROS acts as a cellular messenger regulating processes such as cell 
proliferation and differentiation (Sauer et al., 2001). It is therefore conceivable that some 
nanoparticles with antioxidant properties such as, e.g. CeO2 could impair the normal ROS 
balance and by these means alter cellular functions. This is investigated in Paper IV of this 
thesis.  
 Inflammation 
Lung inflammation was closely correlated with oxidative stress and has been reported for a 
wide range of nanomaterials (Braakhuis et al., 2014b). Properties such as particle size, shape, 
crystallinity and composition are important factors for the outcome of lung inflammation. In 
general, HARN, particles with a highly reactive surface and/or positively charged showed a 
higher induction of lung inflammation (Braakhuis et al., 2014b). Lung inflammation can be 
investigated in vivo by performing a cytological analysis (total cell count, neutrophils, 
eosinophils and lymphocytes) and by evaluating the cytokine/chemokine levels in 
bronchoalveolar lavage fluid (Cho et al., 2010). It was reported that intratracheal instillation of 
metal oxide nanoparticles in mice lead to distinct inflammatory patterns; exposure to NiO 
nanoparticles induced a mild lung inflammation 24-hours post-exposure, which was amplified 
after 4 weeks; CuO nanoparticles induced a severe lung inflammation 24-hours post-exposure 
that resolved almost completely after 4 weeks (Cho et al., 2010). 
Figure 6. Hierarchical oxidative stress response model 
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 Genotoxicity 
Nanoparticles have the potential to induce DNA damage via primary and/or secondary 
genotoxic mechanisms (Magdolenova et al., 2014), summarized in Figure 7. If unrepaired or 
mis-repaired DNA damage can lead to mutations that in turn can promote cancer development. 
Primary genotoxicity can be the result of either direct or indirect mechanisms and is much 
easier to assess in vitro due to technical and biological considerations.  
Direct primary genotoxicity could occur by close interaction of nanoparticles with the DNA 
and can take place following entry to the nucleus (for small particles that can pass through the 
nuclear pore) or during cell division when the nuclear envelope is disassembled (Magdolenova 
et al., 2014). Theoretically, entities with a size of ~5 nm could diffuse through the nuclear pore 
while larger cargos, up to 40 nm, could be shuttled to the nucleus via e.g. interaction with the 
nuclear pore complex (Wente and Rout, 2010). Once in the nucleus and depending on the cell 
cycle phase nanoparticles could interact with the DNA and induce genotoxicity. For example, 
during mitosis particles might induce breaks in the chromosomes (clastogenic effect) or loss of 
chromosomes (aneuploidy) by e.g. direct interaction with centromeric regions, whereas during 
interphase particles could alter DNA replication and transcription (Magdolenova et al., 2014). 
Aneuploidy can in turn increase the genomic instability which is a precipitating factor for 
cancer development (Giam and Rancati, 2015).   
In addition, nanoparticles were shown to induce indirect primary genotoxicity via several 
mechanisms (Magdolenova et al., 2014): 
(i) interaction with DNA repair proteins (Jugan et al., 2012)  
(ii) interference with the mitotic spindle and cell cycle control checkpoints with 
subsequent aneuploidy (Huang et al., 2009) 
(iii) ROS generation from the surface of the nanoparticles (or from the corresponding 
released ions in the case of metal based materials) can induce oxidative DNA 
damage and DNA strand breaks 
(iv) depletion of antioxidants such as glutathione, superoxide dismutase and catalase 
(Sharma et al., 2009) 
Another type of indirect genotoxicity which can also be regarded as secondary genotoxicity 
was reported by Bhabra and colleagues; cobalt-chromium nanoparticles induced both 
chromosomal and DNA damage to fibroblasts across an intact cellular barrier of BeWo 
placental cells via ATP-mediated activation of the purinergic receptor P2 on the surface of the 
fibroblasts (Bhabra et al., 2009). 
Conventionally, secondary genotoxicity is triggered during inflammatory responses (‘oxidative 
burst’) and is mediated by ROS released from activated immune cells (Magdolenova et al., 
2014). This type of genotoxicity is mostly studied in vivo due to the biological limitations of 
the in vitro systems. A typical case of secondary genotoxicity can be the ‘frustrated 
phagocytosis’ and subsequent mesothelioma induction, which is relevant for HARN 
(Donaldson et al., 2010). In addition, the general understanding for particle induced 
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carcinogenesis is that it involves the classic oxidative stress/inflammation pathway (Donaldson 
and Poland, 2012). In this thesis, mechanisms underlying genotoxicity of nanoparticles were 
studied in Paper I.  
1.3.3 Considerations on dosimetry    
Despite over a decade of nanotoxicology research there is still a lack of consensus as regards 
dosimetry issues, which play a crucial role in interpreting and comparing toxicological data 
(Hussain et al., 2015). Most of the in vitro studies describe the dose as mass per volume 
(µg/mL) but that can introduce confounders when comparing studies with each other, as the 
exposure volume can differ between experimental setups. Alternative metrics that are used in 
some studies include mass per surface area (µg/cm2) or particle number per surface area. In 
addition, there are some clear distinctions that should be made between the nominal dose i.e. 
the theoretical mass that is administered, the delivered dose i.e. the dose that mechanically 
reaches the desired target and the cellular dose i.e. the internalized mass (Kong et al., 2011a). 
The delivered dose is more relevant to what the particles ‘see’ than the nominal dose and is 
related among others to the nanoparticle colloidal stability in the biological environment and 
the viscosity of the dispersion medium. Since most of the in vitro systems use an upright setup 
for cell culture, nanoparticle sedimentation plays an important role in determining the delivered 
dose. Cho and colleagues reported that the uptake of gold nanoparticles was higher under 
upright versus inverted cell culture conditions for particles with high sedimentation velocity as 
compared to diffusion velocity (Cho et al., 2011).   
Figure 7. Mechanisms of nanoparticle-induced genotoxicity 
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Computational approaches such as the In vitro Sedimentation, Diffusion and Dosimetry 
(ISDD) model, which take into account the kinetics of nanoparticles in the dispersion medium, 
have been established for estimating the delivered dose in vitro (Hinderliter et al., 2010). The 
ISDD model predicts the delivered dose (particle number, mass) in a time-dependent manner, 
it can be applied to spherical nanoparticles and takes into account parameters such as 
hydrodynamic particle size, agglomeration state, particle density, temperature, medium height, 
medium viscosity and density (Hinderliter et al., 2010). The Multiple Pathway Particle 
Dosimetry (MPPD) model is another approach used to estimate the in vivo lung distribution 
and deposition, which has been successfully applied to e.g. predict total lung burden and 
alveolar distribution of Ag nanoparticles (Braakhuis et al., 2014a). Both the ISDD and the 
MPPD models are valuable for predicting the delivered dose and can aid in vitro-in vivo 
correlations.  
In general, the cellular dose is believed to be closely correlated with the toxic outcome, however 
some nanoparticles (or released metal ions) could exert effects from outside the cellular 
compartment. While modelling the delivered dose is certainly informative, the best practice 
would be to quantify the actual cellular uptake, when possible. The cellular uptake can be 
quantified for metal and metal nanoparticles by using techniques such as inductively coupled 
plasma mass spectrometry (ICP-MS) or atomic absorption spectroscopy (AAS) that will be 
further described and discussed in Section 3.3-3.4 of this thesis. Even flow-cytometry can be 
used to get an estimation of cellular uptake for nanomaterials due to the increase in intracellular 
granularity which results in a side scatter shift (Suzuki et al., 2007). Cellular uptake of 
nanoparticles was quantified in Paper II-IV and estimated by flow cytometry in Paper I.   
1.3.4 In vitro versus in vivo models and correlations 
With the increase in the number of nanomaterials that are in need of toxicological testing, fast, 
reasonably priced and ethically sound models are required i.e. in vitro models. Efforts have 
been made to increase the complexity of in vitro models for lung exposure to nanoparticles in 
an attempt to better resemble the in vivo scenario and better translate the results to real life 
exposure. For example, the lung-on-a-chip device mimics the breathing pattern and reported 
an increased inflammatory response to silica nanoparticles as compared to static conditions 
(Huh et al., 2010). However, more complex models do not always have a better predictive 
power. It was reported that in the case of Ag nanoparticles, simple mono-layer cultures better 
predicted the in vivo toxic outcome following acute inhalational exposure as compared to more 
complex co-culture models (Braakhuis et al., 2016). In this regard, I believe that the quote of 
George E.P. Box which was mentioned in the context of statistics can be extrapolated to 
biological models.  
“Essentially, all models are wrong, but some are useful.” George E. P. Box 
When adding an additional level of complexity to a model one also adds an additional level of 
uncertainty which in the end could defeat the purpose of the model. On the other hand, living 
  15 
organisms are complex and the development of intelligent models that can encompass that 
complexity and have predictive power for subtle endpoints is one of the future challenges.  
Using in vitro models is advantageous for deriving mechanistic information on the toxicity of 
nanomaterials that is more difficult to obtain from in vivo studies. However, to which extent 
this mechanistic information can be translated to real-life exposure is yet to be established. One 
issue that proved critical in translating in vitro to in vivo data is dosimetry. Several studies 
report that surface area rather than mass is a better metric for correlating in vitro with in vivo 
data (Braakhuis et al., 2016, Han et al., 2012).  
Teeguarden et al. evaluated the in vitro – in vivo correlation by addressing the target tissue 
dosimetry and using superparamagnetic iron oxide nanoparticles as model particle (Teeguarden 
et al., 2014). The authors used the same dose scale and reported that target tissue doses of 0.009 
– 0.4 µg/cm2 in the alveolar region in vivo corresponded to 1.2 – 4 µg/cm2 in vitro in lung 
epithelial cells as regards the induction of inflammatory markers (that were previously 
identified following gene expression profiling in vivo) (Teeguarden et al., 2014). In addition, 
the study found a good correlation regarding inflammation between the nanoparticle cellular 
dose estimated in alveolar macrophages (1-100 pg/cell) and evaluated in vitro in bone marrow 
derived macrophages (8-35 pg/cell) (Teeguarden et al., 2014).  
Finally, it was reported that the predictive value of the in vitro assays revolves around the 
mechanism of toxicity; the majority of in vitro assays that were tested (cytotoxicity, cytokine 
secretion) identified toxicity of highly soluble nanoparticles but had a high degree of failure 
when it came to toxicity mediated by surface reactivity (Cho et al., 2013). The same study 
reported that only the hemolysis assay was appropriate for predicting in vivo lung inflammation 
for insoluble particles such as CeO2 for which it is believed that surface reactivity mediates 
toxicity (Cho et al., 2013).  
 SYSTEMS TOXICOLOGY 
With the emergence of increasing manufacture and use of nanoparticles, new approaches are 
needed in order to aid the risk assessment processes and enable sustainable development of 
nanotechnology. On one hand, fast, high-throughput technologies are required for screening 
and predictive purposes (Nel et al., 2013). On the other hand, in line with ‘toxicity testing in 
the 21st century’, emerging technologies such as ‘omics’ would provide a mechanistic insight 
into the pathways of toxicity with the ultimate goal of establishing the human ‘toxome’ 
(Hartung et al., 2012, Hartung and McBride, 2011).  
Systems toxicology approaches have developed from integrating systems biology and 
toxicology and are envisioned to provide a holistic and mechanistic understanding of the 
interactions between xenobiotics and biological systems at different levels of organization 
(Costa and Fadeel, 2016). The ultimate purpose of these approaches is to help establish adverse 
outcome pathways, derive predictive models of biological interactions and lay a solid 
foundation for risk assessment (Costa and Fadeel, 2016, Sturla et al., 2014). In addition, 
‘omics’ technologies can open up the field of toxicology for hypothesis-free research, however, 
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during the downstream data analysis and interpretation previous knowledge can be used to 
narrow-down the results (Costa and Fadeel, 2016). The systems toxicology framework in the 
context of nanosafety research is illustrated in Figure 8.  
Systems toxicology integrates different ‘omics’ technologies to globally assess gene expression 
(transcriptomics), proteins (proteomics), lipids (lipidomics), metabolites (metabolomics) or 
epigenetic traits (epigenomics). Two of these approaches, namely transcriptomics and 
epigenomics will be further discussed below.  
Transcriptomic approaches are used to quantify genome-wide mRNA levels and comprise of 
oligonucleotide hybridization techniques (microarray) or newer sequencing techniques such as 
RNA sequencing (RNA-Seq). Toxicogenomics (mostly hybridization technologies) have been 
used in toxicological research for over a decade and are considered a powerful approach for 
identifying perturbed biological pathways, novel toxicological mechanisms as well as 
biomarkers of toxicity (Chen et al., 2012). One important advantage of using toxicogenomics 
is the holistic approach that allows for understanding of gene changes in the context of altered 
pathways and networks thus providing a better understanding of both the mechanisms of 
toxicity and the toxic response. RNA-seq is a novel technology that allows for robust 
measurements of RNA transcripts on a genome-wide level (Wang et al., 2009). In contrast to 
microarray techniques, RNA-Seq is more accurate, has a higher dynamic range, allows for 
detection of alternative splicing and can be used without preexisting knowledge of the genomic 
sequence (Wang et al., 2009). Recently, RNA-Seq has emerged as a tool in (nano)toxicology, 
bound to supersede microarrays in the toxicogenomics field (Costa and Fadeel, 2016). Thus 
far, RNA-Seq has been employed in nanotoxicology to e.g. unravel the low-dose effects of 
Figure 8. The systems toxicology framework for risk assessment of nanomaterials. Reproduced from 
Costa and Fadeel, 2016, with permission from Elsevier. 
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dendrimers on human lung cells (Feliu et al., 2015) and to identify the effects of exposure to 
metal nanoparticles in green alga, Chlamydomonas reinhardtii (Simon et al., 2013).  
Epigenomics approaches aim to understand the genome wide changes in the epigenetic patterns 
of cells. Epigenetic phenomena such as DNA-methylation, histone modifications and non-
coding RNAs are involved in modulating genome-environment interactions without involving 
changes in the DNA sequence (Mensaert et al., 2014). Epigenomic technologies are relatively 
new and include both microarray and sequencing technologies for the assessment of DNA 
methylation and microRNAs (Mensaert et al., 2014). It is currently believed that nanoparticles 
have the potential to induce epigenetic changes (Shyamasundar et al., 2015) and epigenomics 
could help unravel some of those effects. DNA methylation arrays have been widely used for 
epigenome-wide association studies (Morris and Beck, 2015) but to a lesser extent in 
nanotoxicology studies. There are, however, accounts of micro-RNA studies which addressed 
the effects of MWCNTs in human lung cells (Nymark et al., 2015) and the effects of Ag 
nanoparticles in Jurkat cells (Eom et al., 2014).  
With time, the cost of ‘omics’ technologies is bound to decline and the flow of data analysis 
will become more and more standardized and fast, which will ultimately enable the switch from 
traditional toxicological approaches to comprehensive ‘omics’ approaches on a routine basis.  
 METAL AND METAL OXIDE NANOPARTICLES 
Metal and metal oxide nanoparticles are a heterogenous group of particles important from an 
occupational and environmental toxicological perspective (Karlsson, 2015a). Metal oxide 
nanoparticles have semiconductive and catalytical properties and are being manufactured in 
large quantities for industrial purposes (Zhang et al., 2012). The same traits that are appealing 
from a technical point of view can, however, imply a propensity for ROS generation and can 
thus lead to toxicological effects such as e.g. lung inflammation that was reported upon 
inhalation of welding fumes (Antonini et al., 2004). There are currently two theories that aim 
to predict the lung inflammation potential of metal and metal oxide nanoparticles: the band gap 
theory and the zeta potential theory.  
The band gap theory is based on the likelihood of electron transfer between the valence band 
of metal oxide nanoparticles and cellular redox couples (Zhang et al., 2012). If valence band 
energy levels overlap with the biological redox potential, electron transfer should occur more 
easily with the formation of ROS and oxidized biomolecules, that was in turn correlated with 
cytotoxicity and lung inflammation (Zhang et al., 2012). From all the tested metal 
nanoparticles, CuO and ZnO did not fit the prediction and that was believed to be related to 
their high dissolution and release of toxic ions (Zhang et al., 2012).  
The zeta potential theory (Figure 9) postulates that metal and metal oxide nanoparticles with 
low solubility and high zeta potential in acidic conditions (ζP acid) are more likely to inflict 
damage on the lysosomal membrane thereby inducing lung inflammation (Cho et al., 2012). 
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For highly soluble particles, the inflammation is triggered by the release of toxic ions that 
destabilize the lysosomal membrane (Cho et al., 2012). 
 
In Paper I several metal and metal oxide nanoparticles (CuO, Fe3O4, ZnO, TiO2, NiO, CeO2 
and Ag) were screened, Paper II-III was focused on Ag nanoparticles while Paper IV was 
focused on CeO2 nanoparticles. The particular interest placed on the Ag nanoparticles is related 
to it having the highest manufacture among nanoparticles as well as incidence in consumer 
products, whereas the focus on CeO2 nanoparticles stemmed from its outstanding antioxidant 
properties and promising industrial as well as biomedical applications. All nanoparticles will 
be briefly introduced below with a more extensive discussion on Ag and CeO2 nanoparticles.  
1.5.1 Copper oxide nanoparticles 
Copper oxide (CuO) nanoparticles have semi-conductive as well as catalytic properties and 
have multiple industrial applications such as e.g. sensors, batteries, solar energy conversion 
(Karlsson, 2015a). Karlsson and colleagues found that CuO nanoparticles were more toxic than 
other metal oxide nanoparticles and were able to induce DNA damage (Karlsson et al., 2008). 
In addition, CuO nanoparticles generated oxidative stress and induced lung inflammation, 
effects that were correlated with their high dissolution (Zhang et al., 2012, Cho et al., 2013). 
Another study revealed that the acute lung inflammation following CuO exposure was resolved 
with time (4 weeks) leaving behind signs of lung fibrosis (Cho et al., 2010). There are accounts 
of a ‘Trojan horse’ effect for CuO nanoparticles by which the particulate form increases 
bioavailability of Cu ions, that in turn induce oxidative stress, disrupt the metal homeostasis 
and upregulate the expression of metallothioneins (Cuillel et al., 2014) as depicted in Figure 
10.  
Figure 9. Depiction of the hypothetical 'zeta potential theory’ by which metal and metal oxide 
nanoparticles induce lung inflammation. Reproduced from Cho et al., 2012, with permission from 
Oxford University Press. 
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1.5.2 Zinc oxide nanoparticles 
Zinc oxide (ZnO) nanoparticles bear properties that are appealing for industrial applications 
i.e. high chemical- and photo- stability as well as broad spectra of radiation absorbtion 
(Kołodziejczak-Radzimska and Jesionowski, 2014). As a result, ZnO nanoparticles are used in 
the electronic industry, in photocatalysis, as well as in the pharmaceutical and cosmetic 
industries (Kołodziejczak-Radzimska and Jesionowski, 2014).  George and colleagues reported 
that the toxicity of ZnO nanoparticles is mediated by the dissolved ions that trigger ROS 
generation, intracellular calcium flux, mitochondrial depolarization, and plasma membrane 
leakage; effects that were reduced by iron doping and consequent reduction in solubility 
(George et al., 2010). There are contradicting studies regarding the ‘Trojan horse’ effect of 
ZnO nanoparticles. One in vitro study in Jurkat cells showed that the extracellular release of 
Zn ions elicited a similar cytotoxic effect as the ZnO nanoparticles (Buerki-Thurnherr et al., 
2013), whereas another study reported that the effects of ZnO nanoparticles occur following 
particle uptake by BEAS-2B cells and subsequent dissolution (Gilbert et al., 2012). These 
inconsistencies could be explained by the use of different particles as well as cell systems that 
could also imply different cell media. Inhalation of ZnO nanoparticles was correlated with lung 
inflammation in vivo, that was again related to the dissolution and release of Zn ions (Cho et 
al., 2013, Cho et al., 2012, Zhang et al., 2012). ZnO nanoparticles are currently used as 
sunscreens with a reported low dermal penetration and toxicity when applied in form of a 
cream, however, there are potential hazards related to spray formulations that could result in 
inhalation of ZnO nanoparticles (Karlsson, 2015a).  
1.5.3 Titanium oxide nanoparticles 
Titanium oxide (TiO2) nanoparticles are currently used in food products and paints as pigments, 
as well as in sunscreen products for their UV reflective properties (Weir et al., 2012). The 
cytotoxicity of TiO2 nanoparticles is considered to be modest and was reported to occur only 
at high doses (Karlsson, 2015a). However, low-dose, long-term exposure to anatase TiO2 
nanoparticles induced cell transformation in BEAS-2B cells (Vales et al., 2015). In addition, 
Figure 10. CuO nanoparticles disturb metal homeostasis in hepatocytes. Reproduced from Cuillel et 
al., 2014, with permission from The Royal Society of Chemistry. (MET1: metallothionein 1, MFT1: 
metal regulatory transcription factor 1, ZNT1: Zn transporter 1, HMOX1: Heme Oxygenase 1) 
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TiO2 nanoparticles were found to inhibit DNA repair activity in A549 cells (Jugan et al., 2012). 
Rutile TiO2 nanoparticles have been shown to induce IL-1β secretion in vitro but did not result 
in lung inflammation following in vivo exposure in rats (Cho et al., 2013). The crystalline 
structure was found to be important for the photocatalytic properties of TiO2; anatase TiO2 
induced more DNA damage under light conditions as compared to the rutile form (Karlsson et 
al., 2015b, Di Bucchianico et al., 2016). Similar to ZnO nanoparticles, European Commission 
regards TiO2 nanoparticles as being safe when present in sunscreen products, however, it states 
that there is not sufficient data to establish safety recommendations for spray products 
(Karlsson, 2015a).  
1.5.4 Nickel oxide nanoparticles  
Nickel oxide (NiO) nanoparticles are used for various industrial applications such as catalysis, 
gas sensors, battery cathodes (El-Kemary et al., 2013) and exposure is likely to occur in 
occupational settings. Metallic nickel and nickel compounds are classified as carcinogenic to 
humans (Class 1A), however the IARC report identified differences between different forms 
of nickel, and stated that there is limited evidence for carcinogenicity for soluble nickel forms 
such as e.g. nickel sulfate and nickel chloride (IARC, 2012, 100C). According to the nickel ion 
bioavailability theory, the carcinogenicity of nickel compounds is related to the cellular uptake, 
subsequent dissolution and nuclear availability of nickel ions (Goodman et al., 2011). It is still 
unclear to which extent this theory applies to nickel nanoparticles. NiO nanoparticles have been 
reported to induce DNA damage following short-term exposure in A549 and BEAS-2B cells 
(Latvala et al., 2016, Kain et al., 2012). Exposure to NiO nanoparticles in vivo induced a 
distinct lung inflammation profile characterized by mild lung toxicity 24-hours post-exposure 
and severe toxicity accompanied by lymphocyte infiltration at 4-weeks post-exposure (Cho et 
al., 2010).  
1.5.5 Iron oxide nanoparticles  
Iron oxide (Fe3O4, Fe2O3) nanoparticles have a wide spectrum of applications, from catalysts, 
pigments and sensors to biomedical applications for diagnostic purposes (Karlsson, 2015a). 
Superparamagnetic iron oxide nanoparticles have been approved by the US Food and Drug 
Administration and are now in clinical use as contrast agents for magnetic resonance imaging 
(Li et al., 2013), which implies they are safe for systemic administration, however, the effects 
following inhalational exposure are less clear. In vitro studies report in general a low 
cytotoxicity with no DNA damage or ROS generation in A549 cells (Karlsson et al., 2008). In 
vivo studies are inconsistent and show either no lung inflammation following oropharyngeal 
aspiration in mice (Zhang et al., 2012) or inflammation in the alveolar region associated with 
macrophage infiltration following inhalational exposure in mice (Teeguarden et al., 2014).   
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1.5.6 Silver nanoparticles 
 Uses and exposure 
Ag nanoparticles are currently one of the most manufactured and used nanomaterials in 
consumer products (Vance et al., 2015), with an estimated production of 320 tons per year 
(Nowack et al., 2011). As a result of their antimicrobial properties, Ag nanoparticles are used 
in textiles, food industry, household products, paints, cosmetics and medical devices. Recently, 
Ag nanoparticles have gained attention for their bioimaging and allegedly chemotherapeutic 
properties (Sotiriou and Pratsinis, 2011, Wei et al., 2015). However, exposure to nanoscale Ag 
is not new as it has over a century of use in pigments, wound dressings and photographics, 
under the form/name colloidal Ag (Nowack et al., 2011). Despite this historical use of Ag, it is 
nevertheless expected that the occupational and environmental exposure to Ag nanoparticles 
will increase, in line with the increase production and use. In addition, new types of Ag 
nanoparticles are being manufactured, such as Ag nanowires that might pose new toxicological 
hazards (Stoehr et al., 2011).  
Exposure to large amounts of Ag in humans has been reported to induce argyria (discoloration 
of the skin) and argyrosis (discoloration of the ocular globe due to deposition of silver) but 
without associated clinical implications (Rosenman et al., 1979). The current occupational 
exposure limit (OEL) to airborne Ag is 0.01 mg/m3 for soluble Ag, and 0.1 mg/m3 for metallic 
Ag dust and fumes, and is expected to prevent argyria (Weldon et al., 2016). There are no 
official OELs for Ag nanoparticles but a recent study by Weldon et al. derived a OEL of 
0.19 µg/m3 based on sub-chronic inhalational exposure in rats (Weldon et al., 2016). As regards 
consumer exposure, the inhalational exposure is expected to be low as Ag nanoparticles are 
often found embedded in various matrices. However, there are specifically formulated spray 
products such as anti-odour and throat sprays for which inhalational exposure is of particular 
concern (Quadros and Marr, 2011).  
 In vitro studies 
The in vitro effects of Ag nanoparticles have been investigated in a large amount of studies that 
report on cytotoxicity, oxidative stress and genotoxicity, among others. Some of the common 
pitfalls of these studies is the use of poorly characterized materials as well as exposure to high 
doses of nanomaterials, sometimes deriving mechanistic information under cytotoxic 
conditions. In addition, considering the wide array of Ag nanoparticles tested with different 
sizes and coatings and the different cell types, it can be difficult to relate the results with each-
other.    
The size-dependent cytotoxicity of Ag nanoparticles, with smaller particles being more potent, 
has been well-established in cell models such as BEAS-2B (Wang et al., 2014), HepG2, HL-
60 (Avalos et al., 2014) and BALB/3T3 (Onodera et al., 2015) as well as in Paper II of this 
thesis. In Paper II we addressed some of the knowledge gaps at that time by using well-
characterized Ag nanoparticles. Our results showed that small, 10 nm Ag nanoparticles were 
more cytotoxic than larger nanoparticles, independent of the coating, polyvinylpyrrolidone 
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(PVP) or citrate, and that was likely related to the intracellular release of Ag. Similar effects 
were reported by Wang et al. who, in addition, also found coating dependent cytotoxicity with 
citrate coated 110 nm particles being more toxic than same-sized PVP particles (Wang et al., 
2014). This was explained by the inability of the citrate surface to coordinate the released Ag+ 
whereas the PVP coating allowed the formation of N-Ag+ and O-Ag+ complexes that reduced 
the Ag bioavailability and cytotoxicity (Wang et al., 2014). In the same study they correlated 
the Ag cytotoxicity with generation of ROS (Wang et al., 2014). 
Additional studies also involved ROS in the toxic effects of Ag nanoparticles. For example, 
Carlson et al. showed a size-dependent induction of ROS in rat alveolar macrophages with 15 
nm particles being more potent than 30 and 55 nm ones (Carlson et al., 2008). Some of these 
studies (Carlson et al., 2008, Wang et al., 2014) determined ROS under cytotoxic conditions 
which has questionable relevance, as it cannot be causally correlated with the induction of cell 
death. On the other hand, determining the ROS levels prior to cell death, under non-cytotoxic 
conditions could indeed unravel potential implications of ROS for the cytotoxic endpoint. 
Onodera et al. reported ROS generation as early as 5 min following exposure of BALB/3T3 
cells to 1 nm Ag nanoparticles (Onodera et al., 2015), however the observation was not 
quantitative. In another study Avalos et al. showed ROS generation, glutathione depletion but 
no alteration of the superoxide dismutase activity following exposure of HepG2, HL-60 cells 
to Ag nanoparticles (4.7 nm and 42 nm) (Avalos et al., 2014). In addition, the same study 
reported that the pre-treatment with N-acetyl-cysteine (NAC) rescued the cells from dying, 
allegedly linking oxidative stress induction by Ag nanoparticles to cytotoxicity (Avalos et al., 
2014). ROS generation by Ag nanoparticles was evaluated in Paper II.  
As regards in vitro genotoxicity, Ag nanoparticles have been reported to induce DNA damage 
observed by the comet assay in BEAS-2B cells (Nymark et al., 2013), human lung fibroblast 
cells (IMR-90) and human glioblastoma cells (U251) (AshaRani et al., 2009) as well as 
micronucleus in IMR-90 and U251 cells (AshaRani et al., 2009). The doses used by AshaRani 
and colleagues were, however, extremely high (up to 200 µg/mL). Another study by Foldbjerg 
et al. reported the formation of DNA adducts following Ag nanoparticle exposure in A549 
cells, which was correlated with increase in ROS levels, and was inhibited by pretreatment with 
NAC (Foldbjerg et al., 2011). Recently, Guo et al. performed an extensive cytotoxicity and 
genotoxicity assessment for a panel of well-characterized particles as well as ionic Ag using 
OECD tests (Guo et al., 2016). The results showed a size- and coating-dependent cytotoxicity 
and genotoxicity in the mouse lymphoma assay and the micronucleus test, with the smaller 
particles and the citrate coated particles being more potent (Guo et al., 2016). Genotoxicity of 
Ag nanoparticles has been tested in Paper I-III.  
There is increasing amount of evidence that the toxicity of Ag nanoparticles occurs via a 
‘Trojan horse’ mechanism that mediates Ag bioavailability with subsequent intracellular 
release of toxic ions (Park et al., 2010, Hsiao et al., 2015). In a recent review entitled ‘Silver 
nanoparticles – Wolves in sheep’s clothing?’ Foldbjerg et al. further looked into this theory 
(Foldbjerg et al., 2015) which is depicted in Figure 11. Upon cellular uptake, Ag nanoparticles 
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are reported to undergo fast dissolution with release of Ag+ that is first oxidized to Ag-O- 
followed by binding to thiol groups with the formation of Ag-S- (Jiang et al., 2015). The 
intracellular interaction of Ag with the thiol groups from proteins and peptides could result in 
a change of protein structure and functionality together with depletion of glutathione (as a result 
of binding the cysteine residue) (Foldbjerg et al., 2015). The high affinity of Ag towards thiol 
groups has been explored in the past, when Ag-based compounds were used to stain proteins 
(Merril, 1990). 
Despite a lot of research performed on Ag nanoparticles there are still many unknowns as 
regards their chronic effects. Thus far there is only one study that addressed the chronic effect 
of long-term (3 months), low-dose (pg/mL) exposure of human keratinocytes to Ag 
nanoparticles (50 nm), which reported induction of sustained cellular stress (activation of p38, 
increased Ki67 expression, and altered expression of stress related genes) (Comfort et al., 
2014). 
Figure 11. The 'Trojan horse' mechanism of toxicity for Ag nanoparticles. Reproduced from Foldbjerg 
et al., 2015, with permission from The Royal Society of Chemistry 
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 In vivo studies 
In general, in vivo studies report size-dependent lung inflammation following acute inhalation 
of Ag nanoparticles. For example, rats exposed nose-only to 15 nm and 410 nm Ag 
nanoparticles for 6 hours a day for 4 days, showed a significant lung inflammation for the 15 
nm particles 24-hours post-exposure, which resolved after 7 days (Braakhuis et al., 2014a). 
The reasons behind the size-dependent toxicity were attributed to the increased alveolar 
deposition (Braakhuis et al., 2014a). In a similar study, rats were exposed nose-only to 20 nm 
or 110 nm Ag nanoparticles for 6 hours and the results showed an inflammatory peak response 
7-days post-exposure which was more pronounced for the smaller particles, and that resolved 
with time (21- and 56-days post-exposure) (Silva et al., 2016). A similar pattern was observed 
after oropharyngeal aspiration in rats; 20 nm and 110 nm Ag nanoparticles induced acute lung 
inflammation at 40-hours post-exposure, with more potent effects for the 20 nm particles which 
was correlated to higher Ag+ release (Wang et al., 2014).  In addition, the same study showed 
an increase in neutrophil count and collagen content, indicative of early fibrosis for the 110 nm 
particles at 3-weeks post-exposure (Wang et al., 2014).  
A 28-day inhalation study on rats (6 hours/day, 5 days/week) at levels close to the Ag dust limit 
(0.1 mg/m3) reported no significant health effects of Ag nanoparticles sized 10-15 nm in terms 
of hematological and histopathological changes, despite significant Ag distribution in the liver, 
brain as well as olfactory bulb (Ji et al., 2007). A follow-up study by the same group reported 
that 90-day inhalational exposure (6 hours/day) performed according to the OECD guidelines 
to 18 nm Ag nanoparticles resulted in chronic alveolar inflammation and reduction of lung 
function (Sung et al., 2008) together with dose dependent bile-duct hyperplasia from which 
they derived a no-observed-adverse-effect-level (NOAEL) of 100 µg/m3 (Sung et al., 2009). 
Moreover, it was concluded that there was no micronuclei induction in the bone marrow of 
exposed animals (Kim et al., 2011), in the absence of data on the genotoxicity in the target 
organs, lung or liver. In addition, at the respective NOAEL, lung physiological alterations were 
still present and were found to be gender-dependent, the males being more sensitive. In an 
additional follow-up study using the same experimental setup, the authors found a persistent 
lung inflammation in male rats throughout a 12-week period of recovery post-exposure in the 
high exposure group (at doses above the NOAEL) (Song et al., 2013). These studies point out 
the importance of the duration of exposure but, thus far, there are no available in vivo studies 
on the chronic effects of Ag nanoparticles.  
It has recently been reported that following inhalational exposure, Ag nanoparticles can be 
transported to the brain, presumably via the olfactory bulb which could represent additional 
health hazards (Patchin et al., 2016). This is of particular relevance as non-cytotoxic 
concentrations of Ag nanoparticles could disrupt cytoskeletal organization and alter neurite 
extension in rat-derived cultured adult neural stem cells (Cooper and Spitzer, 2015). 
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1.5.7 Cerium oxide nanoparticles  
 Uses and exposure 
Cerium oxide (CeO2) nanoparticles (nanoceria) bear outstanding physico-chemical properties 
such as catalytic, oxidant/antioxidant as well as spectroscopic traits that make them appealing 
for industrial purposes such as e.g. polishing and catalytical agents, environmental remediation 
(Andreescu et al., 2014). In addition, nanoceria is used as a combustion catalyst in diesel fuel 
where it acts by increasing the combustion efficiency and consequently decreasing the emission 
of soot (Cassee et al., 2011). Apart from the industrial applications, nanoceria has gained 
interest for biomedical applications which are mainly driven by the broad range of antioxidant 
properties: superoxide dismutase mimetic, catalase mimetic, nitric oxide radical scavenger, 
peroxynitrite scavenger (Walkey et al., 2015). Exposure to nanoceria can be industrial (during 
synthesis and product manufacture), environmental (as a result of its use as a diesel fuel 
additive) and intentional (for potential biomedical applications). As regards intentional 
exposure, to date, no clinical trials have been approved with nanoceria.  
Environmental exposure to nanoceria, particularly via inhalation can occur as a result of its use 
as diesel additive (Cassee et al., 2011). Following nanoceria inhalation, the lung is the main 
target organ, however, translocation to other sites, and even brain (via the olfactory bulb) could 
occur. This latter mechanism has been confirmed for other nanoparticles such as Ag (Patchin 
et al., 2016), MnO (Elder et al., 2006) and ZnO (Kao et al., 2012). It was postulated that the 
addition of nanoceria as a diesel additive would reduce the CO2 emissions, the total particulate 
mass, aldehydes and several polycyclic aromatic hydrocarbons, however, these changes were 
correlated with an increase in ultrafine particle emission, nitric oxide species and 
benzo[a]pyrene (Zhang et al., 2013). On the other hand, inhalation studies on atherosclerosis-
prone mice indicated that exposure to exhaust fumes from fuel with nanoceria, actually had a 
protective effect against atherosclerosis induction, but lead to mild inflammation in the brain 
(Cassee et al., 2012). The same study noted a reduction both in the number and surface area of 
the diesel exhaust particles following addition of nanoceria (Cassee et al., 2012). Moreover, it 
was revealed that addition of nanoceria reversed the effects of exposure to diesel exhaust i.e. 
decreased the stress-responsive transcription factor AP-1 (Lung et al., 2014).  
 In vitro studies 
Nanoceria has been shown to have an antioxidant and anti-apoptotic effect in endothelial cells 
(Chen et al., 2013), in isolated rat pancreatic cells (Hosseini et al., 2013) and in U937 
monocytes and Jurkat cell lymphocytes (Celardo et al., 2011). The latter study revealed that 
the protective antioxidants effects were correlated with the presence of Ce3+/Ce4+ redox couple 
at the surface of the particles (Celardo et al., 2011). In addition, nanoceria provided antioxidant 
protection up to 7-days post-exposure in cardiac progenitor cells, without interfering with the 
cellular differentiation (Pagliari et al., 2012) and prevented UV-induced mutagenesis in Jurkat 
cells (Caputo et al., 2015). Nanoceria was also shown to prevent ROS generation and cell death 
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induced by cigarette smoke extract in rat embryonic myocytes by suppressing the NF-κB 
pathway activation (Niu et al., 2011).  
Nanoceria was reported to have neuroprotective effects in vitro by increasing neuronal survival 
in a human Alzheimer Disease model via modulation of the brain-derived neurotrophic factor 
pathway (D'Angelo et al., 2009) and by reducing ischemic cell death in a hippocampal brain 
slice model of ischemia (Estevez et al., 2011). In addition, nanoceria was shown to promote 
neuronal differentiation and dopamine secretion (Ciofani et al., 2013) along with alterations in 
the expression profile of genes involved in antioxidant defense (Ciofani et al., 2014).  
On the other hand, several studies have identified potential toxicological implications of 
nanoceria. For example, nanoceria was reported to induce apoptosis and oxidative stress in 
BEAS-2B cells (Park et al., 2008), which was later correlated with an induction of heme 
oxygenase-1 allegedly via the p38-Nrf2 signaling pathway (Eom and Choi, 2009). Similar 
effects were observed in human peripheral blood monocytes where nanoceria induced 
apoptosis and autophagy (Hussain et al., 2012) and in A549 cells where nanoceria lead to ROS 
mediated DNA damage and apoptosis, effects that were attenuated by treatment with the 
antioxidant NAC (Mittal and Pandey, 2014).  
 In vivo studies 
Some of the beneficial in vitro effects of nanoceria were also corroborated in vivo in a series 
of disease models. Nanoceria administered via peritoneal injections reduced the oxidative 
stress levels, had beneficial anti-angiogenic effects and reduced the size of the endometrial 
lesions in mice with endometriosis (Chaudhury et al., 2013). Nanoceria was reported to have 
similar anti-angiogenic effects and restricted tumor growth in a mouse model of ovarian 
cancer (Giri et al., 2013). Moreover, topical applications of nanoceria accelerated wound 
healing in mice by increasing cellular proliferation and migration (Chigurupati et al., 2013).  
In addition, several studies report neuroprotective effects following nanoceria treatment. 
Intravenous injections of nanoceria reduced ROS levels as well as apoptosis and decreased 
infarct volume in a rat brain ischemic stroke model (Kim et al., 2012). Following intravenous 
administration nanoceria crossed the blood-brain barrier, reduced ROS levels and diminished 
motor symptoms in a mouse multiple sclerosis model (Heckman et al., 2013). Moreover, 
nanoceria in combination with lenalidome, an anti-inflammatory drug, reduced 
demyelination and clinical symptoms in the same mouse multiple sclerosis model (Eitan et 
al., 2015). In addition, intravitreal administration of nanoceria had an anti-inflammatory and 
anti-angiogenic effect in a mouse model of age-related macular degeneration (Kyosseva et 
al., 2013), whereas systemic injection improved retinal response to light, slowed down the 
photoreceptor degeneration and reduced the retinal ROS levels in a mouse model of retinal 
degeneration (Kong et al., 2011b).  
On the other hand, Hardas et al. reported that a single intravenous administration of nanoceria 
(5 nm) induced pro-oxidant effects in the brain 30-days post-exposure in the absence of brain 
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translocation and that those changes were similar to the age- or Alzheimer disease-related 
effects (Hardas et al., 2012). In another study the same group revealed that a single intravenous 
administration of nanoceria (approx. 30 nm) elicited a hierarchical oxidative stress response in 
the rat hippocampus with a peak at day 30 and resolution at day 90 post-exposure (Hardas et 
al., 2014). The same study noted that the levels of nanoceria in the brain were very low and 
much of it could be attributed to the levels in the blood vessels perfusing the brain (Hardas et 
al., 2014). Moreover, in a similar experimental setup nanoceria was found to induce liver injury 
at day 30 and day 90 post-exposure in the form of granulomas (nanoceria loaded Kupffer cells 
and mononuclear cells) and increase blood levels of alanine aminotransferase (Tseng et al., 
2014).  
Apart from the potential toxicity, biodistribution is another problem that might stand in the way 
of nanoceria being used for clinical applications in neurodegenerative diseases. Yokel et al. 
investigated the biodistribution of different sized nanoceria (5, 15, 30, 55 nm) following 
intravenous administration and found that particles concentrated in the liver and the spleen with 
little amounts in the brain parenchyma and with minor differences between the sizes (Yokel et 
al., 2013).  
The reported discrepancies on the effects of nanoceria could be related to the different models 
and endpoints investigated, different range of doses as well as different physico-chemical 
properties of nanoceria used in these studies e.g. size, shape, surface charge and surface 
valence. It is known that the ratio Ce3+/Ce4+, which is responsible for some of the antioxidant 
properties, is negatively correlated with the size or the nanoparticles (Deshpande et al., 2005), 
and so is their hydroxyl radical scavenging activity (Xue et al., 2011). The percentage of Ce3+ 
at the particle surface was correlated with toxic outcome in Pseudokirchneriella subcapitata 
(aquatic organism model); particles with a higher (58%, 40%) percentage were toxic whereas 
particles with lower (36%, 38% and 26%) percentage of Ce3+ were not (Pulido-Reyes et al., 
2015). In addition, long-aspect ratio nanorods were more toxic than spherical nanoceria in a 
mouse lung model and gastrointestinal tract of zebrafish larvae (Lin et al., 2014). Surface 
chemistry was also found to be important and studies showed that coating of nanoceria with a 
layer of amorphous silica reduces lung inflammation and fibrosis in rats (Ma et al., 2015). Also, 
the reagents used during the manufacturing process can have an influence on the surface 
reactivity, catalytic properties and toxicity; hexamethylenetetamine (HMT) nanoceria was 
taken up more and was more toxic to HUVEC cells than H2O2 nanoceria or NH4OH nanoceria 
(Dowding et al., 2013). The same study indicated that nanoceria with high levels of Ce4+ at the 
surface (HMT and NH4OH nanoceria) exhibit phosphatase and ATPase activity (Dowding et 
al., 2013).  
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 AIM 
With the high increase in the manufacturing and use of nanomaterials, toxicological sciences 
need to evolve in order to address relevant safety concerns and to ensure the sustainable 
development of nanotechnology. The overall aim of this thesis was to address some of the 
challenges as well as knowledge gaps in nanotoxicology using in vitro models. To this end we 
explored a new method for mechanism-based screening (Paper I), we used well-characterized 
Ag nanoparticles in both short and long-term/low-dose exposure scenarios (Paper II and III) 
and we applied next generation sequencing for in-depth understanding of nanoparticle-cell 
interactions (Paper III and IV). 
The specific aims for each included project were: 
- to evaluate the suitability of new toxicological approaches i.e. the ToxTracker reporter 
stem cells lines, for rapid mechanism-based genotoxicity screening of a panel of metal 
oxide nanoparticles (Paper I); 
- to investigate the size- and coating-dependent acute toxicity of a panel of well-
characterized Ag nanoparticles in a human lung cell model (BEAS-2B) and to correlate 
their toxicity with parameters such as nanoparticle uptake, nanoparticle 
agglomeration/sedimentation as well as Ag release (Paper II); 
- to investigate the low-dose effects following chronic exposure of human lung cells 
(BEAS-2B) to Ag nanoparticles using conventional as well as systems toxicology 
approaches (Paper III); 
- to explore the effects of antioxidant CeO2 nanoparticles on neural stem cells with a 
focus on neuroprotection and neuronal differentiation using traditional toxicological 
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 METHODOLOGICAL CONSIDERATIONS 
In this thesis several methods and in vitro models were used in order to investigate the toxicity 
of nanoparticles as well as to correlate some of the observed effects with their physico-chemical 
properties. This section provides an overview of these methods and models with an emphasis 
on their advantages as well as their limitations. Detailed technical information is presented in 
the Materials and Methods section of the appended articles.  
 NANOMATERIALS 
The metal and metal oxide nanomaterials used in this thesis are summarized in Table 1.  







Coating Form Study References 
CuO 20 – 40   - powder I 
(Karlsson et al., 2008) 
Fe3O4 20 – 40   - powder I 
ZnO 20 – 200  - powder I 
TiO2 20 – 100  - powder I 
NiO 2 – 70  - powder I (Kain et al., 2012) 
Ag 
10  citrate 1 mg/mL dispersion 
 2 mM citrate  
I, II, III 
(Gliga et al., 2014) 
10 * PVP 1 mg/mL dispersion II 
40  citrate 1 mg/mL dispersion I, II 
75 * citrate 1 mg/mL dispersion II, III 
40 – 50   - powder II 
CeO2 
4 – 30  - powder I (Kain et al., 2012) 
6   - powder IV 
(Celardo et al., 2011) 
Sm- CeO2 13  - powder IV 
* OECD reference material; primary particle size was estimated by transmission electron microscopy in the 
corresponding references. 
 CELL MODELS 
Mouse embryonic reporter stem cells were used as a cell model in Paper I. Using mouse 
embryonic stem cells (mES) is advantageous as they are untransformed, have an indefinite 
potential for cell division, are proficient in relevant DNA damage response pathways and 
sensitive to DNA damage as well as oxidative stress (Hendriks et al., 2012). The reporter stem 
cells were developed for selected biomarker genes using green fluorescent protein (GFP)-
 32 
tagged fusion proteins located on bacterial artificial chromosomes, in this way preserving the 
physiological gene promoter and most of the regulatory elements (Hendriks et al., 2012). Three 
reporter stem cells were used: Bscl2-GFP which reports on direct DNA damage associated with 
stalled replication forks, Srxn1-GFP which reports on Nrf2 dependent oxidative stress and 
Btg2-GFP which is activated by p53 dependent cellular stress. These reporters were validated 
for a panel of genotoxic chemicals (Hendriks et al., 2012).  
The human lung bronchial cell line, BEAS-2B, was used in Paper II and III. BEAS-2B are 
bronchial epithelial cells isolated upon autopsy from healthy individual and immortalized by 
infection with the adenovirus 12-SV40 (Reddel et al., 1989). BEAS-2B are a transformed but 
non-tumorigenic cell line that upon injection into nude mice does not form tumors (Reddel et 
al., 1989). The cells are recommended to be cultured in serum free medium enriched with 
growth factors, because the presence of serum can induce squamous cell differentiation. BEAS-
2B cells are suitable for cell transformation studies induced by heavy metals (Park et al., 2015, 
Sun et al., 2011). In addition, BEAS-2B cells express the CD14 receptor and respond to 
lipopolysaccharides (LPS) by secreting cytokines (Verspohl and Podlogar, 2012), thus they can 
be useful for studying the innate immunity of bronchial cells. The cell culture media was shown 
to influence the cytokine secretion in response to LPS, metals and soil particles (Veranth et al., 
2008). In addition, cells grown in 5% serum conditions had a dramatically altered phenotype 
and were more sensitive to arsenic induced cytotoxicity as compared to serum free conditions 
(Zhao and Klimecki, 2015). A possible explanation could be given by the large number of 
common genes affected by both arsenic and FBS, which could result in a synergistic effect 
(Zhao and Klimecki, 2015). For particle research, the presence of serum in the culture media 
can additionally alter the toxic response due to the formation of the protein corona that in turn 
can affect the particle stability in cell media as well as the particle uptake. In the current projects 
BEAS-2B cells were grown on pre-coated dishes (collagen, fibronectin, albumin), in serum 
free conditions, supplemented with growth factors, as recommended by the manufacturer.    
In Paper IV we used the mouse embryonic stem cell line, C17.2, as a cell model. C17.2 cells 
are a multipotent neuronal progenitor cell line initially isolated from mouse cerebellum and 
immortalized by transfection with avian myelocytomatosis viral-related oncogene (v-myc) 
(Snyder et al., 1992). C17.2 cells can differentiate into a mixed culture of neurons and 
astrocytes and are suggested to be a good model for neurotoxicity testing (Lundqvist et al., 
2013). C17.2 cells can be grown in a proliferating state or they can be induced to differentiate 
by serum deprivation and N2 supplementation, with or without the addition of neuronal growth 
factors. In addition to C17.2 cells, some of the results were corroborated in human neural stem 
cells (hNPC). Neural stem cells are present during neuronal development but are also found in 
adult brains in stem cells niches, therefore, this model is relevant both from a developmental 
toxicology perspective as well as for neurotoxicity targeting the adult brain (Tofighi et al., 
2011).  
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 NANOMATERIAL CHARACTERIZATION 
A thorough nanomaterial characterization is critical for nanotoxicology studies and it can allow 
for correlations to be made between properties such as shape, size, agglomeration, purity and 
toxicological outcome. Unfortunately, not all studies report on particle properties, which makes 
it difficult to relate studies with each other. In this thesis an emphasis was placed on particle 
characterization as well as particle cellular uptake. The following section will shed light on 
some of the methods used to assess primary particle size distribution, agglomeration and 
stability in biological media as well as particle uptake.  
3.3.1 Particle size distribution 
Primary particle size is the size of the nanomaterials following their synthesis and before they 
are introduced in biological media. Some particles come in powder form or in concentrated 
stock dispersions. One of the methods used to estimate particle size in this thesis was by 
transmission electron microscopy (TEM). TEM is a two-dimensional high-resolution 
technique that can give reliable information of the particle size, shape and surface 
characteristics (Powers et al., 2012). A determining factor for this analysis is making sure that 
the sample is representative and that enough particles have been considered for the analysis. In 
Paper II we used TEM to confirm the primary size of Ag nanoparticles.   
Particle size distribution in cell media gives indications on particle agglomeration/aggregation 
as well as sedimentation and is commonly evaluated by dynamic light scattering (DLS) 
techniques. DLS is based on photon correlation spectroscopy and implies illuminating the 
sample with a laser and measuring the intensity of the scattered light, which is proportional to 
the particle diameter, that in turn is correlated with the hydrodynamic size of the particles 
(Fissan et al., 2014). DLS is a straight-forward measurement to perform but has limitations 
when it comes to poly-dispersed suspensions where larger particles screen out smaller ones, 
and is recommended to be accompanied by other techniques such as TEM, which are more 
reliable (Tomaszewska et al., 2013). In addition, in order to avoid multiple scattering, the DLS 
work should be performed on diluted samples. Some of these limitations (working with highly 
diluted and monodispersed suspensions) are overcome by the use of photon cross correlation 
spectroscopy (PCCS). PCCS employs a split in the incident laser beam into two beams that hit 
the sample at different angles, with the subsequent collection of the scattered lights by two 
detectors, followed by cross-correlation of the light intensities, and with the exclusion of the 
multiple scatter that does not cross-correlate (Xu, 2008). In addition to DLS techniques, one 
can use UV-Vis spectroscopy to characterize particle size distribution. Nanoparticles have 
distinct optical properties that change with e.g. size, shape, agglomeration and sedimentation, 
that can be easily acquired by UV-Vis spectroscopy (Tomaszewska et al., 2013). The UV-Vis 
technique has however similar limitations with the DLS technique in the sense that it is difficult 
to pick apart small particles from larger particles in poly-disperse suspensions (Tomaszewska 
et al., 2013). In Paper I and II we used a PCCS technique to characterize the particle size 
distribution and sedimentation over time in cell media whereas in Paper IV we used the 
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classical DLS approach. In addition, in Paper II the PCCS technique was complemented with 
UV-Vis spectroscopy.  
3.3.2 Particle dissolution in cell media 
The quantification of metal release from metal and metal oxide nanoparticles in cell media is 
important as it gives indications about the particle stability and the potential contribution of the 
released ions to the biological effects. In addition to cell media, particle dissolution can be 
tested in other physiologically relevant environments e.g. artificial lysosomal fluid (Paper II). 
Several methods were employed for this purpose: atomic absorption spectroscopy (AAS), 
inductively coupled plasma mass spectrometry (ICP-MS), inductively coupled plasma with 
optical emission spectroscopy (ICP-OES).  
The graphite furnace (GF)-AAS is technically superior than the classical flame AAS and it has 
improved sensitivity, however, it has a limited dynamic range and potential matrix effects from 
e.g. analyte retention on the graphite tube (Tyler, 2005). ICP-OES has better detection limits 
than GF-AAS but it is prone to spectral interferences, whereas ICP-MS has the best detection 
limits, a high linear dynamic range and allows for analysis of isotopes (Tyler, 2005). ICP-MS 
has known spectral interferences than can be accounted for, and, improved technologies using 
collision with e.g. He, can further minimize these interferences (Koppenaal et al., 2004). ICP-
MS techniques are prone to matrix effects that can be evaluated and overcome by matrix 
matching (preparation of the calibration standards in the same solution as the samples) and 
addition of an internal standard (e.g. In, Rh). Prior to the analysis, sample digestion is required 
for all mentioned techniques. Sample digestion is usually performed in acids (e.g. HNO3) and 
can be complemented with microwave or UV treatments. The ultimate goal is to ensure that all 
the organic molecules are mineralized and all the metal nanoparticles are dissolved. Sample 
digestion should be optimized for each type of nanoparticle and matrix. Ag might pose 
problems as an analyte due to the presence of Cl- in the cell media matrix that enables the 
formation of insoluble AgCl that can precipitate and bind to the plastic tubes. For Ag analysis, 
addition of HCl will ensure the formation of soluble AgCl2
- complexes that allow for a good 
analyte recovery. The same techniques can be used for analysis of cellular uptake that will be 
discussed below.  
In Paper I we used both AAS and ICP-OES techniques to determine the metal release in cell 
medium. In Paper II we used GF-AAS to determine the Ag release in cell medium over time 
and the cellular uptake. In Paper III and IV we used ICP-MS to evaluate the cellular uptake of 
nanoparticles.  
 CELLULAR UPTAKE OF NANOMATERIALS 
Transmission electron microscopy (TEM) is a well-established technique widely used to 
visualize the intracellular localization of nanomaterials. When using metal and metal oxide 
nanoparticles which have a high electronic density there is no need for heavy metal stains as 
the contrast is high enough between the nanoparticles and the cellular structures (Brown et al., 
2014). This approach allows for qualitative evaluation of the localization of the nanoparticles 
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inside the cells as well as intracellular particle agglomeration/aggregation, and to some extent 
can be used for quantitative purposes (Belade et al., 2012). It should be noted that the TEM 
sections have a width of 60 – 80 nm which implies that for larger particles artefacts can form 
during the cutting procedure, e.g. particles can smear and slide to other parts of the section. 
Intracellular uptake by TEM was evaluated in all papers appended to this thesis.  
Quantification of the cellular uptake was performed by the GF-AAS (Paper I, II) and by ICP-
MS (Paper III and IV). Cell washing prior to harvesting is a critical factor which ensures that 
most of the nanoparticles attached to the surface of the cells are washed away and will not skew 
the analysis. Another important aspect that has to be optimized is sample digestion. To note 
that following cell mineralization, the analysis provides information on the total metal content 
and cannot distinguish between metal nanoparticle and metal ions. Several techniques have 
been developed to separate Ag nanoparticles and ions that use Triton-X 114-based cloud point 
extraction (Yu et al., 2013) or magnetic separation (Mwilu et al., 2014).  
 CELL VIABILITY ASSAYS 
Lactate-dehydrogenase (LDH) assay detects the presence of LDH in the extracellular 
environment that leaks upon membrane damage that occurs in necrotic and late apoptotic cells. 
LDH is a cytosolic enzyme that is kept inside the cells when the cell membrane is intact. The 
enzymatic activity of LDH can be detected via a colorimetric assay in which the enzyme 
catalyzes an oxidative reaction that results in the formation of a red formazan compound; the 
half-life of the enzyme in the extracellular environment is estimated to be approx. 9 hours 
(Promega, 2016). The enzyme activity is usually determined in the supernatant but can be 
determined in the cells as well (upon lysis) to account for the total enzyme. Since it involves 
an enzymatic reaction this assay is prone to interference with the tested nanomaterials by 
oxidation or adsorbtion of the substrate, inactivation of the enzyme activity, nanomaterial 
absorbance in a similar wavelength (Han et al., 2011). The LDH assay was used in Paper II to 
assess the toxicity of Ag nanoparticles.   
Alamar blue assay is a cytotoxicity method that detects the metabolic activity of cells 
(Lancaster, 1996). Healthy cells maintain a reducing environment that can convert resorufin 
(blue, no fluorescence) to resazurin (red, fluorescent); the detection can be either by 
fluorescence or absorbtion, with a higher sensitivity for the fluorescence detection (Lancaster, 
1996). The metabolic activity of the cells is proportional to the health status as well as to the 
cell number, therefore Alamar blue can also be used as a proliferation assay. The principle is 
similar to the traditional tetrazolium dye (MTT) assay but it requires fewer steps and it 
maintains cell viability as it does not require cell lysis. Nanomaterials can interfere with the 
detection method and evaluation of this interference should be performed on a case by case 
scenario. For Ag nanoparticles this method was deemed to have low interference rates 
(Samberg et al., 2010). The Alamar blue assay was used in all studies from this thesis.   
Cell-IQ assay. The Cell-IQ is an automated live cell imaging platform (Chip-man 
Technologies) that can be used to acquire images over a wide time-frame, while the cells are 
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placed in an incubator with temperature and CO2 control; the images are then scored based on 
their morphology. The Cell-IQ assay was found suitable to assess the toxicity of carbon 
nanotubes (Meindl et al., 2013). In Paper IV we scored the cells in terms of dead cells, flat cells 
as well as mitotic cells and cell viability/cell death was deducted. This assay has the advantage 
of allowing for a time-dependent cell viability assessment. In Paper IV we used the Cell-IQ 
assay to evaluate the neuroprotective effects of nanoceria in the presence of an oxidative stress 
insult.   
 EVALUATION OF ROS GENERATION 
For the evaluation of intracellular ROS generation the dichloro-dihydro-fluorescein diacetate 
(DCFH-DA) assay was used. DCFH-DA is a lipophilic cell permeable compound that is de-
acetylated to DCFH2 and then converted to DCFH anion that can further be oxidized by ROS 
to DCF which is a fluorescent molecule that can be detected via fluorimetric techniques (flow, 
cytometry, microscopy, plate reader). DCFH reacts with hydroxyl, peroxyl, alkoxyl and 
carbonate radicals but to a lower extent with hydrogen peroxide (Kalyanaraman et al., 2012). 
Karlsson and colleagues argue that the DCFH-DA assay can reflect the lysosomal and 
mitochondrial membrane integrity since the dye is not able to diffuse through the organelle 
membrane; upon rupture/permeabilization, redox-active ions and cytochrome c are released 
into the cytoplasm and are available to interact with the DCFH probe (Karlsson et al., 2010). 
In addition, during apoptosis, cytochrome c is released from the mitochondria (Karlsson et al., 
2010) and might interfere with the assay if nanoparticles are tested at cytotoxic concentrations. 
The intracellular ROS generation was evaluated by DCFH-DA assay in Paper II and IV.  
In addition to the intracellular evaluation of ROS, this assay can be adjusted to detect ROS 
production under acellular conditions. As a result of their intrinsic surface reactivity, 
nanoparticles can oxidize the DCFH2 substrate (following chemical de-acetylation of the 
DCFH-DA probe).  Acellular generation of ROS was evaluated in Paper I.  
 GENOTOXICITY ASSESSMENT 
3.7.1 The comet assay 
The comet assay, or single cell gel electrophoresis, is a well-established method for 
quantification of DNA damage at a single cell level. Single cells are embedded in agarose and 
lysed, followed by DNA denaturation and electrophoresis. DNA fragments (negatively 
charged) from individual cells will migrate upon electrophoresis towards the positively charged 
anode and will subsequently appear as ‘comets’ upon visualization with fluorescent dyes. The 
quantification of the comets is commonly performed using a specific software by scoring at 
least 50 cells per gel. The results can be expressed using the tail lengths, % DNA in tail as well 
as the tail moment. Depending of the working pH, different classes of DNA damage can be 
detected as follows: in neutral conditions mainly double strand breaks, whereas under alkaline 
(pH>13) the comet assay can detect double- and single-strand breaks as well as alkali labile 
sites (oxidized bases, alkylated sites, intermediates in base excision repair) (Tice et al., 2000). 
A variant of the comet assay, employing formamidopyrimidine DNA glycosylase (FPG) can 
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be used to detect 8oxo guanine, a marker of oxidative DNA damage (Collins, 2004). The 
sensitivity of the comet assay is very high, and it can detect as low as 50 strand breaks per 
diploid mammalian cell (Olive and Banath, 2006). It should be noted that under cytotoxic 
conditions, apoptotic and necrotic cells can appear as ‘comets’ and confound the results (Tice 
et al., 2000). In addition, nanoparticles might interfere with the comet assay, for example by 
interacting with the FPG enzyme (Kain et al., 2012). The in vivo mammalian comet assay is 
part of the OECD guidelines (Test No. 489) for testing chemicals since 2014. The alkaline 
comet assay was used in Paper I – III, while the neutral and the FPG comet assay were 
additionally employed in Paper I.  
3.7.2 The micronucleus assay 
The micronucleus assay is a well-established assay to evaluate cytogenetic damage upon 
exposure to toxicants. Micronuclei are formed when whole chromosomes or acentric 
chromosomes fail to be included in the daughter nuclei, because they are unable to attach to 
the mitotic spindle and migrate towards the poles in anaphase (Fenech et al., 2011). The 
mechanisms behind micronuclei formation can consist of mis-repaired or unrepaired double 
strand breaks, defects in the kinetochore assembly, dysfunctional spindle or unresolved 
replication stress (Fenech et al., 2011). The cytokinesis-block micronucleus assay uses 
cytochalasin-B that inhibits cytokinesis and makes it possible to distinguish the cells that have 
undergone cell division as they will appear binucleated (Fenech, 2007). In this way the scoring 
can be performed only on binucleated cells and reduce the confounding effects of impaired 
kinetics of the cell division, thus restricting the scoring to the cells that were damaged during 
the cell exposure (Fenech, 2007). The micronucleus assay is part of the OECD guidelines for 
in vivo setups, Test No. 474: Mammalian Erythrocyte Micronucleus Test, and for in vitro, Test 
No. 487: In Vitro Mammalian Cell Micronucleus Test. Gonzalez and colleagues have reviewed 
the literature on the use of micronucleus assay for evaluating the genotoxicity of nanoparticles 
and have put forward some critical aspects such as: (i) cytochalasin treatment might interfere 
with the nanoparticle uptake and (ii) the necessity for cells to undergo mitosis, that would allow 
for closer contact between nanoparticles and chromatin, especially for the particles that do not 
cross the nuclear membrane (Gonzalez et al., 2011). In Paper III we used the flow cytometry 
version of the micronucleus assay which was previously validated against the ‘cytome’ 
microscopy version for genotoxicity testing of TiO2 nanoparticles (Di Bucchianico et al., 
2016). This flow cytometry version of the micronucleus assay allows for concomitant 
determination of cell cycle and cell viability.   
3.7.3 γH2AX and RAD51 foci formation 
Double strand breaks are the most deleterious type of DNA damage that if not repaired properly 
or in time can lead to genomic instability (Mah et al., 2010). Upon DNA double strand break 
induction, the histone variant H2AX is phosphorylated at the Ser-139 residue to form γH2AX 
foci that are involved in signaling and initiation of DNA repair (Mah et al., 2010). In addition, 
in mES, γH2AX can also occur at sites of single strand breaks as well as sites of chromatin 
relaxation (Banath et al., 2009). γH2AX was assessed in Paper I and II by fluorescence 
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microscopy. RAD51, another marker of double strand breaks, is a protein which has a critical 
role in DNA repair by homologous recombination (Daboussi et al., 2002). The formation of 
RAD51 foci was visualized by fluorescence microscopy in Paper I.  
3.7.4 The ToxTracker assay 
The ToxTracker assay (see Section 3.2 for details on the cell model) is a reporter cell system 
that was initially developed to screen and give mechanistic insight into the genotoxicity of 
chemicals (Hendriks et al., 2012). The assay can distinguish between different mechanisms of 
DNA damage i.e. stalled replication forks, oxidative stress and p53 dependent cellular stress, 
and allows for concurrent assessment of cytotoxicity. Another advantage is the increased 
throughput that allows for fast screening of several compounds at the same time. In Paper I we 
evaluated the suitability of the ToxTracker assay to test the genotoxicity of metal and metal 
oxide nanoparticles.  
 FLOW CYTOMETRY 
Flow cytometry allows for performing multiple measurements at a single cell levels by using 
a fluidics system that collects and evaluates single cells. Flow cytometry employs a laser beam 
that collides with the cells followed by light scattering that is collected along the same axis 
(forward scatter, gives information on the circumference of the cells) or at a 90° angle (side 
scatter, gives information on the intracellular structure of the cells) (Bakke, 2001). If 
fluorescent probes are used, they will be excited by the laser light and will give off a fluorescent 
signal that is recorded by a detector (Bakke, 2001). 
In nanotoxicology, flow cytometry can give indications on the nanoparticle uptake, which is 
correlated with an increase in intracellular granularity, that in turn results in shift in the side 
scattered light (Suzuki et al., 2007). In Paper I, flow cytometry was used to evaluate the GFP 
expression from the reporter stem cells; the evaluation was performed only on the gate 
corresponding to viable cells. In Paper III we used flow cytometry to evaluate the surface 
expression of E-cadherin and N-cadherin. The advantage of using flow cytometry in this 
context was the possibility to identify the percentage of cells which expressed these surface 
markers, thereby identifying distinct phenotypes. Moreover, in Paper III we used the flow 
cytometry version of the micronucleus assay to identify the potential of Ag nanoparticles to 
induce micronuclei or hypodiploid nuclei after long-term exposure. The flow cytometry 
version of the micronucleus assay has the advantages of being fast and medium throughput, 
however, as compared to the ‘cytome’ version it cannot identify the formation of nuclear buds 
and nucleoplasmic bridges, which are a measure of DNA amplification and chromosomal 
rearrangements, respectively (Nelson et al., 2016, Fenech et al., 2011).   
 ASSESSMENT OF CANCER-LIKE PHENOTYPES 
In Paper III we used cell migration, cell invasion and soft agar cell transformation assay in 
order to validate the RNA-Seq findings. For the migration and invasion assays we used a 
transwell approach. Briefly, cells are seeded on top of transwells with 8 µm pores, which are 
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either coated with the relevant coating for BEAS-2B cells (for the migration assay) or covered 
with a layer of matrigel (invasion assay). Cells are seeded in supplement free medium on the 
apical side of the transwell, while medium with supplements is added to the basal side, thus 
creating a nutrient/growth factor gradient. Cells with cancer-like phenotype will migrate and 
invade the transwell and attach to its bottom side. The migrating/invading cells can be stained 
and counted at the end of the experiment. The results can be expressed as the number of 
invading and migrating cells or by calculating the ‘invasion index’ (ratio invading/migrating 
cells) that indicates the specific contribution of cell invasion which is a relevant marker of 
metastasis (Albini and Benelli, 2007).  
The soft agar cell transformation is a well-established assay used to test the potential of cells 
to escape anoikis and form colonies in a 3D environment which is informative of carcinogenic 
cell transformation (Borowicz et al., 2014). Single cells are seeded in 0.3-0.5%, agar (37°C) 
and kept in the incubator for 2-3 weeks followed by evaluation of the number (and/or size) of 
the colonies. In addition, colonies can be recovered in order to establish treatment-related 
transformed cell lines (Sun et al., 2011) in this way performing a phenotypic selection and 
reducing the effect of cell culture heterogeneity. In Paper III we resumed at counting the 
transformed colonies.  
Cell migration, cell invasion and soft agar cell transformation assay have been previously used 
to assess cancer-like phenotype induced by nanomaterials e.g. SWCNTs (Luanpitpong et al., 
2014), MWCNTs (Vales et al., 2016) and TiO2 nanoparticles (Vales et al., 2015).  
 EVALUATION OF NEURONAL DIFFERENTIATION 
In Paper IV we investigated the neuronal differentiation of C17.2 cells and human neural 
progenitor cells (hNPC). Both C17.2 and hNPC cells undergo differentiation following serum 
deprivation and addition of N2 supplement (transferrin, insulin, progesterone, putrescine, 
selenite). The evaluation of neuronal differentiation was performed after 7 days for C17.2 cells 
and after 4 days for hNPC and was based on a conventional immunofluorescence technique 
using β3-tubulin as a neuronal marker. Fluorescence images were taken using at least 6 fields 
per slide and scored thereafter. The scoring was based on staining intensity as well as neuronal 
morphology and the results were expressed as percentage neuronal differentiation as compared 
to the total number of cells (evident from the 4',6-diamidino-2-phenylindole - DAPI nuclear 
staining).    
 CYTOKINE ANALYSIS 
In Paper III, the cytokine secretion was evaluated using a multiplex assay (Luminex – BioRad) 
that allows for detection of multiple analytes in one sample, thus providing a comprehensive 
picture of the cytokine profile. The assay is based on a capture sandwich immunoassay with 
capture antibodies coupled with fluorescently dyed magnetic beads and biotinylated detection 
antibodies, which can allow for detection by streptavidin-phycoerythrin (de Jager et al., 2003). 
The detection is performed with a flow-cytometer which can quantify the fluorescence 
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corresponding to each bead color, which is in turn specific for each analyte. The following 
cytokines were analyzed: IL-1β, IL-1ra, IL-6, IL-8, IL-10, TNF-α and MIP-1α.  
 OMICS APPROACHES 
3.12.1 RNA-Sequencing 
RNA-seq is a novel technology that allows for identification and robust quantification of RNA 
transcripts in biological samples. In contrast to previous transcriptomic techniques such as 
microarray, RNA-Seq provides a resolution at single base level, low background noise, high 
dynamic range (>8000 fold) and is able to distinguish different isoforms and allelic expression 
(Wang et al., 2009). The main steps in an RNA-Seq experiment are discussed below and 
illustrated in Figure 12 (Illumina, 2016).  
A. cDNA library construction  
B. cluster amplification 
C. sequencing by synthesis (for the Illumina platform) 
D. mapping and estimation of the abundance for each gene 
Briefly, the library construction starts with the reversed transcription of the RNAs to cDNA 
and subsequent double strand (ds) cDNA synthesis; next, adaptors (oligonucleotide sequences) 
specific for each library will be ligated to both ends of the ds cDNA, followed by polymerase 
chain reaction amplification of the library using adaptor sequences as primers; the final step is 
the quality control, normalization and pooling of the libraries (Korpelainen, 2014).  
After library construction, the ds cDNA is hybridized on a flow cell based on the 
complementarity with adaptor sequences resulting in the formation of so-called ‘bridges’ that 
will be further amplified to generate clusters. Next, one strand from the ds cDNA clusters is 
removed to enable the sequencing per se. The Illumina platform employs the sequencing by 
synthesis approach which implies a series of additions of fluorescently labelled nucleotides and 
imaging of the fluorescence signal (Illumina, 2016). The sequencing can be performed either 
at one end of the cDNA (single read mode) or from both ends (paired-end read mode). Using 
paired-end read modes can make the analysis more robust and reduce potential biases from the 
library preparation process (Korpelainen, 2014). Following sequencing, the transcripts are 
mapped to a reference genome (if that is available) and the expression level of a gene is 
determined by the number of reads that are mapped to it by alignment (which are named 














Figure 12. Next-generation sequencing overview. Reproduced from (Illumina, 2016) with permission from Illumina.  
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3.12.2 DNA methylation array  
In Paper III we investigated the genome-wide changes in DNA methylation array using the 
Infinium Human Methylation450 Bead chip. The Illumina Infinium assay is a multiplex 
technology based on bisulfite conversion of genomic DNA; upon bisulfite treatment 
unmethylated cytosines are converted to uracil, which changes their base-pair binding, whereas 
methylated cytosines are protected from conversion (Illumina, 2012). Following conversion, 
each locus is tested by using two probes, one against methylated and the other against 
unmethylated cytosines; the relative methylation (β value) is calculated as the ratio of signal 
for the methylated probe against the total signal intensity for that locus (Illumina, 2012). The 
Illumina Human Methylation450 is a widely used assay for epigenome-wide association 
studies with probes covering 99% of the reference sequence genes (Morris and Beck, 2015). 
Some of the issues with this technology could be the batch effect and the incomplete bisulfite 
conversion, which is common to all bisulfite-based methods (Dedeurwaerder et al., 2011). The 
differential methylation analysis was performed using RnBeads package on Bioconductor, 
which is a well-established tool for DNA methylation analysis (Assenov et al., 2014).  
3.12.3 Bioinformatics analysis of ‘omics’ data 
‘Omics’ experiments generate immense amounts of data that require further analyses to extract 
significant differences between the experimental conditions, as well as to put those 
observations into a biological context. For the RNA-Seq experiments, after identification of the 
abundance of gene expression, the next step is to identify the genes that are significantly 
differentially expressed between the samples. In toxicology, a common comparison is done 
between the treated and untreated samples. There are several methods to perform the 
differential gene expression analysis, most of which are available as packages in the 
Bioconductor project (Gentleman et al., 2004). In this thesis we used the DESeq2 package for 
Paper III and the limma package for Paper IV. The DESeq2 package uses counts as input data 
and a negative binomial approach (Love et al., 2014), whereas limma uses a linear model for 
which the count data needs to be transformed to continuous values (Ritchie et al., 2015). 
Next, the differentially expressed genes need to be put into the biological context by performing 
a set of downstream analyses. In Paper III and IV we used Ingenuity Pathway analysis software 
to perform canonical pathway analysis as well as network analysis to identify the biological 
pathways and networks that were significantly altered in the dataset. For certain pathways, 
activity scores are available that indicate whether the pathway is activated or inhibited by the 
treatment of interest. Gene ontology (GO) enrichment is another type of downstream analysis 
that identifies significantly enriched ontologies for three domains, namely, biological process, 
cellular component and molecular function. In Paper IV we used the online tool GOEast which 
employs a Fischer exact test and an improved weighted scoring algorithm (Zheng and Wang, 
2008) and has the advantage that it enriches the lower and most biologically specific 
hierarchical levels of the GO tree, thereby aiding interpretations of the results. These analyses 
are valuable for describing the data in an unbiased way and set the stage for hypothesis 
generation which can take into account previous knowledge on the topic. However, generating 
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a new hypothesis is merely the first step, and experimental validation of the RNA-Seq data 
critical for drawing sound conclusions. Experimental validation can be performed either at the 
protein level or at the functional level. The correlation between mRNA and protein levels was 
reported to be as low as 40% (Vogel and Marcotte, 2012). A suggested explanation is that 
transcription acts more like an on-off switch, whereas post-transcriptional and translational 
events together with the regulation of protein degradation finely-tune the process, thereby 
playing an important role in controlling the protein levels (Vogel and Marcotte, 2012). These 
new hypotheses should be further tested experimentally. In Paper III our focus was 
carcinogenicity and we therefore selected relevant pathways such as Hepatic fibrosis and 
Regulation of epithelial-mesenchymal transition pathway. In addition, the Acute phase 
response signaling pathway was also selected for further experimental validation. In Paper IV, 
the RNA-Seq data confirmed the reduction of β3-tubulin that was previously observed 
experimentally, but also revealed gene expression alteration of additional genes from the 
neuronal differentiation network. Moreover, the RNA-Seq aided in the generation of a new 
hypothesis based on the interaction with the cytoskeletal organization, that was further 
validated experimentally.  
 SUPER-RESOLUTION MICROSCOPY TECHNIQUES 
In Paper IV we used two super-resolution microscopy techniques, namely, structured 
illumination microscopy (SIM) and stimulated emission depletion (STED) microscopy to 
visualize the structure of the neuronal growth cones. STED microscopy uses selected 
stimulated depletion of fluorescence which allows the fluorescence to take place within a 
nanoscale area of the sample, resulting in much sharper images with a maximum resolution of 
20 to 50 nm (Blom and Brismar, 2014). STED is a useful tool in cellular imaging and its uses 
are expected to increase in the future (Blom and Widengren, 2014). An advantage of STED 
imaging is that there is no need for image processing, even though that can be done to enhance 
the contrast (Blom and Brismar, 2014). In SIM microscopy the sample is illuminated in a series 
of sinusoidal stripped patterns which when encounter fine structures in the sample, lead to the 
formation of interference patterns that are acquired and further mathematically processed to 
give a high-resolution image (Schermelleh et al., 2010). In contrast to STED, which can require 











 PAPER I: REPORTER STEM CELLS CAN PROVIDE RAPID MECHANISTIC 
INSIGHT INTO THE TOXICITY OF METAL OXIDE NANOPARTICLES  
The rapid increase in the manufacture and use of nanomaterials stimulates the development of 
tools for rapid toxicity screening. ToxTracker is one such tool, that consists of a panel of GFP-
tagged mouse embryonic stem cells that report on different pathways of toxicity and that was 
previously developed to screen for the toxicity of chemicals (Hendriks et al., 2012). The panel 
consists of three cell lines: Bscl2-GFP (reports on direct DNA damage associated with stalled 
replication forks), Srxn1-GFP (reports on Nrf2 dependent oxidative stress) and Btg2-GFP 
(activated by p53 dependent cellular stress). The different GFP reporters are combined in one 
assay and the readout is performed by flow cytometry (Figure 13).  
The aim of this study was to test whether ToxTracker assay can be used to screen for 
genotoxicity of a panel of well-characterized metal (Ag) and metal oxide (CuO, ZnO, NiO, 
CeO2, Fe3O4, TiO2) nanoparticles. In addition, we used quartz material DQ12 as an insoluble 
benchmark particle, diesel particles (standard reference material SRM1650b) and MWCNTs.  
First we performed a comprehensive characterization of the nanomaterials which included size 
distribution measurements, metal release in cell medium, acellular ROS and particle cellular 
uptake. Our results indicated that all particles were taken up by the mouse stem cells and 
Figure 13. The ToxTracker tool for rapid genotoxicity screening of chemicals and nanomaterials. 
Reproduced from Karlsson et al., 2014 (Paper I).  
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dissolved to various extents in cell medium. ZnO and CuO dissolved to the highest extent in 
cell medium whereas NiO and CuO nanoparticles were the most efficient in generating ROS 
under acellular conditions. 
Next we used the ToxTracker panel to test a range of doses for each nanoparticle following 
24 hours of exposure. Our results indicated that Srxn1, the oxidative stress reporter, was 
activated by CuO and NiO nanoparticles whereas the Btg2, the p53 reporter, was activated only 
by NiO. None of the nanoparticles activated the Bscl2, the DNA replication stress reporter. For 
ZnO nanoparticles the activation of Srxn1 occurred at highly toxic doses which deemed the 
results inconclusive. We then proceeded to validate the ToxTracker response with conventional 
DNA damage assays (FPG-comet assay, RAD51 and γH2AX foci induction). The results 
indicated that CuO nanoparticles predominantly induced DNA damage in the form of single 
strand breaks and oxidative DNA lesions, whereas NiO nanoparticles predominantly induced 
single strand breaks, in line with the ToxTracker observations.  
Our follow-up aim was to test to which extent the released metal ions played a role in the 
observed ToxTracker effects. We therefore tested a series of metal salts corresponding to the 
nanoparticles that had a positive effect (CuO, NiO, ZnO). The results indicated that, for CuO 
nanoparticles the activation of Srxn1 was mainly an ionic effect (due to the extracellular release 
of toxic Cu ions), whereas for NiO nanoparticles the Srxn1 and Btg2 activation was a particle 
effect. The results for ZnO were again inconclusive due to the high toxicity.  
Finally, in order to benchmark the ToxTracker response we investigated the effect of quartz 
particles, diesel reference material and MWCNTs. Exposure to quartz activated the oxidative 
stress reporter, Srxn1, in line with previous findings (Schins et al., 2002). However, neither 
diesel particles nor MWCNTs activated the ToxTracker reporters.  
In summary, we demonstrated that the ToxTracker assay is a suitable medium/high-throughput 
tool for genotoxicity screening of metal oxide nanoparticles. In addition, the ToxTracker assay 
provided mechanistic information on the modes of genotoxicity: the DNA damage induced by 
CuO and NiO was mainly related to oxidative stress and not direct DNA interaction. Moreover, 
NiO also induced p53 activation suggesting additional reactivity and cellular stress. The 
response to CuO nanoparticles was mediated by the extracellularly released ions, whereas for 
the NiO nanoparticles the toxic effect was particle-mediated. Finally, the suitability of the 
ToxTracker assay for carbon-based nanomaterials requires further investigation.   
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 PAPER II. SILVER NANOPARTICLES INDUCE A SIZE-DEPENDENT 
CYTOTOXICITY FOLLOWING SHORT-TERM EXPOSURE OF BRONCHIAL 
EPITHELIAL CELLS 
Ag nanoparticles are currently one of the most manufactured and used nanomaterials. At the 
time this study was conducted (2013-2014) there were already a multitude of toxicological 
studies on Ag nanoparticles. However, these studies reported contradicting results and the issue 
of size-dependent toxicity hadn’t been resolved. The reasons behind the lack of consistency 
between the studies could be attributed to the different cell models and nanoparticles (size, 
shape, coating) used, different particle purity, absence of reference materials and in general a 
lack of thorough particle characterization in cell medium.   
In this study the aim was to address the size-dependent toxicity of thoroughly characterized Ag 
nanoparticles in human lung cells (BEAS-2B). To this end we selected a panel of five Ag 
nanoparticles with different sizes and coatings out of which two were OECD reference 
materials: 10 nm OECD PVP-coated, 10 nm citrate-coated, 40 nm citrate-coated, 75 nm OECD 
citrate-coated and 40-50 nm uncoated.  
First we performed a thorough characterization of the nanoparticles both in water and in cell 
medium in terms of primary size, agglomeration as well as sedimentation by means of TEM, 
PCCS and UV-Vis spectroscopy. The results indicated that all particles agglomerated with time 
in cell medium and that the PVP-coated particles were more stable than the citrate-coated 
particles. Next we investigated acute cytotoxicity following short-term exposure (4 and 24 
hours) using two assays, Alamar blue and LDH assay. After 24 hours, only the 10 nm 
Ag nanoparticles (PVP- and citrate-coated) were cytotoxic in both assays, indicating a clear 
size-dependent toxicity. 
The following endpoint of interest was DNA damage and for that we used non-cytotoxic doses 
of Ag nanoparticles and performed comet assay as well as imaged γH2AX foci induction. Our 
results indicated that all Ag nanoparticles induced DNA damage in the comet assay after 24 
hours, independent of size or coating and in the absence of γH2AX foci. This suggested that 
that DNA damage was more likely to be in the form of single strand breaks and/or oxidized 
bases. In addition, the induction of DNA damage was not size-dependent suggesting distinct 
mechanisms for cytotoxicity and genotoxicity. To test whether oxidative stress could be 
involved in the observed cytotoxicity and DNA damaged, we performed the DCFH-DA assay 
and we found that neither of the Ag nanoparticles increased the generation of intracellular ROS.  
Next we examined additional possible mechanisms for the observed size-dependent toxicity 
and proceeded to quantify cellular uptake together with the uptake mechanisms (by AAS), 
image intracellular localization (by TEM) and Ag released in cell medium (by AAS). Our 
results indicated that all Ag nanoparticles were taken up to a similar extent by a combination 
of active uptake mechanisms (clathrin- and caveolin-mediated endocytosis, macropinocytosis) 
with localization in membrane-bound structures inside the cytoplasm. Moreover, all tested 
Ag nanoparticles released Ag in the cell medium in a time-dependent way, with the 10 nm 
citrate- and PVP-coated particles having the highest release after 24 hours. Our next question 
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was whether this high (approx. 20%) extracellular release of Ag from the 10 nm Ag 
nanoparticles could explain the observed cytotoxicity. To this end we tested the toxicity of the 
released fraction and found that the extracellular release of Ag did not play a role in the 
cytotoxicity of the 10 nm Ag nanoparticles.   
In summary, in this study we used a panel of well-characterized Ag nanoparticles to address 
their size-dependent toxicity in BEAS-2B cells. Our results indicated that the 10 nm Ag 
nanoparticles were more toxic than their larger counterparts, independent of the coating and at 
similar intracellular concentrations. We also found evidence that the 10 nm Ag nanoparticles 
released considerably more Ag in cell medium and we speculated that this pattern could follow 
inside the cytoplasm as well. Finally, our results are in line with the ‘Trojan horse’ hypothesis 
by which the particle form promotes the uptake thereby increasing the intracellular 
bioavailability of toxic metals.   
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 PAPER III. LOW-DOSE, LONG-TERM EXPOSURE TO SILVER 
NANOPARTICLES INDUCES A CANCER-LIKE PHENOTYPE IN 
BRONCHIAL EPITHELIAL CELLS 
While there are a multitude of studies on the acute effects of Ag nanoparticles, there is currently 
scarce data on their long-term effects both in vitro and in vivo. Nevertheless, long-term studies 
are critical for evaluating complex processes such as carcinogenesis which develops over time. 
To our knowledge, only one in vitro study addressed the chronic effects of Ag nanoparticles 
and found that Ag nanoparticles in the pg/mL range induced a sustained stress response and 
modified cell functionality following 14-week exposure of the HaCaT keratinocyte cell line 
(Comfort et al., 2014).  
In this study the aim was to address the knowledge gaps related to long-term exposure to Ag 
nanoparticles, from an inhalational exposure perspective. To this end, we designed a long-term, 
low-dose, in vitro experimental setup where BEAS-2B cells were exposed for 6 weeks to low-
doses (1 µg/mL) of well-characterized Ag nanoparticles (10 and 75 nm) (Figure 14). We used 
a combination of conventional toxicology assays to address endpoints such as e.g. cell 
proliferation, genotoxicity, cell transformation together with ‘omics’ approaches such as RNA-
Seq and genome-wide DNA methylation.  
The results indicated that Ag nanoparticles altered cell proliferation in a time- and size-
dependent way, with the 10 nm Ag nanoparticles being more potent than the 75 nm particles. 
In addition, only the 10 nm Ag nanoparticles induced DNA damage measured by the alkaline 
version of the comet assay after 3 and 6 weeks of exposure, but none of the particles had 
clastogenic or aneuploidogenic effects as indicated by the micronucleus assay. Moreover, there 
was a clear size-dependent effect in terms of the number of differentially expressed genes 
Figure 14. Experimental setup of study III. 
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(DEGs) following RNA-Seq after 6 weeks of exposure (1717 DEGs for the 10 nm Ag versus 
21 DEGs for the 75 nm Ag). The low number of DEGs for the 75 nm Ag nanoparticles 
precluded further analysis. Next we performed pathway analysis of the RNA-Seq data for 10 
nm Ag nanoparticles using the Ingenuity Pathway Analysis tool and identified a series of 
altered pathways, out of which three pathways were considered for further validation: Hepatic 
fibrosis, Regulation of epithelial-mesenchymal transition (EMT) pathway and Acute phase 
response signaling pathway. The initial focus of the study was to identify cancer related 
alterations induced by chronic exposure to Ag nanoparticles, which was important criteria for 
the pathway selection.  
The Hepatic fibrosis pathway was altered in a way consistent with pathway activation evident 
from the up-regulation the gene expression of 7 out of 8 collagen related genes as well as of 
TGFβ1, an important pro-fibrotic factor, among others. For the experimental validation of this 
pathway we determined the soluble collagen secreted in the cell medium as well as the collagen 
deposited on the well plates after 6 weeks of exposure (5 days from the last re-seeding). Our 
results showed that both Ag nanoparticles altered the collagen kinetics by increasing the 
collagen deposition, which is an indication of pro-fibrotic potential.  
Next, the RNA-Seq data revealed that the Regulation of EMT pathway was also activated as 
defined by cadherin switching (down-regulation of CDH1 and up-regulation of CDH12) as 
well as up-regulation of genes correlated to EMT induction (TGFβ1, NOTCH3, MMP2, 
MRAS). The experimental validation of this pathway consisted of determination of soft agar 
cell transformation, cell migration and invasion as well as E- and N-cadherin surface markers. 
The results indicated that the 10 nm Ag nanoparticles induced cell transformation already after 
3 weeks and that both nanoparticles had this effect after 6 weeks. In addition, both particles 
increased the invasion index (albeit only significant for the 75 nm particles) and induced 
cadherin switching.  
Finally, the Acute phase response signaling pathway had an activity pattern consistent with 
pathway inhibition characterized by down-regulation of the gene expression of IL-1α, IL-1β, 
IL-18, MYD88 and SAA2, among others. For the experimental validation of this pathway we 
determined the cytokine secretion in response to bacterial LPS using a multiplex assay. Results 
indicated that exposure to Ag nanoparticles reduced the secretion of pro-inflammatory 
cytokines (IL-1β, IL-6, IL-8 and TNF-α) following LPS treatment, which is in line with the 
RNA-Seq data.   
In summary, our results indicate that low-dose chronic exposure to Ag nanoparticles can induce 
a cancer-like phenotype in BEAS-2B cells, characterized by cell transformation, EMT and 
fibrosis and that these effects occur independent of alterations in the DNA methylation pattern. 
In addition, we show that Ag nanoparticles can have immunosuppressive effects by reducing 
the cytokine secretion in response to LPS, which is of concern considering the biomedical 
applications of Ag nanoparticles.  Ultimately, we show that traditional toxicological assays can 
be complemented with ‘omics’ techniques to provide a comprehensive understanding of how 
nanoparticles perturb cellular functions.  
 50 
 PAPER IV. ANTIOXIDANT CERIUM OXIDE NANOPARTICLES SUPPRESS 
DIFFERENTIATION OF NEURAL STEM CELLS 
CeO2 nanoparticles display catalytic antioxidant activity that makes them appealing for both 
industrial and biomedical applications (Andreescu et al., 2014, Walkey et al., 2015). CeO2 
nanoparticles have been shown to have neuroprotective effects in vitro (D'Angelo et al., 2009, 
Estevez et al., 2011) and beneficial effects in animal models of neurodegenerative diseases 
(Kim et al., 2012, Heckman et al., 2013). Since oxidative stress has been associated with a 
series of neurodegenerative diseases (Andersen, 2004), antioxidant therapies have been 
considered as treatment options (Uttara et al., 2009). On the other hand, reactive oxidative 
species play an important role as mediators during neuronal development (Kennedy et al., 
2012), which raises concern over the potential neurotoxic effects of antioxidants.  
With this is mind, our aim was to investigate the effects of antioxidant CeO2 nanoparticles on 
neural stem cells (C17.2). Our initial goal was to assess the antioxidant, neuroprotective effect 
of CeO2 nanoparticles in this model using traditional assays. The next goal was to evaluate the 
effects of CeO2 nanoparticles on the neuronal differentiation of C17.2 cells using both 
traditional and ‘omics’ technologies, namely RNA-Seq. Samarium -doped CeO2 (Sm-CeO2) 
nanoparticles, which bear a reduced antioxidant activity, were used as a particle control. In 
addition, NAC was used as a conventional antioxidant control.  
First, by using TEM and ICP-MS we confirmed that both CeO2 and Sm-CeO2 nanoparticles 
were taken up by proliferating C17.2 cells without cytotoxicity. Then, we used 2,3-dimethoxy-
1,4-naphthoquinone (DMNQ) as an oxidative stress challenge and evaluated the ROS 
generation (DCFH-DA assay) as well as cell viability (automated microscopic morphological 
assessment). Our results showed that CeO2, but not Sm-CeO2 reduced the ROS generation 
following DMNQ exposure, suggestive of an antioxidant affect. In addition, CeO2, but not Sm-
CeO2 reduced the cell death induced by DMNQ after an early time-point (8 hours), again 
suggestive of an antioxidant effect. However, at longer time-points (12 hours) none of the 
particles had any effect on reducing DMNQ induced cell death which indicates that the 
neuroprotective effect was in essence a delay of cell death and was not correlated with cell 
recovery.  
Next we focused on the effects of CeO2 nanoparticles on the differentiation of C17.2 cells, 
which was induced by serum deprivation and addition of N2 supplement. We evaluated 
neuronal differentiation after 7 days using immunofluorescence staining of β3-tubulin (TuJ1) 
as an early neuronal marker. Our results showed that that CeO2 reduced neuronal differentiation 
at all tested doses (10 – 50 µg/mL) whereas Sm-CeO2 reduced neuronal differentiation only at 
the highest tested dose (50 µg/mL). This again is suggestive of an antioxidant effect since Sm-
CeO2 retains a small antioxidant effect that could be enough to inhibit neuronal differentiation 
at higher doses. However, we cannot exclude the contribution of a particle, antioxidant-
independent effect. NAC, the conventional antioxidant, suppressed neuronal differentiation 
and was proven to be a good control for this endpoint. In addition, we corroborated our results 
on neuronal differentiation in human progenitor stem cells. 
  51 
In order to further explore these observations, we decided to perform RNA-Seq at different 
time-points during differentiation (undifferentiated – day 0, day 1 and day 7) (Figure 15).  
The RNA-Seq downstream analysis using Ingenuity Pathway Analysis tool revealed that both 
CeO2 and NAC, but not Sm-CeO2 altered the neuronal differentiation network in line with the 
immunofluorescence data. In addition, CeO2 and NAC interfered with axonal guidance 
signaling as well as neuroglial differentiation in a way consistent with pathway inhibition. All 
these observations suggest that antioxidant properties play a role in the observed effects. On 
the other hand, both nanoparticles but to a lesser extent NAC interfered with networks related 
to ‘Cellular assembly and organization’ suggestive of a particle effect. To further validate these 
findings, we used super-resolution microscopy (SIM and STED) to visualize the cytoskeletal 
structure of the neuronal growth cones, which are essential for axonal guidance and 
pathfinding. The results confirmed the particle effect; the growth cones were smaller and less 
likely to have the typical triangular morphology following nanoparticle treatment.  
In summary, in this study we combined conventional assays with ‘omics’ as well as super-
resolution imaging to reveal the dual effects of CeO2 nanoparticles. On one hand, CeO2 
nanoparticles had a temporary protective effect in neural stem cells as a results of its antioxidant 
properties. On the other hand, CeO2 nanoparticles inhibited neuronal differentiation and altered 
the structure of the growth cone which imply potential developmental neurotoxicity.  
Figure 15. Experimental design of the RNA-Seq evaluation in study IV 
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 GENERAL DISCUSSION 
 IN VITRO ASSESSMENT OF NANOMATERIALS USING A COMBINATION 
OF CONVENTIONAL AND NOVEL OMICS-BASED APPROACHES 
In this thesis we used in vitro models and a combination of traditional toxicological assays and 
novel systems toxicology approaches to improve our understanding of the interactions between 
nanoparticles and cellular systems. Omics technologies provide an unprecedentedly detailed 
view into the pathways of toxicity and are bound to increase our understanding of how 
toxicants, including nanoparticles interfere with biological systems. Like in many other 
techniques the quality of the input parameters is crucial to the quality of the output data. Careful 
experimental design such as cell system, dose and time-point selection are, therefore, of utmost 
importance. Pilot studies can be useful to identify dose-response, and time-response trends 
using conventional toxicological assays.   
In Paper III we combined two ‘omics’ techniques, RNA-Seq and genome-wide DNA 
methylation array to explore the effects of low-dose, long-term exposure of human bronchial 
cells to silver nanoparticles. We started off with the observation that low-doses of Ag 
nanoparticles over long time can reduce cell proliferation for the smaller 10 nm Ag 
nanoparticles but not for the larger, 75 nm Ag nanoparticles, with subsequent recovery. Next 
we used an RNA-Seq approach to elucidate these changes and genome-wide DNA methylation 
to identify potential epigenetic effects of Ag nanoparticles. ‘Omics’ allows for a hypothesis-
free unbiased exploration of the data, but it is often helpful if there is an a priori scientific 
question or if previous knowledge on the matter is taken into account. In this case, we designed 
the long-term exposure setup to particularly study the potential carcinogenic effects of Ag 
nanoparticles. We performed a series of comprehensive downstream pathway and network 
analyses and generated two carcinogenesis-related hypotheses i.e. Ag nanoparticles can induce 
(i) fibrosis and (ii) epithelial-mesenchymal transition. These hypotheses based on RNA-Seq 
data were validated experimentally using conventional toxicology assays. Indeed, there is a 
‘long way’ from RNA transcription to functional proteins, with RNA-protein correlation being 
as low as 40% in some cases (Vogel and Marcotte, 2012). In addition to answering our 
questions related to cell transformation and carcinogenesis, RNA-Seq provided insight into 
new ‘territory’ related to the effects of Ag nanoparticles on the innate immune system.  
An interesting finding in this study was the potential of 75 nm Ag nanoparticles to induce 
phenotypical changes despite minimal alterations at the gene expression level. It seems that the 
cell phenotypes of cells treated with 10 and 75 nm Ag nanoparticles were much more similar 
than it would follow from the RNA-Seq data. One possible explanation is that individual gene 
expression changes were too small to pass the significance level following differential gene 
expression for the 75 nm Ag nanoparticles, but overall could still be enough to induce a change 
in phenotype. Another possible explanation, was that the RNA-Seq and the functional 
validation experiments were performed in two different experimental sets, at different time-
points and using different batches of nanoparticles. However, considering the high purity and 
quality of the nanoparticles used (the 75 nm Ag nanoparticles being an OECD reference 
  53 
standard material) it is unlikely that there was a significant particle batch effect. Nevertheless, 
in some functional assays, such as DNA damage and cell proliferation only 10 nm Ag 
nanoparticles elicited an effect, clearly indicating size-dependent toxicity, in line with the 
RNA-Seq data. In addition, 10 nm Ag nanoparticles were more potent in inducing G1 arrest 
and it is conceivable that cell cycle alterations will result in more ‘severe’ effects that could 
possibly lead to a higher number of differentially expressed genes. 
The genome wide DNA methylation did not indicate any relevant significant changes that could 
explain the RNA-Seq results. Interestingly, even for genes such as E-cadherin, in which 
promoter methylation plays an important role in controlling gene expression (Reinhold et al., 
2010) there was no significant differential methylation (even when disregarding the false 
discovery rate correction). Despite no observed effect at the DNA methylation level, Ag 
nanoparticles could still bear potential epigenetic effects via other mechanisms such as histone 
modifications or micro-RNAs, the latter being found to play a role in the up-regulation of 
metallothioneins by Ag nanoparticles in Jurkat cells (Eom et al., 2014). 
In Paper IV we used RNA-Seq to explore the effect of nanoceria on neuronal differentiation. 
In this study we already had experimental indications of alterations in neuronal differentiation 
and we wanted to further investigate these effects. RNA-Seq indicated that nanoceria not only 
reduced the expression of β3-tubulin as a marker of neuronal differentiation but interfered with 
the whole network of neuronal differentiation. By using appropriate controls, such as Sm-
doped nanoceria (reduced antioxidant effect as a particle control) and NAC (antioxidant 
control), we could also distinguish between antioxidant related effects and potential particle 
effects. This experimental setup allowed us to conclude that the effects on the neuronal 
differentiation overlapped between nanoceria and NAC and were probably related to their 
antioxidant function. On the other hand, both particles, but not NAC, shared effects related to 
interference with cellular assembly and filopodia formation. This lead to the generation of a 
new hypothesis, namely that the particle could interfere with the neuronal growth cone 
structure, which was validated experimentally by super-resolution microscopy.  
On the whole ‘omics’ approaches are excellent tools for obtaining mechanistic insight into the 
mechanism of toxicity and for generating new hypotheses. However, in order to close the ‘loop’ 
these hypotheses require experimental validation using conventional assays to confirm changes 
in cellular phenotypes. In addition, ‘omics’ assay could help identify biomarkers of toxicity 
that could then be used in conventional or high-throughput assays for screening purposes.  
One criticism brought up by Krug H. is the use of high doses which offer pure mechanistic 
information are of no toxicological relevance (Krug, 2014). While it is true that ‘toxicological’ 
studies are required for hands-on risk assessment purposes, mechanistic studies that identify 
new pathways of action and/or new toxic endpoints are equally valuable. Omics-derived 
approaches such as the one comprising this thesis are therefore particularly useful for 
understanding the complexity of nanoparticle – cell interactions and for generating new 
hypotheses.  
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 INCREASING THE THROUGHPUT OF ASSAYS TO SCREEN AND 
PREDICT TOXICITY OF NANOPARTICLES 
The increasing number of nanomaterials that are being produced and used in various 
applications requires appropriate screening tools to enable hazard identification and risk 
assessment endeavors. In a seminal article published in 2013, Nel and colleagues put forward 
some guiding directions for the toxicity testing of nanomaterials in which they emphasize the 
use of mechanism-based toxicity screening tools along with high-throughput technologies (Nel 
et al., 2013). Enacting these guidelines would increase the predictive power of the assays, allow 
for hazard ranking and prioritization, and ultimately enable safety by design strategies (Nel et 
al., 2013). In addition, the use of in vitro high-throughput technologies that have predictive 
power would reduce unnecessary animal testing which require a lot of resources and raise 
ethical concerns (Nelson et al., 2016). Compared to high-content approaches such as ‘omics’, 
that aid in the generation of new hypotheses and in the identification of new important 
endpoints for toxicity testing, high-throughput technologies enable the testing of numerous 
endpoints and materials at the same time.  
In Paper I we investigated the use of a moderate/high-throughput assay, ToxTracker, for 
mechanism-based genotoxicity screening of metal and metal oxide nanoparticles. The 
ToxTracker assay has been developed and validated for screening the genotoxic potential of 
chemicals (Hendriks et al., 2012), however, assays developed for chemicals cannot be directly 
translated to nanoparticle research due to potential interferences of the particles with reagents 
from the assay or the assay readout (Nelson et al., 2016). Since the ToxTracker assay is based 
on flow cytometry measurements, the presence of particles in the intracellular compartment 
could lead to side-scatter shifts of the cell populations but this issue can be overcome by 
adjusting the data analysis.  
Following validation with conventional genotoxicity assays, we showed that the ToxTracker 
was able to identify that the genotoxicity of CuO and NiO nanoparticles was correlated with 
oxidative stress and dependent on Nrf2 activation. For ZnO nanoparticles, the reporter was 
activated only at highly cytotoxic doses which could be interpreted as a secondary effect and 
not the main mechanism of toxicity. An advantage of the assay is the ability to gate the viable 
cell population and diminish the artefacts related to cell death. On the other hand, when reporter 
activation occurs only at highly cytotoxic doses it makes it difficult to draw any sound 
conclusions and questions the sensitivity of the assay. ZnO nanoparticles induced the Srxn1 
reporter, only at highly cytotoxic doses, however, other studies showed that ZnO nanoparticles 
can induce oxidative stress in a tiered manner, in line with the hierarchical oxidative stress 
paradigm (Xia et al., 2008). In addition, ZnO nanoparticles did not induce genotoxicity after 
short-term exposure using OECD in vitro and in vivo assays (Kwon et al., 2014) or after long-
term exposure in vitro (Annangi et al., 2016). 
Another interesting observation was the lack of reporter activation or cytotoxicity for the two 
Ag nanoparticles tested. In Paper II we showed that the same Ag nanoparticles (10 and 40 nm) 
can induce DNA damage, as measured by the comet assay, but in the absence of oxidative 
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stress following acute exposure of BEAS-2B cells. One explanation is that the ToxTracker 
assay identifies genotoxicity mediated by Nrf2 dependent oxidative stress, stalled replication 
forks or p53-dependent cellular stress. Despite these being common pathways involved in 
genotoxicity, other unrelated mechanisms are not considered. Also, it is worth noting that the 
comet assay is a highly sensitive assay and measures an endpoint, whereas the ToxTracker 
assay measures activation of a pathway and could therefore have different sensitivity. The lack 
of cytotoxicity of Ag nanoparticles in the mES as compared to the BEAS-2B cells could be 
related to aspects such as different intrinsic cellular sensitivity or different 
agglomeration/sedimentation of the particles in serum containing medium (mES) compared to 
serum free media (BEAS-2B), which can influence the particle deposition and cellular uptake.  
Reporter cells were previously used to address the correlation between physico-chemical 
properties of Ag nanoparticles and induction of inflammation (Prasad et al., 2013). Prasad and 
colleagues used stable NF-κB, Nrf2/ARE and AP1 luciferase reporters in HepG2 cells and 
found that Ag nanoparticles induced all three reporters, with Nrf2/ARE exhibiting the highest 
activation. In addition, smaller (10 nm) particles were more potent than larger (75 nm) particles 
and the effects were similar to those of AgNO3 (Prasad et al., 2013). It should be noted that the 
particles used by Prasad and colleagues had the same source and size (10 nm) as the Ag 
nanoparticles used in Paper I, and it is therefore intriguing that the ToxTracker assay did not 
indicate any activation of Nrf2 dependent pathways. A difference between these two cell 
reporters is their different origin, mouse embryonic stem cells versus hepatocytes, which could 
lead to different sensitivity to nanoparticles. Another explanation for the inconsistent results 
could be the use of cell culture media with different percentages of fetal bovine serum: 1% in 
the study by Prasad et al. and 10% in the ToxTracker assay. This is likely to impact particle 
stability, sedimentation, cellular uptake, Ag speciation and toxicity (Kittler et al., 2010). In 
another study, Stoehr and colleagues showed that a series of lung alveolar cells reporter 
systems, reporting on IL-8 promoter activation can be used to identify the pro-inflammatory 
response of ZnO nanoparticles in submerged as well as in air-liquid interface cultures (Stoehr 
et al., 2015).  
In addition to the ToxTracker assay, in this thesis we used the flow cytometry version of the 
micronucleus assay in Paper III, as a fast tool for genotoxicity assessment, as well as a 
multiplex assay for cytokine secretion. The flow cytometry version of the micronucleus test is 
faster, has a higher throughput and considers more events compared with the ‘cytome’ assay, 
where all observations are done using microscopy. In addition, we could concurrently analyze 
the cell cycle progression, and get indications on cell viability. The flow cytometry version of 
the micronucleus assay has limitations in respect to the identification of nuclear anomalies such 
as budding and nucleoplasmic bridges, it cannot distinguish between mononucleated and 
binucleated cells, it scores multiple micronuclei in one cell as separate events, and there are 
possible interferences of particle agglomerates with the measurement (Nelson et al., 2016).  
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 HIGH-DOSE ACUTE VERSUS LOW-DOSE CHRONIC EXPOSURE TO 
NANOPARTICLES  
The large majority of studies in nanotoxicology have focused on the acute effects of 
nanoparticles using short-term exposure scenarios and there is a current demand for more 
chronic studies to address the long-term effects of exposure to nanomaterials (Johnston et al., 
2013). Short-term studies can be useful for crude toxicity assessment, screening and 
prioritization purposes but they cannot give comprehensive information on e.g. the 
carcinogenic potential of nanoparticles. Other drawbacks of nanotoxicology studies are the use 
of poorly characterized materials, exposure to high doses together with the lack of reference 
materials (Krug, 2014).  
Moreover, it should not be taken for granted that the mechanistic profile observed at high doses 
can be translated to low-doses; dose does not only make the poison but also has a bearing on 
the toxic mechanism. 
In Paper II and III we addressed some of the challenges in nanotoxicology studies using BEAS-
2B as a cell model. To this end we used two distinct experimental setups to test the toxicity of 
a panel of well-characterized Ag nanoparticles:  
(i) Paper II - moderate/high dose (5-50 µg/mL) acute exposure (4 and 24 hours) to 10 
nm citrate-coated, 10 nm OECD PVP-coated, 40 nm citrate-coated, 50 nm uncoated 
and 75 nm OECD citrate-coated Ag nanoparticles; 
(ii) Paper III - low-dose (1 µg/mL) chronic exposure (3 and 6 weeks) to 10 nm citrate-
coated and 75 nm OECD citrate-coated Ag nanoparticles; 
In Paper II we observed a size-dependent cytotoxicity with the small (10 nm) particles being 
more toxic than the larger particles, independent of their surface coating. This was correlated 
with an increased release of Ag in cell medium, while the extracellular fraction was not 
cytotoxic. For the long-term, low-dose exposure in Paper III, we observed a similar pattern, 
with the 10 nm particles reducing cell proliferation in a time-dependent manner as compared 
to 75 nm particles which had no effect. In the chronic exposure setup, we observed effects on 
cell proliferation at much lower doses compared to the short-term exposure. This indicates that 
similar doses given in an acute or chronic regimen have different outcomes in respect to cell 
death and cell proliferation. In addition, it is likely that under chronic, low-dose exposure the 
cells develop mechanisms to cope with the toxic insult correlated with a phenotypical selection.  
In both Paper II and III we visualized as well as quantified the cellular uptake. The TEM 
pictures revealed that after both acute and chronic exposure, Ag nanoparticles were localized 
in endo-lysosomal compartments, with no indications of nuclear localization. However, the 
cellular uptake was significantly different for the two exposure scenarios. Following 4-hour 
exposure, there was no difference in cellular metal content between the 10 nm and the 75 nm 
particles (approx. 3 pg/cell at doses of 10 µg/mL). After long-term exposure, the metal content 
for the 10 nm Ag nanoparticles as compared to the 75 nm Ag nanoparticles was lower at both 
3 and 6 weeks. In addition, while the uptake of 75 nm Ag nanoparticles was relatively constant 
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(approx. 1 pg/cell) between 3 and 6 weeks, the uptake of 10 nm Ag nanoparticles decreased 
significantly from week 3 (approx. 0.7 pg/cell) to week 6 (approx. 0.25 pg/cell). This could be 
an adaptive mechanism related to a down-regulation of cell uptake mechanisms and/or 
upregulation of exocytosis pathways. Exocytosis of nanoparticles has not received much 
interest but it is an important mechanism that can modulate the toxicity of nanoparticles which 
should be investigated further. However, despite a reduction in Ag content there were no major 
changes in molecular endpoints (DNA damage) or phenotype (cell transformation, response to 
LPS) from week 3 to week 6.  
Genotoxicity is another end-point studied in both Paper II and III. In Paper II, all tested 
nanoparticles induced genotoxicity after 24-hour exposure to non-cytotoxic doses (10 µg/mL) 
and there was no size-dependent difference as observed in the alkaline comet assay. However, 
following chronic exposure there was a size-dependent genotoxicity measured by the same 
alkaline comet assay, with the 10 nm particles inducing more DNA damage than the 75 nm 
particles at both investigated time-points (3 and 6 weeks). Moreover, there was no micronuclei 
or hypodiploid nuclei induction. Genotoxicity induction provided an indication for 
carcinogenic potential that was further evaluated after long-term exposure as discussed below.    
In Paper III we generated a hypothesis based on the next-generation sequencing data, namely 
that Ag nanoparticles are able to induce EMT. This hypothesis was experimentally validated 
and we showed that Ag nanoparticles can induce a cancer-like phenotype in BEAS-2B cells 
after long-term exposure. Several in vitro studies have revealed that long-term exposure of cells 
to nanomaterials such as carbon nanotubes (Luanpitpong et al., 2014, Wang et al., 2011, Vales 
et al., 2016), titanium dioxide (Vales et al., 2015) and cobalt nanoparticles (Annangi et al., 
2015) can induce cell transformation. For single-walled carbon nanotubes, the in vitro cell 
transformation potential in BEAS-2B cells was corroborated with in vivo tumorigenicity 
(Wang et al., 2011, Luanpitpong et al., 2014). This provides proof that long-term exposure in 
cells such as BEAS-2B can be a useful model for identifying the carcinogenic potential of 
nanomaterials. In addition, some of the changes observed after long-term exposure to single-
walled carbon nanotubes (Luanpitpong et al., 2014, Wang et al., 2011) were similar to the 
changes induced by Ag nanoparticles in Paper III: reduction in E-cadherin expression, 
increased cell invasion and migration as well as increased soft-agar cell transformation.  
BEAS-2B cells are considered a good model for long-term studies on carcinogenesis induced 
by heavy metals and nanoparticles (Park et al., 2015, Wang et al., 2011). However, during 
long-term exposure, a change in cell phenotype and even cell transformation can occur as a 
result of cell culture per se. Indeed, in Paper III we observed that parameters such as anchorage 
independent cell growth, N-cadherin expression and the length of G1 cell cycle phase increased 
at week 6 as compared to week 3, indicating cell transformation. On the other hand, the 
background level of DNA damage as measured by the comet assay did not change, neither was 
there an increase in micronuclei, suggesting genomic stability. The phenotypic changes with 
cell culture should be therefore addressed in in vitro studies and the duration of the 
exposure/cell culture should be optimized.  
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 REACTIVE OXYGEN SPECIES: TOXIC INSULT VERSUS SIGNALLING 
MOLECULE 
It is well established that one mechanism by which (nano)particles can exert toxic effects lies 
in their ability to elicit oxidative stress in a hierarchical manner in line with the oxidative stress 
paradigm (Nel et al., 2006, Manke et al., 2013). If out of balance, oxidative stress can induce 
cellular injuries such as DNA damage, lipid peroxidation, protein denaturation, which in turn 
can lead to cell death, inflammation, mutations, cancer and fibrosis (Manke et al., 2013). 
Several pathologies relevant for inhalation of particles such as silicosis following inhalation of 
quartz (Vallyathan et al., 1997) and pulmonary as well as cardiovascular effects following 
exposure to air pollution derived particulate matter (Møller et al. 2010) have been associated 
with increased oxidative stress. 
In Paper I we showed that both NiO and CuO nanoparticles induced DNA damage via oxidative 
stress as indicated by the activation of the Srxn1 reporter which accounts for Nrf2 dependent 
signaling. In the case of CuO nanoparticles, the oxidative stress was related to the dissolution 
of ions in the extracellular medium, whereas for NiO nanoparticles the Srxn1 activation 
occurred following particle uptake. Cu ions can induce oxidative stress either by entering 
Fenton as well as Haber-Weiss reactions or by depleting glutathione levels (Jomova and Valko, 
2011). It should be noted that both NiO and CuO nanoparticles were potent in generating ROS 
under acellular conditions. In Paper II, all tested Ag nanoparticles induced DNA damage 
following 24-hour exposure in human lung cells, but in this case, there was no correlation with 
ROS generation, suggesting additional mechanisms of DNA damage.  
On the other hand, ROS function as secondary messengers and are involved in regulating 
processes such as cell proliferation and differentiation (Sauer et al., 2001). Endogenous ROS 
production occurs following electron leaking from the respiratory chain, electron release from 
the NADPH cytochrome P450 reductase and NADPH oxidase systems with the subsequent 
activation signaling cascades (e.g. ERK1/2, JNK and p38 MAPK pathways) or direct 
regulation of transcription factors (e.g. NF-κB, AP-1, SP-1, HIF-1α, p53) (Sauer et al., 2001).  
Ultimately, according to the ‘free radical theory of development’ put forward in 1989 by Allen 
and Balin, ROS influence cellular antioxidant defense mechanisms and modulate gene 
expression during development of organisms (Allen and Balin, 1989). This raises the question 
whether antioxidant nanoparticles, could act like a double-edged sword depending on the 
physiological context, similar to other exogenous antioxidants (Bouayed and Bohn, 2010).  
In Paper IV we investigated the effects of antioxidant nanoceria on neural stem cells. Our 
results showed that pre-incubation of cells with nanoceria delayed cell death induced by 
oxidative stress, suggesting neuroprotective effects, which have been previously reported for 
nanoceria (D'Angelo et al., 2009, Estevez et al., 2011). However, nanoceria also reduced the 
ROS levels in the absence of an oxidative stress inducer indicating that it can interfere with the 
physiological ROS balance. Next, we reported that nanoceria reduced expression of β3 tubulin, 
which is a marker of neuronal differentiation, in a way similar to NAC, a conventional 
antioxidant. The RNA-Seq experiments further confirmed this observation and revealed that 
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both nanoceria and NAC alter the neuronal differentiation as well as the neuroglial 
differentiation network in similar ways, however, the effects of nanoceria were more extensive. 
We therefore showed that the same antioxidant effects which are considered promising for 
therapeutical applications can lead to detrimental neurotoxic effects i.e. interference with 
neuronal development and differentiation.   
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 CONCLUDING REMARKS 
This thesis shows that challenges in nanotoxicology can be addressed and overcome using in 
vitro models and a combination of thoroughly characterized nanoparticles, suitable 
experimental setups, novel screening tools as well as systems toxicology approaches.  
In Paper I we demonstrated that the ToxTracker reporter assay is a suitable tool for rapid 
medium-throughput screening of genotoxicity of metal oxide nanoparticles. In addition, the 
assay gave insight into the mechanisms of genotoxicity which occurred mainly by oxidative 
stress (for NiO and CuO nanoparticles) and not by binding to DNA with subsequent stalled 
replication forks. After further analysis of the corresponding ion salts, we concluded that the 
effects of CuO were mediated by the ions released in the cell medium, whereas for NiO the 
effects were related to the particle form.   
In Paper II we showed that the acute cytotoxicity of Ag nanoparticles in human lung cells is 
size-dependent, with smaller particles being more toxic than larger ones. All particles were 
taken up to similar extents and all particles induced comparable genotoxicity. In addition, the 
smaller particles had a higher release of Ag in cell medium, which, provided that the same 
pattern of dissolution follows inside the cells, could explain the observed differences in toxicity.  
In Paper III we combined ‘omics’ and conventional assays to explore the low-dose, long-term 
effects of Ag nanoparticles in human lung cells. We showed that Ag nanoparticles induced a 
cancer-like phenotype evidenced by cell transformation, induction of fibrosis markers and 
epithelial-mesenchymal transition. In addition, both particles had immunosuppressive effects 
by reducing cytokine secretion following challenge with LPS.  
In Paper IV we showed that, on one hand, CeO2 nanoparticles are antioxidant and have 
temporary neuroprotective effects in neural stem cells. On the other hand, due to the antioxidant 
properties, CeO2 nanoparticles reduced neuronal differentiation which was first evidenced by 
immunofluorescence and then confirmed by RNA-Seq. In addition, RNA-Seq revealed an 
antioxidant-independent particle effect i.e. interference with the neuronal growth cone that was 
validated by super-resolution microscopy.  
This thesis sheds light on several critical aspects raised by Harald Krug in his review article 
from 2014 (Krug, 2014) such as: particle characterization, cellular particle uptake, low-dose 
chronic exposure setups and use of appropriate controls. I hope the work described in this thesis 
will guide future toxicological endeavors and ultimately aid risk assessment of nanomaterials. 
I would like to particularly emphasize the importance of particle characterization and 
quantification of cellular uptake that would facilitate comparisons between studies as well as 
in vitro – in vivo correlations. Next, I hope this thesis will prompt a shift from high-dose, acute 
exposure experimental setups to low-dose, long-term exposure scenarios that can unravel new 
and subtle mechanisms of toxicity. Moreover, I believe this thesis could guide future work 
using systems toxicology approaches to gain more in-depth understanding of the interaction 
between nanomaterials and biological systems that will be of great benefit in both toxicology 
and nanomedicine.    
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 FUTURE OUTLOOK - PERSONAL REFLECTIONS 
The virtuous cycle of science. On one hand, good research answers questions, on the other hand 
it gives rise to new questions that in turn stimulate the development of novel approaches to 
answer those questions. Below are a few personal scientific ruminations that emerged while 
working on this thesis. I regard the first point as a general issue in nanotoxicology, while the 
last two items are potential follow-up studies to this thesis. 
- How does the cell culture heterogeneity influence the toxicity of nanoparticles? 
Exposure to nanoparticles (as opposed to conventional chemicals) in cell culture is not 
homogenous and some cells will ‘see’ and/or take up more particles than others. It would be 
valuable to investigate whether there are correlations between toxicological endpoints and 
particle uptake at a single cell level. On one hand, it might seem obvious that these correlations 
exist but they have yet to be unraveled. Do cells with higher particle uptake exhibit more DNA 
damage than cells with lower particle uptake from the same dish? On the other hand, depending 
on the endpoint of interest, the cellular response might be homogenous and orchestrated. Is the 
gene expression of cytokines following exposure to nanoparticles correlated with the metal 
uptake or is this a more orchestrated, homogenous effect at cell culture level? In addition, it is 
conceivable that these correlations are very much dependent on the nanoparticle per se. Are 
there differences between highly soluble nanoparticles (CuO, ZnO) and less soluble particles 
(TiO2, CeO2) for which the particulate form is more important for the toxic outcome? In 
addition, cells during cell culture are present in various stages of the cell cycle that could result 
in different outcomes following exposure to nanoparticles.  
By working with pooled samples, it is impossible to address the cell heterogeneity, and some 
significant effects could be diluted and less likely to be discovered. It is biologically relevant 
e.g. if a few percentage of cells acquire a cancer-like phenotype, however when working with 
pooled samples these effects could become diluted and have no statistical significance.  
I believe that emerging high resolution technologies, such as mass cytometry and single cell 
RNA-Seq techniques could enable us to answer these fundamental questions. Ultimately this 
would advance not only our understanding of the cell-nanoparticle interaction but also our 
understanding of in vitro cell culture, and allow us to improve our experimental design.   
- How does the formation of lung surfactant bio-corona affect the toxicity of Ag 
nanoparticles? 
In the current thesis we evaluated the effects of Ag nanoparticles on human lung cells, BEAS-
2B. These cells grow in serum free medium with a low amount of proteins (less than 0.5%). 
However, these working conditions do not reflect the physiology of the lung. It would therefore 
be of relevance to study how the presence of lung surfactant affects both Ag nanoparticle 
stability and uptake, as well as the toxic outcome.   
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- Could antioxidant nanoparticles induce genomic instability in neuronal stem cells? 
It was reported that physiological levels of reactive oxidative species play an important role in 
preserving genomic stability in stem cells by activating DNA repair complexes (Li and Marbán, 
2010). It is therefore conceivable that antioxidant nanoparticles such as CeO2 could increase 
the background DNA damage in neuronal stem cells, and by these means induce 
neurodevelopmental effects and/or carcinogenesis. I would argue that there are good grounds 
for further investigation into this hypothesis.   
Finally, I hope to explore some of the questions raised within these pages (and many more that 
will emerge on the way), and to continue contributing to the fascinating field of (nano)particle 
toxicology.  
  
  63 
 ACKNOWLEDGEMENTS 
The studies described in this thesis were carried out at the Division of Molecular Toxicology 
and Division of Biochemical Toxicology, Institute of Environmental Medicine, Karolinska 
Institute and were supported by grants from the Swedish Research Council for Health, Working 
Life and Welfare (FORTE), Swedish Research Council (VR), Swedish Cancer and Allergy 
Foundation, EU Framework 7 Programme (NANOREG) and KI faculty grant for PhD students 
(KID). Firstly, I wish to express my deepest gratitude to my main supervisor, Assoc. Prof. 
Hanna Karlsson for all her support and unfailing positivity. I am also grateful to my co-
supervisor Prof. Bengt Fadeel for his invaluable feedback, inspiring scientific expertise and 
continuous encouragements. I would also like to acknowledge my co-supervisor Jessica 
Lindvall for generously sharing her knowledge in bioinformatics, my co-supervisor Prof. Inger 
Odnevall-Wallinder for providing competent advice on the characterization of nanoparticles 
and my external mentor Klas Udekwu for his friendly advice. Special thanks are due to 
Sebastiano Di Bucchianico for all his guidance and contagious passion for science, to Pekka 
Kohonen who was my true mentor during the ‘omics’ part of this thesis, and to Karin Edoff 
who guided me through the world of neuroscience. I would like to particularly thank Sara 
Skoglund, my collaborator and dear friend throughout the years, and Jessica De Loma, for 
giving me the opportunity to supervise her master thesis work which was a truly enriching 
experience. In addition, I would like to thank Annika Hanberg, Ralf Morgenstern, Kristian 
Dreij and Penny Nymark for allowing me to be involved in the education of master students in 
toxicology. I would also like to thank current and former members of the Molecular Toxicology 
and Biochemical Toxicology units for creating an enjoyable working environment. Finally, I 
would like to acknowledge all of my collaborators and co-authors for all their work and for 
sharing their expertise in their respective fields, which contributed to the interdisciplinary 














Albini, A. and R. Benelli (2007). "The chemoinvasion assay: a method to assess tumor and 
endothelial cell invasion and its modulation." Nature Protocols 2(3): 504-511. 
Allen, R. G. and A. K. Balin (1989). "Oxidative influence on development and differentiation: 
an overview of a free radical theory of development." Free radical biology & 
medicine 6(6): 631-661. 
Andersen, J. K. (2004). "Oxidative stress in neurodegeneration: cause or consequence?" Nature 
Medicine 10(25): S18-25. 
Andreescu, D., G. Bulbul, R. E. Ozel, A. Hayat, N. Sardesai and S. Andreescu (2014). 
"Applications and implications of nanoceria reactivity: measurement tools and 
environmental impact." Environmental Science: Nano 1(5): 445-458. 
Annangi, B., J. Bach, G. Vales, L. Rubio, R. Marcos and A. Hernandez (2015). "Long-term 
exposures to low doses of cobalt nanoparticles induce cell transformation enhanced 
by oxidative damage." Nanotoxicology 9(2): 138-147. 
Annangi, B., L. Rubio, M. Alaraby, J. Bach, R. Marcos and A. Hernandez (2016). "Acute and 
long-term in vitro effects of zinc oxide nanoparticles." Archives of toxicology 90(9): 
2201-2213. 
Antonini, J. M., M. D. Taylor, A. T. Zimmer and J. R. Roberts (2004). "Pulmonary responses 
to welding fumes: role of metal constituents." Journal of Toxicology and 
Environmental Health, Part A 67(3): 233-249. 
AshaRani, P. V., M. G. Low Kah, M. P. Hande and S. Valiyaveettil (2009). "Cytotoxicity and 
genotoxicity of silver nanoparticles in human cells." ACS Nano 3(2):279–290. 
Assenov, Y., F. Muller, P. Lutsik, J. Walter, T. Lengauer and C. Bock (2014). "Comprehensive 
analysis of DNA methylation data with RnBeads." Nature Methods 11(11): 1138-
1140. 
Auffan, M., J. Rose, J.-Y. Bottero, G. V. Lowry, J.-P. Jolivet and M. R. Wiesner (2009). 
"Towards a definition of inorganic nanoparticles from an environmental, health and 
safety perspective." Nature Nanotechnology 4(10): 634-641. 
Avalos, A., A. I. Haza, D. Mateo and P. Morales (2014). "Cytotoxicity and ROS production of 
manufactured silver nanoparticles of different sizes in hepatoma and leukemia 
cells." Journal of Applied Toxicology 34(4): 413-423. 
Bakke, A. C. (2001). "The Principles of Flow Cytometry." Laboratory Medicine 32(4): 207-
211. 
Banath, J. P., C. A. Banuelos, D. Klokov, S. M. MacPhail, P. M. Lansdorp and P. L. Olive 
(2009). "Explanation for excessive DNA single-strand breaks and endogenous repair 
foci in pluripotent mouse embryonic stem cells." Experimental Cell Research 
315(8): 1505-1520. 
Belade, E., L. Armand, L. Martinon, L. Kheuang, J. Fleury-Feith, A. Baeza-Squiban, S. 
Lanone, M.-A. Billon-Galland, J.C. Pairon and J. Boczkowski (2012). "A 
comparative transmission electron microscopy study of titanium dioxide and carbon 
black nanoparticles uptake in human lung epithelial and fibroblast cell lines." 
Toxicology in Vitro 26(1): 57-66. 
  65 
Bhabra, G., A. Sood, B. Fisher, L. Cartwright, M. Saunders, W. H. Evans, A. Surprenant, G. 
Lopez-Castejon, S. Mann, S. A. Davis, L. A. Hails, E. Ingham, P. Verkade, J. Lane, 
K. Heesom, R. Newson and C. P. Case (2009). "Nanoparticles can cause DNA 
damage across a cellular barrier." Nature Nanotechnology 4(12): 876-883. 
Bhattacharya, K., C. Sacchetti, R. El-Sayed, A. Fornara, G. P. Kotchey, J. A. Gaugler, A. Star, 
M. Bottini and B. Fadeel (2014). "Enzymatic 'stripping' and degradation of 
PEGylated carbon nanotubes." Nanoscale 6(24): 14686-14690. 
Blom, H. and H. Brismar (2014). "STED microscopy: increased resolution for medical 
research?" Journal of Internal Medicine 276(6): 560-578. 
Blom, H. and J. Widengren (2014). "STED microscopy - towards broadened use and scope of 
applications." Current Opinion in Chemical Biology 20: 127-133. 
Borowicz, S., M. Van Scoyk, S. Avasarala, M. K. Karuppusamy Rathinam, J. Tauler, R. K. 
Bikkavilli and R. A. Winn (2014). "The soft agar solony formation assay." Journal 
of Visualized Experiments (92): e51998. 
Bouayed, J. and T. Bohn (2010). "Exogenous antioxidants—Double-edged swords in cellular 
redox state: Health beneficial effects at physiologic doses versus deleterious effects 
at high doses." Oxidative Medicine and Cellular Longevity 3(4): 228-237. 
Braakhuis, H. M., C. Giannakou, W. J. Peijnenburg, J. Vermeulen, H. van Loveren and M. V. 
Park (2016). "Simple in vitro models can predict pulmonary toxicity of silver 
nanoparticles." Nanotoxicology 10(6): 770-779. 
Braakhuis, H. M., I. Gosens, P. Krystek, J. A. Boere, F. R. Cassee, P. H. Fokkens, J. A. Post, 
H. van Loveren and M. V. Park (2014a). "Particle size dependent deposition and 
pulmonary inflammation after short-term inhalation of silver nanoparticles." 
Particle and Fibre Toxicology 11(49): 014-0049. 
Braakhuis, H. M., M. V. Park, I. Gosens, W. H. De Jong and F. R. Cassee (2014b). 
"Physicochemical characteristics of nanomaterials that affect pulmonary 
inflammation." Particle and Fibre Toxicology 11(1): 1-25. 
Brook, R. D. (2008). "Cardiovascular effects of air pollution." Clinical science (London, 
England: 1979) 115(6): 175-187. 
Brown, A. P., R. M. D. Brydson and N. S. Hondow (2014). "Measuring in vitro cellular uptake 
of nanoparticles by transmission electron microscopy." Journal of Physics: 
Conference Series 522(1): 012058. 
Buerki-Thurnherr, T., L. Xiao, L. Diener, O. Arslan, C. Hirsch, X. Maeder-Althaus, K. Grieder, 
B. Wampfler, S. Mathur, P. Wick and H. F. Krug (2013). "In vitro mechanistic study 
towards a better understanding of ZnO nanoparticle toxicity." Nanotoxicology 7(4): 
402-416. 
Caputo, F., M. De Nicola, A. Sienkiewicz, A. Giovanetti, I. Bejarano, S. Licoccia, E. Traversa 
and L. Ghibelli (2015). "Cerium oxide nanoparticles, combining antioxidant and UV 
shielding properties, prevent UV-induced cell damage and mutagenesis." Nanoscale 
7(38): 15643-15656. 
Carlson, C., S. M. Hussain, A. M. Schrand, L. K. Braydich-Stolle, K. L. Hess, R. L. Jones and 
J. J. Schlager (2008). "Unique cellular interaction of silver nanoparticles: size-
dependent generation of reactive oxygen species." The Journal of Physical 
Chemistry B 112(43): 13608-13619. 
 66 
Cassee, F. R., A. Campbell, A. J. Boere, S. G. McLean, R. Duffin, P. Krystek, I. Gosens and 
M. R. Miller (2012). "The biological effects of subacute inhalation of diesel exhaust 
following addition of cerium oxide nanoparticles in atherosclerosis-prone mice." 
Environmental Research 115: 1-10. 
Cassee, F. R., E. C. van Balen, C. Singh, D. Green, H. Muijser, J. Weinstein and K. Dreher 
(2011). "Exposure, health and ecological effects review of engineered nanoscale 
cerium and cerium oxide associated with its use as a fuel additive." Critical Reviews 
in Toxicology 41(3): 213-229. 
Celardo, I., M. De Nicola, C. Mandoli, J. Z. Pedersen, E. Traversa and L. Ghibelli (2011). 
"Ce(3)+ ions determine redox-dependent anti-apoptotic effect of cerium oxide 
nanoparticles." ACS Nano 5(6): 4537-4549. 
Chaudhury, K., K. N. Babu, A. K. Singh, S. Das, A. Kumar and S. Seal (2013). "Mitigation of 
endometriosis using regenerative cerium oxide nanoparticles." Nanomedicine 9(3): 
439-448. 
Chen, M., M. Zhang, J. Borlak and W. Tong (2012). "A decade of toxicogenomic research and 
its contribution to toxicological science." Toxicological Sciences 130(2): 217-228. 
Chen, S., Y. Hou, G. Cheng, C. Zhang, S. Wang and J. Zhang (2013). "Cerium oxide 
nanoparticles protect endothelial cells from apoptosis induced by oxidative stress." 
Biological Trace Element Research 154(1): 156-166. 
Chigurupati, S., M. R. Mughal, E. Okun, S. Das, A. Kumar, M. McCaffery, S. Seal and M. P. 
Mattson (2013). "Effects of cerium oxide nanoparticles on the growth of 
keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound 
healing." Biomaterials 34(9): 2194-2201. 
Cho, E. C., Q. Zhang and Y. Xia (2011). "The effect of sedimentation and diffusion on cellular 
uptake of gold nanoparticles." Nature Nanotechnology 6(6): 385-391. 
Cho, W.S., R. Duffin, C. A. Poland, S. E. M. Howie, W. MacNee, M. Bradley, I. L. Megson 
and K. Donaldson (2010). "Metal oxide nanoparticles induce unique inflammatory 
footprints in the lung: important implications for nanoparticle testing." 
Environmental Health Perspectives 118(12): 1699-1706. 
Cho, W.S., R. Duffin, F. Thielbeer, M. Bradley, I. L. Megson, W. MacNee, C. A. Poland, C. 
L. Tran and K. Donaldson (2012). "Zeta potential and solubility to toxic ions as 
mechanisms of lung inflammation caused by metal/metal-oxide nanoparticles." 
Toxicological Sciences 126(2):469-477 
Cho, W.S., R. Duffin, M. Bradley, I. L. Megson, W. MacNee, J. K. Lee, J. Jeong and K. 
Donaldson (2013). "Predictive value of in vitro assays depends on the mechanism 
of toxicity of metal oxide nanoparticles." Particle and Fibre Toxicology 10(1): 55. 
Ciofani, G., G. G. Genchi, I. Liakos, V. Cappello, M. Gemmi, A. Athanassiou, B. Mazzolai 
and V. Mattoli (2013). "Effects of cerium oxide nanoparticles on PC12 neuronal-
like cells: proliferation, differentiation, and dopamine secretion." Pharmaceutical 
Research 30(8): 2133-2145. 
Ciofani, G., G. G. Genchi, B. Mazzolai and V. Mattoli (2014). "Transcriptional profile of genes 
involved in oxidative stress and antioxidant defense in PC12 cells following 
treatment with cerium oxide nanoparticles." Biochimica et Biophysica Acta 1: 495-
506. 
  67 
Collins, A. R. (2004). "The comet assay for DNA damage and repair." Molecular 
Biotechnology 26(3): 249-261. 
Colognato, R., Park, M.V.D.Z., Wick, P., De Jong, W.H. (2012). Chapter 1. Interactions with 
the human body. In: "Adverse effects of engineered nanomaterials: Exposure, 
Toxicology, and Impact on Human Health" (Fadeel, B., Pietroiusti, A., Shvedova, 
A.A. Eds), pp 3-24. Academic Press-Elsevier, San Diego.  
Comfort, K. K., L. K. Braydich-Stolle, E. I. Maurer and S. M. Hussain (2014). "Less is more: 
long-term in vitro exposure to low levels of silver nanoparticles provides new 
insights for nanomaterial evaluation." ACS Nano 8(4): 3260-3271. 
Cooper, R. J. and N. Spitzer (2015). "Silver nanoparticles at sublethal concentrations disrupt 
cytoskeleton and neurite dynamics in cultured adult neural stem cells." 
Neurotoxicology 48: 231-238. 
Costa, P. M. and B. Fadeel (2016). "Emerging systems biology approaches in nanotoxicology: 
Towards a mechanism-based understanding of nanomaterial hazard and risk." 
Toxicology and Applied Pharmacology 299: 101-111. 
Crist, R. M., J. H. Grossman, A. K. Patri, S. T. Stern, M. A. Dobrovolskaia, P. P. Adiseshaiah, 
J. D. Clogston and S. E. McNeil (2013). "Common pitfalls in nanotechnology: 
lessons learned from NCI's Nanotechnology Characterization Laboratory." 
Integrative Biology 5(1): 66-73. 
Cuillel, M., M. Chevallet, P. Charbonnier, C. Fauquant, I. Pignot-Paintrand, J. Arnaud, D. 
Cassio, I. Michaud-Soret and E. Mintz (2014). "Interference of CuO nanoparticles 
with metal homeostasis in hepatocytes under sub-toxic conditions." Nanoscale 6(3): 
1707-1715. 
Cupaioli, F. A., F. A. Zucca, D. Boraschi and L. Zecca (2014). "Engineered nanoparticles. How 
brain friendly is this new guest?" Progress in Neurobiology 119-120: 20-38. 
D'Angelo, B., S. Santucci, E. Benedetti, S. Di Loreto, R. Phani, S. Falone, F. Amicarelli, M. P. 
Ceru and A. Cimini (2009). "Cerium oxide nanoparticles trigger neuronal survival 
in a human Alzheimer disease model by modulating BDNF pathway." Current 
Nanoscience 5(2): 167-176. 
Daboussi, F., A. Dumay, F. Delacote and B. S. Lopez (2002). "DNA double-strand break repair 
signalling: the case of RAD51 post-translational regulation." Cellular Signaling 
14(12): 969-975. 
de Jager, W., H. te Velthuis, B. J. Prakken, W. Kuis and G. T. Rijkers (2003). "Simultaneous 
detection of 15 human cytokines in a single sample of stimulated peripheral blood 
mononuclear cells." Clinical and Diagnostic Laboratory Immunology 10(1): 133-
139. 
Dedeurwaerder, S., M. Defrance, E. Calonne, H. Denis, C. Sotiriou and F. Fuks (2011). 
"Evaluation of the Infinium Methylation 450K technology." Epigenomics 3(6): 771-
784. 
Deshpande, S., S. Patil, S. V. Kuchibhatla and S. Seal (2005). "Size dependency variation in 
lattice parameter and valency states in nanocrystalline cerium oxide." Applied 
Physics Letters 87(13): 133113. 
 
 68 
Di Bucchianico, S., F. Cappellini, F. Le Bihanic, Y. Zhang, K. Dreij and H. L. Karlsson (2016). 
"Genotoxicity of TiO2 nanoparticles assessed by mini-gel comet assay and 
micronucleus scoring with flow cytometry." Mutagenesis. Published online: July 5, 
2016 [Epub ahead of print]. 
Docter, D., D. Westmeier, M. Markiewicz, S. Stolte, S. K. Knauer and R. H. Stauber (2015). 
"The nanoparticle biomolecule corona: lessons learned - challenge accepted?" 
Chemical Society Reviews 44(17): 6094-6121. 
Donaldson, K. and C. A. Poland (2012). "Inhaled nanoparticles and lung cancer - what we can 
learn from conventional particle toxicology." Swiss Medical Weekly 142: w13547. 
Donaldson, K. and C. A. Poland (2013). "Nanotoxicity: challenging the myth of nano-specific 
toxicity." Current Opinion in Biotechnology 24(4): 724-734. 
Donaldson, K., C. A. Poland, F. A. Murphy, M. MacFarlane, T. Chernova and A. Schinwald 
(2013). "Pulmonary toxicity of carbon nanotubes and asbestos - similarities and 
differences." Advanced Drug Delivery Reviews 65(15): 2078-2086. 
Donaldson, K., C. A. Poland and R. P. F. Schins (2010). "Possible genotoxic mechanisms of 
nanoparticles: Criteria for improved test strategies." Nanotoxicology 4(4): 414-420. 
Donaldson, K. and A. Seaton (2012). "A short history of the toxicology of inhaled particles." 
Particle and Fibre Toxicology 9: 13. 
Donaldson, K., V. Stone, C. L. Tran, W. Kreyling and P. J. Borm (2004). "Nanotoxicology." 
Occupational and Environmental Medicine 61(9): 727-728. 
Dowding, J. M., S. Das, A. Kumar, T. Dosani, R. McCormack, A. Gupta, T. X. T. Sayle, D. C. 
Sayle, L. von Kalm, S. Seal and W. T. Self (2013). "Cellular Interaction and Toxicity 
Depends on Physiochemical Properties and Surface Modification of Redox Active 
Nanomaterials." ACS Nano 7(6): 4855-4868 
Korpelainen, E., J. Tuimala, P. Somervuo, M. Huss, G. Wong (2014). Chapter 1. Introduction 
to RNA-Sequencing. In: "RNA-Seq data analysis:a practical approach", pp: 1-26, 
CRC Press, Taylor and Francis Group. 
Eitan, E., E. R. Hutchison, N. H. Greig, D. Tweedie, H. Celik, S. Ghosh, K. W. Fishbein, R. G. 
Spencer, C. Y. Sasaki, P. Ghosh, S. Das, S. Chigurapati, J. Raymick, S. Sarkar, S. 
Chigurupati, S. Seal and M. P. Mattson (2015). "Combination therapy with 
lenalidomide and nanoceria ameliorates CNS autoimmunity." Experimental 
Neurology 273: 151-160. 
El-Kemary, M., N. Nagy and I. El-Mehasseb (2013). "Nickel oxide nanoparticles: Synthesis 
and spectral studies of interactions with glucose." Materials Science in 
Semiconductor Processing 16(6): 1747-1752. 
Elder, A., R. Gelein, V. Silva, T. Feikert, L. Opanashuk, J. Carter, R. Potter, A. Maynard, Y. 
Ito, J. Finkelstein and G. Oberdörster (2006). "Translocation of inhaled ultrafine 
manganese oxide particles to the central nervous system." Environmental Health 
Perspectives 114(8): 1172-1178. 
Eom, H.J., N. Chatterjee, J. Lee and J. Choi (2014). "Integrated mRNA and micro RNA 
profiling reveals epigenetic mechanism of differential sensitivity of Jurkat T cells to 
AgNPs and Ag ions." Toxicology Letters 229(1): 311-318. 
  69 
Eom, H.J. and J. Choi (2009). "Oxidative stress of CeO2 nanoparticles via p38-Nrf-2 signaling 
pathway in human bronchial epithelial cell, Beas-2B." Toxicology Letters 187(2): 
77-83. 
Estevez, A. Y., S. Pritchard, K. Harper, J. W. Aston, A. Lynch, J. J. Lucky, J. S. Ludington, P. 
Chatani, W. P. Mosenthal, J. C. Leiter, S. Andreescu and J. S. Erlichman (2011). 
"Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse 
hippocampal brain slice model of ischemia." Free Radical Biology and Medicine 
51(6): 1155-1163. 
EU commission (2011). Commission Recommendation on the definition of nanomaterial. 
Official Journal of the European Union 2011/696/EU. 
Fadeel, B., A. Fornara, M. S. Toprak and K. Bhattacharya (2015). "Keeping it real: The 
importance of material characterization in nanotoxicology." Biochemical and 
Biophysical Research Communications 468(3): 498-503. 
Feliu, N., P. Kohonen, J. Ji, Y. Zhang, H. L. Karlsson, L. Palmberg, A. Nystrom and B. Fadeel 
(2015). "Next-generation sequencing reveals low-dose effects of cationic 
dendrimers in primary human bronchial epithelial cells." ACS Nano 9(1): 146-163. 
Fenech, M. (2007). "Cytokinesis-block micronucleus cytome assay." Nature Protocols 2(5): 
1084-1104. 
Fenech, M., M. Kirsch-Volders, A. T. Natarajan, J. Surralles, J. W. Crott, J. Parry, H. Norppa, 
D. A. Eastmond, J. D. Tucker and P. Thomas (2011). "Molecular mechanisms of 
micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and 
human cells." Mutagenesis 26(1): 125-132. 
Fissan, H., S. Ristig, H. Kaminski, C. Asbach and M. Epple (2014). "Comparison of different 
characterization methods for nanoparticle dispersions before and after 
aerosolization." Analytical Methods 6(18): 7324-7334. 
Foldbjerg, R., D. A. Dang and H. Autrup (2011). "Cytotoxicity and genotoxicity of silver 
nanoparticles in the human lung cancer cell line, A549." Archives of Toxicology 
85(7): 743-750. 
Foldbjerg, R., X. Jiang, T. Miclaus, C. Chen, H. Autrup and C. Beer (2015). "Silver 
nanoparticles - wolves in sheep's clothing?" Toxicology Research 4(3): 563-575. 
Fröhlich, E. (2012). "The role of surface charge in cellular uptake and cytotoxicity of medical 
nanoparticles." International Journal of Nanomedicine 7: 5577-5591. 
Gentleman, R. C., V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. 
Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. 
Leisch, C. Li, M. Maechler, A. J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. 
Tierney, J. Y. Yang and J. Zhang (2004). "Bioconductor: open software 
development for computational biology and bioinformatics." Genome Biology 
5(10): R80. 
George, S., S. Pokhrel, T. Xia, B. Gilbert, Z. Ji, M. Schowalter, A. Rosenauer, R. Damoiseaux, 
K. A. Bradley, L. Madler and A. E. Nel (2010). "Use of a rapid cytotoxicity 
screening approach to engineer a safer zinc oxide nanoparticle through iron doping." 
ACS Nano 4(1): 15-29. 
Giam, M. and G. Rancati (2015). "Aneuploidy and chromosomal instability in cancer: a jackpot 
to chaos." Cell Division 10(1): 1-12. 
 70 
Gilbert, B., S. C. Fakra, T. Xia, S. Pokhrel, L. Mädler and A. E. Nel (2012). "The fate of ZnO 
nanoparticles administered to human bronchial epithelial cells." ACS Nano 6(6): 
4921-4930. 
Giri, S., A. Karakoti, R. P. Graham, J. L. Maguire, C. M. Reilly, S. Seal, R. Rattan and V. 
Shridhar (2013). "Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic 
therapeutic agent in ovarian cancer." PLoS One 8(1): e54578. 
Gliga, A. R., S. Skoglund, I. Odnevall Wallinder, B. Fadeel and H. L. Karlsson (2014). "Size-
dependent cytotoxicity of silver nanoparticles in human lung cells: the role of 
celbalklular uptake, agglomeration and Ag release." Particle and Fibre Toxicology 
11(1): 1-17. 
Gonzalez, L., B. J. Sanderson and M. Kirsch-Volders (2011). "Adaptations of the in vitro MN 
assay for the genotoxicity assessment of nanomaterials." Mutagenesis 26(1): 185-
191. 
Goodman, J. E., R. L. Prueitt, S. Thakali and A. R. Oller (2011). "The nickel ion bioavailability 
model of the carcinogenic potential of nickel-containing substances in the lung." 
Critical Reviews in Toxicology 41(2): 142-174. 
Grosse, Y., D. Loomis, K. Z. Guyton, B. Lauby-Secretan, F. El Ghissassi, V. Bouvard, L. 
Benbrahim-Tallaa, N. Guha, C. Scoccianti, H. Mattock and K. Straif (2014). 
"Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon 
nanotubes." The Lancet Oncology 15(13): 1427-1428. 
Guo, X., Y. Li, J. Yan, T. Ingle, M. Y. Jones, N. Mei, M. D. Boudreau, C. K. Cunningham, M. 
Abbas, A. M. Paredes, T. Zhou, M. M. Moore, P. C. Howard and T. Chen (2016). 
"Size- and coating-dependent cytotoxicity and genotoxicity of silver nanoparticles 
evaluated using in vitro standard assays." Nanotoxicology 10(9): 1373-1384. 
Hamilton, R. F., N. Wu, D. Porter, M. Buford, M. Wolfarth and A. Holian (2009). "Particle 
length-dependent titanium dioxide nanomaterials toxicity and bioactivity." Particle 
and Fibre Toxicology 6(1): 1-11. 
Han, X., N. Corson, P. Wade-Mercer, R. Gelein, J. Jiang, M. Sahu, P. Biswas, J. N. Finkelstein, 
A. Elder and G. Oberdörster (2012). "Assessing the relevance of in vitro studies in 
nanotoxicology by examining correlations between in vitro and in vivo data." 
Toxicology 297(1-3): 1-9. 
Han, X., R. Gelein, N. Corson, P. Wade-Mercer, J. Jiang, P. Biswas, J. N. Finkelstein, A. Elder 
and G. Oberdörster (2011). "Validation of an LDH Assay for Assessing 
Nanoparticle Toxicity." Toxicology 287(1-3): 99-104. 
Hardas, S. S., R. Sultana, G. Warrier, M. Dan, R. L. Florence, P. Wu, E. A. Grulke, M. T. 
Tseng, J. M. Unrine, U. M. Graham, R. A. Yokel and D. A. Butterfield (2012). "Rat 
brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after 
exposure." Neurotoxicology 33(5): 1147-1155. 
Hardas, S. S., R. Sultana, G. Warrier, M. Dan, P. Wu, E. A. Grulke, M. T. Tseng, J. M. Unrine, 
U. M. Graham, R. A. Yokel and D. A. Butterfield (2014). "Rat hippocampal 
responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative 
stress model for nanoparticle toxicity." Nanotoxicology 1: 155-166. 
Hartung, T. and M. McBride (2011). "Food for Thought ... on mapping the human toxome." 
Alternatives to Animal Experimentation 28(2): 83-93. 
  71 
Hartung, T., E. van Vliet, J. Jaworska, L. Bonilla, N. Skinner and R. Thomas (2012). "Systems 
toxicology." Alternatives to Animal Experimentation 29(2): 119-128. 
Heckman, K. L., W. DeCoteau, A. Estevez, K. J. Reed, W. Costanzo, D. Sanford, J. C. Leiter, 
J. Clauss, K. Knapp, C. Gomez, P. Mullen, E. Rathbun, K. Prime, J. Marini, J. 
Patchefsky, A. S. Patchefsky, R. K. Hailstone and J. S. Erlichman (2013). "Custom 
cerium oxide nanoparticles protect against a free radical mediated autoimmune 
degenerative disease in the brain." ACS Nano 7(12): 10582-10596. 
Hendriks, G., M. Atallah, B. Morolli, F. Calleja, N. Ras-Verloop, I. Huijskens, M. Raamsman, 
B. van de Water and H. Vrieling (2012). "The ToxTracker assay: novel GFP reporter 
systems that provide mechanistic insight into the genotoxic properties of chemicals." 
Toxicological Sciences 125(1): 285-298. 
Hinderliter, P. M., K. R. Minard, G. Orr, W. B. Chrisler, B. D. Thrall, J. G. Pounds and J. G. 
Teeguarden (2010). "ISDD: A computational model of particle sedimentation, 
diffusion and target cell dosimetry for in vitro toxicity studies." Particle and Fibre 
Toxicology 7(1): 36. 
Holt, B. D., P. A. Short, A. D. Rape, Y. L. Wang, M. F. Islam and K. N. Dahl (2010). "Carbon 
nanotubes reorganize actin structures in cells and ex vivo." ACS Nano 4(8): 4872-
4878. 
Hosseini, A., M. Baeeri, M. Rahimifard, M. Navaei-Nigjeh, A. Mohammadirad, N. Pourkhalili, 
S. Hassani, M. Kamali and M. Abdollahi (2013). "Antiapoptotic effects of cerium 
oxide and yttrium oxide nanoparticles in isolated rat pancreatic islets." Human and 
Experimental Toxicology 32(5): 544-553. 
Hsiao, I. L., Y. K. Hsieh, C. F. Wang, I. C. Chen and Y. J. Huang (2015). "Trojan-horse 
mechanism in the cellular uptake of silver nanoparticles verified by direct intra- and 
extracellular silver speciation analysis." Environmental Science & Technology 
49(6): 3813-3821. 
Huang, S., P. J. Chueh, Y. W. Lin, T. S. Shih and S. M. Chuang (2009). "Disturbed mitotic 
progression and genome segregation are involved in cell transformation mediated 
by nano-TiO2 long-term exposure." Toxicology and Applied Pharmacology 241(2): 
182-194. 
Hubbs, A. F., L. M. Sargent, D. W. Porter, T. M. Sager, B. T. Chen, D. G. Frazer, V. 
Castranova, K. Sriram, T. R. Nurkiewicz, S. H. Reynolds, L. A. Battelli, D. 
Schwegler-Berry, W. McKinney, K. L. Fluharty and R. R. Mercer (2013). 
"Nanotechnology: Toxicologic Pathology." Toxicologic pathology 41(2): 395-409. 
Hubert R., G. Roebben, A. Boix Sanfeliu, H. Emons, P. Gibson, R. Koeber, T. Linsinger, K. 
Rasmussen, J. Riego Sintes, B. Sokull-Kluettgen, H. Stamm (2015). Towards a 
review of the EC Recommendation for a definition of the term "nanomaterial": Part 
3: Scientific-technical evaluation of options to clarify the definition and to facilitate 
its implementation, Publications Office of the European Union. 
Huh, D., B. D. Matthews, A. Mammoto, M. Montoya-Zavala, H. Y. Hsin and D. E. Ingber 
(2010). "Reconstituting Organ-Level Lung Functions on a Chip." Science 
328(5986): 1662-1668. 
Hussain, S., F. Al-Nsour, A. B. Rice, J. Marshburn, B. Yingling, Z. Ji, J. I. Zink, N. J. Walker 
and S. Garantziotis (2012). "Cerium dioxide nanoparticles induce apoptosis and 
autophagy in human peripheral blood monocytes." ACS Nano 6(7): 5820-5829. 
 72 
Hussain, S. M., D. B. Warheit, S. P. Ng, K. K. Comfort, C. M. Grabinski and L. K. Braydich-
Stolle (2015). "At the crossroads of nanotoxicology in vitro: past achievements and 
current challenges." Toxicological Sciences 147(1): 5-16. 
IARC (1997, 68). "IARC monographs on the evaluation of carcinogenic risks to humans. 
Silica, Some Silicates, Coal Dust and para-Aramid Fibrils." 
IARC (2012, 100C). "IARC monographs on the evaluation of carcinogenic risks to humans. 
Arsenic, metals, fibres and dusts." 
IARC (2013, 105). "IARC monographs on the evaluation of carcinogenic risks to humans. 
Diesel and Gasoline Engine Exhausts and Some Nitroarenes." 
IARC (2016, 109). "IARC monographs on the evaluation of carcinogenic risks to humans. 
Outdoor Air Pollution." 
Illumina. (2012). "DNA Methylation Analysis." Pub. No.270-2008-001, current as of 6 April 
2012, accessed Sept 2016 from: 
http://www.illumina.com/Documents/products/datasheets/datasheet_dna_methylation_analysis.pdf. 
 
Illumina. (2016). "An Introduction to Next-Generation Sequencing Technology." Pub. No. 
770-2012-008 current as of 25 May 2016, accessed Sept 2016 from: 
 http://www.illumina.com/content/dam/illumina-marketing/documents/products/illumina_sequencing_introduction.pdf.  
Ji, J. H., J. H. Jung, S. S. Kim, J. U. Yoon, J. D. Park, B. S. Choi, Y. H. Chung, I. H. Kwon, J. 
Jeong, B. S. Han, J. H. Shin, J. H. Sung, K. S. Song and I. J. Yu (2007). "Twenty-
eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats." 
Inhalation Toxicology 19(10): 857-871. 
Jiang, X., T. Miclaus, L. Wang, R. Foldbjerg, D. S. Sutherland, H. Autrup, C. Chen and C. 
Beer (2015). "Fast intracellular dissolution and persistent cellular uptake of silver 
nanoparticles in CHO-K1 cells: implication for cytotoxicity." Nanotoxicology 9(2): 
181-189. 
Johnston, H., G. Pojana, S. Zuin, N. R. Jacobsen, P. Moller, S. Loft, M. Semmler-Behnke, C. 
McGuiness, D. Balharry, A. Marcomini, H. Wallin, W. Kreyling, K. Donaldson, L. 
Tran and V. Stone (2013). "Engineered nanomaterial risk. Lessons learnt from 
completed nanotoxicology studies: potential solutions to current and future 
challenges." Critical Reviews in Toxicology 43(1): 1-20. 
Jomova, K. and M. Valko (2011). "Advances in metal-induced oxidative stress and human 
disease." Toxicology 283(2–3): 65-87. 
Jugan, M.-L., S. Barillet, A. Simon-Deckers, N. Herlin-Boime, S. Sauvaigo, T. Douki and M. 
Carriere (2012). "Titanium dioxide nanoparticles exhibit genotoxicity and impair 
DNA repair activity in A549 cells." Nanotoxicology 6(5): 501-513. 
Kagan, V. E., N. V. Konduru, W. Feng, B. L. Allen, J. Conroy, Y. Volkov, I. I. Vlasova, N. A. 
Belikova, N. Yanamala, A. Kapralov, Y. Y. Tyurina, J. Shi, E. R. Kisin, A. R. 
Murray, J. Franks, D. Stolz, P. Gou, J. Klein-Seetharaman, B. Fadeel, A. Star and 
A. A. Shvedova (2010). "Carbon nanotubes degraded by neutrophil 
myeloperoxidase induce less pulmonary inflammation." Nature Nanotechnology 
5(5): 354-359. 
  73 
Kain, J., H. L. Karlsson and L. Moller (2012). "DNA damage induced by micro- and 
nanoparticles--interaction with FPG influences the detection of DNA oxidation in 
the comet assay." Mutagenesis 27(4): 491-500. 
Kalyanaraman, B., V. Darley-Usmar, K. J. A. Davies, P. A. Dennery, H. J. Forman, M. B. 
Grisham, G. E. Mann, K. Moore, L. J. Roberts and H. Ischiropoulos (2012). 
"Measuring reactive oxygen and nitrogen species with fluorescent probes: 
challenges and limitations." Free radical biology & medicine 52(1): 1-6. 
Kao, Y. Y., T. J. Cheng, D. M. Yang, C. T. Wang, Y. M. Chiung and P. S. Liu (2012). 
"Demonstration of an olfactory bulb-brain translocation pathway for ZnO 
nanoparticles in rodent cells in vitro and in vivo." Journal of Molecular 
Neuroscience 48(2): 464-471. 
Karlsson, H. L., P. Cronholm, J. Gustafsson and L. Möller (2008). "Copper Oxide 
Nanoparticles Are Highly Toxic: A Comparison between Metal Oxide 
Nanoparticles and Carbon Nanotubes." Chemical Research in Toxicology 21(9): 
1726-1732. 
Karlsson, H. L., A. R. Gliga, F. M. Calleja, C. S. Goncalves, I. O. Wallinder, H. Vrieling, B. 
Fadeel and G. Hendriks (2014). "Mechanism-based genotoxicity screening of metal 
oxide nanoparticles using the ToxTracker panel of reporter cell lines." Particle and 
Fibre Toxicology 11: 41. 
Karlsson, H. L., Toprak M.S., Fadeel, B. (2015a). Chapter 4. Toxicity of Metal and Metal 
Oxide Nanoparticles. In: "Handbook on the Toxicology of Metals (4th Edition)". 
(Nordberg G.F., Fowler B.A., Nordberg M. Eds), pp 75-112. Academic Press-
Elsevier, Amsterdam. 
Karlsson, H. L., S. Di Bucchianico, A. R. Collins and M. Dusinska (2015b). "Can the comet 
assay be used reliably to detect nanoparticle-induced genotoxicity?" Environmental 
and Molecular Mutagenesis 56(2): 82-96. 
Karlsson, M., T. Kurz, U. T. Brunk, S. E. Nilsson and C. I. Frennesson (2010). "What does the 
commonly used DCF test for oxidative stress really show?" Biochemical Journal 
428(2): 183-190. 
Kennedy, K. A., S. D. Sandiford, I. S. Skerjanc and S. S. Li (2012). "Reactive oxygen species 
and the neuronal fate." Cellular and Molecular Life Sciences 69(2): 215-221. 
Kim, C. K., T. Kim, I. Y. Choi, M. Soh, D. Kim, Y. J. Kim, H. Jang, H. S. Yang, J. Y. Kim, H. 
K. Park, S. P. Park, S. Park, T. Yu, B. W. Yoon, S. H. Lee and T. Hyeon (2012). 
"Ceria nanoparticles that can protect against ischemic stroke." Angewandte Chemie 
International Edition 51(44): 11039-11043. 
Kim, J. S., J. H. Sung, J. H. Ji, K. S. Song, J. H. Lee, C. S. Kang and I. J. Yu (2011). "In vivo 
Genotoxicity of Silver Nanoparticles after 90-day Silver Nanoparticle Inhalation 
Exposure." Safety and Health at Work 2(1): 34-38. 
Kittler, S., C. Greulich, J. S. Gebauer, J. Diendorf, L. Treuel, L. Ruiz, J. M. Gonzalez-Calbet, 
M. Vallet-Regi, R. Zellner, M. Koller and M. Epple (2010). "The influence of 
proteins on the dispersability and cell-biological activity of silver nanoparticles." 
Journal of Materials Chemistry 20(3): 512-518. 
Kołodziejczak-Radzimska, A. and T. Jesionowski (2014). "Zinc Oxide—From Synthesis to 
Application: A Review." Materials 7(4): 2833. 
 74 
Kong, B., J. H. Seog, L. M. Graham and S. B. Lee (2011a). "Experimental considerations on 
the cytotoxicity of nanoparticles." Nanomedicine (Lond) 6(5): 929-941. 
Kong, L., X. Cai, X. Zhou, L. L. Wong, A. S. Karakoti, S. Seal and J. F. McGinnis (2011b). 
"Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of 
apoptosis/survival signaling pathways." Neurobiology of Disease 42(3): 514-523. 
Koppenaal, D. W., G. C. Eiden and C. J. Barinaga (2004). "Collision and reaction cells in 
atomic mass spectrometry: development, status, and applications." Journal of 
Analytical Atomic Spectrometry 19(5): 561-570. 
Kreyling, W. G., M. Semmler-Behnke, J. Seitz, W. Scymczak, A. Wenk, P. Mayer, S. 
Takenaka and G. Oberdörster (2009). "Size dependence of the translocation of 
inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood 
and secondary target organs." Inhalation Toxicology 21(Suppl 1): 55-60. 
Kroll, A., M. H. Pillukat, D. Hahn and J. Schnekenburger (2012). "Interference of engineered 
nanoparticles with in vitro toxicity assays." Archives of Toxicology 86(7): 1123-
1136. 
Krug, H. F. (2014). "Nanosafety Research—Are We on the Right Track?" Angewandte Chemie 
International Edition 53(46): 12304-12319. 
Krug, H. F. and P. Wick (2011). "Nanotoxicology: An Interdisciplinary Challenge." 
Angewandte Chemie International Edition 50(6): 1260-1278. 
Kuhn, D. A., D. Vanhecke, B. Michen, F. Blank, P. Gehr, A. Petri-Fink and B. Rothen-
Rutishauser (2014). "Different endocytotic uptake mechanisms for nanoparticles in 
epithelial cells and macrophages." Beilstein Journal of Nanotechnology 5: 1625-
1636. 
Kwon, J. Y., S. Y. Lee, P. Koedrith, J. Y. Lee, K.-M. Kim, J.-M. Oh, S. I. Yang, M.-K. Kim, 
J. K. Lee, J. Jeong, E. H. Maeng, B. J. Lee and Y. R. Seo (2014). "Lack of genotoxic 
potential of ZnO nanoparticles in in vitro and in vivo tests." Mutation 
Research/Genetic Toxicology and Environmental Mutagenesis 761: 1-9. 
Kyosseva, S. V., L. Chen, S. Seal and J. F. McGinnis (2013). "Nanoceria inhibit expression of 
genes associated with inflammation and angiogenesis in the retina of Vldlr null 
mice." Experimental Eye Research 116: 63-74. 
Lancaster, M.V. and Fields, R.D (1996). Antibiotic and Cytotoxic Drug Susceptibility Assays 
using Resazurin and Poising Agents. US. [Patent no. 5,501,959] 
Lanone, S., F. Rogerieux, J. Geys, A. Dupont, E. Maillot-Marechal, J. Boczkowski, G. Lacroix 
and P. Hoet (2009). "Comparative toxicity of 24 manufactured nanoparticles in 
human alveolar epithelial and macrophage cell lines." Particle and Fibre Toxicology 
6(1): 1-12. 
Latvala, S., J. Hedberg, S. Di Bucchianico, L. Möller, I. Odnevall Wallinder, K. Elihn and H. 
L. Karlsson (2016). "Nickel release, ROS generation and toxicity of Ni and NiO 
micro- and nanoparticles." PLoS ONE 11(7): e0159684. 
Li, L., W. Jiang, K. Luo, H. Song, F. Lan, Y. Wu and Z. Gu (2013). "Superparamagnetic iron 
oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and 
tracking." Theranostics 3(8): 595-615. 
Li, T.-S. and E. Marbán (2010). "Physiological levels of reactive oxygen species are required 
to maintain genomic stability in stem cells." Stem cells 28(7): 1178-1185. 
  75 
 
Limbach, L. K., P. Wick, P. Manser, R. N. Grass, A. Bruinink and W. J. Stark (2007). 
"Exposure of engineered nanoparticles to human lung epithelial cells:  influence of 
chemical composition and catalytic activity on oxidative stress." Environmental 
Science & Technology 41(11): 4158-4163. 
Lin, J., H. Zhang, Z. Chen and Y. Zheng (2010). "Penetration of lipid membranes by gold 
nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship." 
ACS Nano 4(9): 5421-5429. 
Lin, S., X. Wang, Z. Ji, C. H. Chang, Y. Dong, H. Meng, Y. P. Liao, M. Wang, T. B. Song, S. 
Kohan, T. Xia, J. I. Zink and A. E. Nel (2014). "Aspect ratio plays a role in the 
hazard potential of CeO2 nanoparticles in mouse lung and zebrafish gastrointestinal 
tract." ACS Nano 8(5): 4450-4464. 
Love, M. I., W. Huber and S. Anders (2014). "Moderated estimation of fold change and 
dispersion for RNA-seq data with DESeq2." Genome Biology 15(12): 1-21. 
Luanpitpong, S., L. Wang, V. Castranova and Y. Rojanasakul (2014). "Induction of stem-like 
cells with malignant properties by chronic exposure of human lung epithelial cells 
to single-walled carbon nanotubes." Particle and Fibre Toxicology 11: 22. 
Lundqvist, J., J. El Andaloussi-Lilja, C. Svensson, H. Gustafsson Dorfh and A. Forsby (2013). 
"Optimisation of culture conditions for differentiation of C17.2 neural stem cells to 
be used for in vitro toxicity tests." Toxicology In Vitro 27(5): 1565-1569. 
Lung, S., F. R. Cassee, I. Gosens and A. Campbell (2014). "Brain suppression of AP-1 by 
inhaled diesel exhaust and reversal by cerium oxide nanoparticles." Inhalation 
Toxicology 26(10): 636-641. 
Ma, J., R. R. Mercer, M. Barger, D. Schwegler-Berry, J. M. Cohen, P. Demokritou and V. 
Castranova (2015). "Effects of amorphous silica coating on cerium oxide 
nanoparticles induced pulmonary responses." Toxicology and Applied 
Pharmacology 288(1): 63-73. 
Magdolenova, Z., A. Collins, A. Kumar, A. Dhawan, V. Stone and M. Dusinska (2014). 
"Mechanisms of genotoxicity. A review of in vitro and in vivo studies with 
engineered nanoparticles." Nanotoxicology 8(3): 233-278. 
Mah, L. J., A. El-Osta and T. C. Karagiannis (2010). "gammaH2AX: a sensitive molecular 
marker of DNA damage and repair." Leukemia 24(4): 679-686. 
Maher, B. A., I. A. M. Ahmed, V. Karloukovski, D. A. MacLaren, P. G. Foulds, D. Allsop, D. 
M. A. Mann, R. Torres-Jardón and L. Calderon-Garciduenas (2016). "Magnetite 
pollution nanoparticles in the human brain." Proceedings of the National Academy 
of Sciences. 113(39): 10797–10801 
Manke, A., L. Wang and Y. Rojanasakul (2013). "Mechanisms of nanoparticle-induced 
oxidative stress and toxicity." BioMed Research International Article ID 942916 
Maynard, A. D., D. B. Warheit and M. A. Philbert (2011). "The new toxicology of sophisticated 
materials: nanotoxicology and beyond." Toxicological Sciences 120 (Suppl 1): 
S109-129. 
Meindl, C., M. Absenger, E. Roblegg and E. Fröhlich (2013). "Suitability of cell-based label-
free detection for cytotoxicity screening of carbon nanotubes." BioMed Research 
International 2013: 564804. 
 76 
Mensaert, K., S. Denil, G. Trooskens, W. Van Criekinge, O. Thas and T. De Meyer (2014). 
"Next-generation technologies and data analytical approaches for epigenomics." 
Environmental and Molecular Mutagenesis 55(3): 155-170. 
Merril, C. R. (1990). "Silver staining of proteins and DNA." Nature 343(6260): 779-780. 
Mittal, S. and A. K. Pandey (2014). "Cerium oxide nanoparticles induced toxicity in human 
lung cells: role of ROS mediated DNA damage and apoptosis." BioMed Research 
International 2014: 891934. 
Monopoli, M. P., C. Aberg, A. Salvati and K. A. Dawson (2012). "Biomolecular coronas 
provide the biological identity of nanosized materials." Nature Nanotechnology 
7(12): 779-786. 
Monteiro-Riviere, N. A., A. O. Inman and L. W. Zhang (2009). "Limitations and relative utility 
of screening assays to assess engineered nanoparticle toxicity in a human cell line." 
Toxicology and Applied Pharmacology 234(2): 222-235. 
Monteiro-Riviere, N. A., M. E. Samberg, S. J. Oldenburg and J. E. Riviere (2013). "Protein 
binding modulates the cellular uptake of silver nanoparticles into human cells: 
Implications for in vitro to in vivo extrapolations?" Toxicology Letters 220(3): 286-
293. 
Morris, T. J. and S. Beck (2015). "Analysis pipelines and packages for Infinium 
HumanMethylation450 BeadChip (450k) data." Methods 72: 3-8. 
Mwilu, S. K., E. Siska, R. B. N. Baig, R. S. Varma, E. Heithmar and K. R. Rogers (2014). 
"Separation and measurement of silver nanoparticles and silver ions using magnetic 
particles." Science of The Total Environment 472: 316-323. 
Møller, P., N. R. Jacobsen, J. K. Folkmann, P. H. Danielsen, L. Mikkelsen, J. G. Hemmingsen, 
L. K. Vesterdal, L. Forchhammer, H. Wallin and S. Loft (2010). "Role of oxidative 
damage in toxicity of particulates." Free Radical Research 44(1): 1-46. 
Nel, A., T. Xia, L. Madler and N. Li (2006). "Toxic potential of materials at the nanolevel." 
Science 311(5761): 622-627. 
Nel, A., T. Xia, H. Meng, X. Wang, S. Lin, Z. Ji and H. Zhang (2013). "Nanomaterial toxicity 
testing in the 21st century: use of a predictive toxicological approach and high-
throughput screening." Accounts of Chemical Research 46(3): 607-621. 
Nel, A. E., L. Madler, D. Velegol, T. Xia, E. M. V. Hoek, P. Somasundaran, F. Klaessig, V. 
Castranova and M. Thompson (2009). "Understanding biophysicochemical 
interactions at the nano-bio interface." Nature Materials 8(7): 543-557. 
Nelson, B. C., C. W. Wright, Y. Ibuki, M. Moreno-Villanueva, H. L. Karlsson, G. Hendriks, 
C. M. Sims, N. Singh and S. H. Doak (2016). "Emerging metrology for high-
throughput nanomaterial genotoxicology." Mutagenesis. Published online: August 
26, 2016 [Epub ahead of print] 
Nguyen, T., P. Nioi and C. B. Pickett (2009). "The Nrf2-antioxidant response element signaling 
pathway and its activation by oxidative stress." Journal of Biological Chemistry 
284(20): 13291-13295. 
Niu, J., K. Wang and P. E. Kolattukudy (2011). "Cerium oxide nanoparticles inhibit oxidative 
stress and nuclear factor-kappaB activation in H9c2 cardiomyocytes exposed to 
cigarette smoke extract." Journal of Pharmacology and Experimental Therapeutics 
338(1): 53-61. 
  77 
Nowack, B., H. F. Krug and M. Height (2011). "120 years of nanosilver history: implications 
for policy makers." Environmental Science & Technology 45(4): 1177-1183. 
Nymark, P., J. Catalan, S. Suhonen, H. Jarventaus, R. Birkedal, P. A. Clausen, K. A. Jensen, 
M. Vippola, K. Savolainen and H. Norppa (2013). "Genotoxicity of 
polyvinylpyrrolidone-coated silver nanoparticles in BEAS 2B cells." Toxicology 
313(1): 38-48. 
Nymark, P., P. Wijshoff, R. Cavill, M. van Herwijnen, M. L. Coonen, S. Claessen, J. Catalan, 
H. Norppa, J. C. Kleinjans and J. J. Briede (2015). "Extensive temporal 
transcriptome and microRNA analyses identify molecular mechanisms underlying 
mitochondrial dysfunction induced by multi-walled carbon nanotubes in human lung 
cells." Nanotoxicology 9(5): 624-635. 
Oberdörster, G., E. Oberdörster and J. Oberdörster (2005). "Nanotoxicology: an emerging 
discipline evolving from studies of ultrafine particles." Environmental Health 
Perspectives 113(7): 823-839. 
Oberdörster, G., Z. Sharp, V. Atudorei, A. Elder, R. Gelein, W. Kreyling and C. Cox (2004). 
"Translocation of Inhaled Ultrafine Particles to the Brain." Inhalation Toxicology 
16(6-7): 437-445. 
Olive, P. L. and J. P. Banath (2006). "The comet assay: a method to measure DNA damage in 
individual cells." Nature Protocols 1(1): 23-29. 
Onodera, A., F. Nishiumi, K. Kakiguchi, A. Tanaka, N. Tanabe, A. Honma, K. Yayama, Y. 
Yoshioka, K. Nakahira, S. Yonemura, I. Yanagihara, Y. Tsutsumi and Y. Kawai 
(2015). "Short-term changes in intracellular ROS localisation after the silver 
nanoparticles exposure depending on particle size." Toxicology Reports 2: 574-579. 
Pagliari, F., C. Mandoli, G. Forte, E. Magnani, S. Pagliari, G. Nardone, S. Licoccia, M. Minieri, 
P. Di Nardo and E. Traversa (2012). "Cerium oxide nanoparticles protect cardiac 
progenitor cells from oxidative stress." ACS Nano 6(5): 3767-3775. 
Park, E.-J., J. Yi, Y. Kim, K. Choi and K. Park (2010). "Silver nanoparticles induce cytotoxicity 
by a Trojan-horse type mechanism." Toxicology in Vitro 24(3): 872-878. 
Park, E. J., J. Choi, Y. K. Park and K. Park (2008). "Oxidative stress induced by cerium oxide 
nanoparticles in cultured BEAS-2B cells." Toxicology 245(1-2): 90-100. 
Park, Y. H., D. Kim, J. Dai and Z. Zhang (2015). "Human bronchial epithelial BEAS-2B cells, 
an appropriate in vitro model to study heavy metals induced carcinogenesis." 
Toxicology and Applied Pharmacology 287(3): 240-245. 
Patchin, E. S., D. S. Anderson, R. M. Silva, D. L. Uyeminami, G. M. Scott, T. Guo, L. S. Van 
Winkle and K. E. Pinkerton (2016). "Size-dependent deposition, translocation, and 
microglial activation of inhaled silver nanoparticles in the rodent nose and brain." 
Environmental Health Perspectives Published online: May 6, 2016 [Epub ahead of 
print] 
Powers, K. W., P. L. Carpinone and K. N. Siebein (2012). "Characterization of nanomaterials 
for toxicological studies." Methods in Molecular Biology 926: 13-32. 
Prasad, R. Y., J. K. McGee, M. G. Killius, D. A. Suarez, C. F. Blackman, D. M. DeMarini and 
S. O. Simmons (2013). "Investigating oxidative stress and inflammatory responses 
elicited by silver nanoparticles using high-throughput reporter genes in HepG2 cells: 
effect of size, surface coating, and intracellular uptake." Toxicology In Vitro 27(6): 
2013-2021. 
 78 
Promega (2016). "Technical Bulletin CytoTox 96® Non-Radioactive, Cytotoxicity Assay."   
Accessed September 2016, from:  
https://se.promega.com/-/media/files/resources/protocols/technical-bulletins/0/cytotox-96-nonradioactive-
cytotoxicity-assay-protocol.pdf. 
Pulido-Reyes, G., I. Rodea-Palomares, S. Das, T. S. Sakthivel, F. Leganes, R. Rosal, S. Seal 
and F. Fernández-Piñas (2015). "Untangling the biological effects of cerium oxide 
nanoparticles: the role of surface valence states." Scientific Reports 5: 15613. 
Quadros, M. E. and L. C. Marr (2011). "Silver nanoparticles and total aerosols emitted by 
nanotechnology-related consumer spray products." Environmental Science & 
Technology 45(24): 10713-10719. 
Reddel, R. R., K. Yang, J. S. Rhim, D. Brash, R. T. Su, J. F. Lechner, B. I. Gerwin, C. C. Harris 
and P. Amstad (1989). Immortalized human bronchial epitherial mesothelial cell 
lines [Patent no US4885238] 
Reinhold, W. C., M. A. Reimers, P. Lorenzi, J. Ho, U. T. Shankavaram, M. S. Ziegler, K. J. 
Bussey, S. Nishizuka, O. Ikediobi, Y. G. Pommier and J. N. Weinstein (2010). 
"Multifactorial regulation of E-cadherin expression: an integrative study." 
Molecular Cancer Therapeutics 9(1): 1-16. 
Ritchie, M. E., B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi and G. K. Smyth (2015). "limma 
powers differential expression analyses for RNA-sequencing and microarray 
studies." Nucleic Acids Research 43(7): e47. 
Rosenman, K. D., A. Moss and S. Kon (1979). "Argyria: clinical implications of exposure to 
silver nitrate and silver oxide." Journal of Occupational Medicine 21(6): 430-435. 
Sadauskas, E., N. R. Jacobsen, G. Danscher, M. Stoltenberg, U. Vogel, A. Larsen, W. Kreyling 
and H. Wallin (2009). "Biodistribution of gold nanoparticles in mouse lung 
following intratracheal instillation." Chemistry Central Journal 3(1): 1-7. 
Samberg, M. E., S. J. Oldenburg and N. A. Monteiro-Riviere (2010). "Evaluation of silver 
nanoparticle toxicity in skin in vivo and keratinocytes in vitro." Environmental 
Health Perspectives 118(3): 407-413. 
Sargent, L. M., A. F. Hubbs, S. H. Young, M. L. Kashon, C. Z. Dinu, J. L. Salisbury, S. A. 
Benkovic, D. T. Lowry, A. R. Murray, E. R. Kisin, K. J. Siegrist, L. Battelli, J. 
Mastovich, J. L. Sturgeon, K. L. Bunker, A. A. Shvedova and S. H. Reynolds (2012). 
"Single-walled carbon nanotube-induced mitotic disruption." Mutation Research 
745(1-2): 28-37. 
Sauer, H., M. Wartenberg and J. Hescheler (2001). "Reactive oxygen species as intracellular 
messengers during cell growth and differentiation." Cellular Physiology and 
Biochemistry 11(4): 173-186. 
Schermelleh, L., R. Heintzmann and H. Leonhardt (2010). "A guide to super-resolution 
fluorescence microscopy." Journal of Cell Biology 190(2): 165-175. 
Schins, R. P., A. M. Knaapen, G. D. Cakmak, T. Shi, C. Weishaupt and P. J. Borm (2002). 
"Oxidant-induced DNA damage by quartz in alveolar epithelial cells." Mutation 
Research 517(1-2): 77-86. 
Shannahan, J. H., R. Podila and J. M. Brown (2015). "A hyperspectral and toxicological 
analysis of protein corona impact on silver nanoparticle properties, intracellular 
modifications, and macrophage activation." International Journal of Nanomedicine 
10: 6509-6521. 
  79 
Sharma, V., R. K. Shukla, N. Saxena, D. Parmar, M. Das and A. Dhawan (2009). "DNA 
damaging potential of zinc oxide nanoparticles in human epidermal cells." 
Toxicology Letters 185(3): 211-218. 
Shvedova, A. A., A. Pietroiusti, B. Fadeel and V. E. Kagan (2012). "Mechanisms of carbon 
nanotube-induced toxicity: Focus on oxidative stress." Toxicology and applied 
pharmacology 261(2): 121-133. 
Shyamasundar, S., C. T. Ng, L. Y. Lanry Yung, S. T. Dheen and B. H. Bay (2015). "Epigenetic 
mechanisms in nanomaterial-induced toxicity." Epigenomics 7(3): 395-411. 
Silva, R. M., D. S. Anderson, J. Peake, P. C. Edwards, E. S. Patchin, T. Guo, T. Gordon, L. C. 
Chen, X. Sun, L. S. Van Winkle and K. E. Pinkerton (2016). "Aerosolized Silver 
Nanoparticles in the Rat Lung and Pulmonary Responses over Time." Toxicologic 
Pathology 44(5): 673-686. 
Simon, D. F., R. F. Domingos, C. Hauser, C. M. Hutchins, W. Zerges and K. J. Wilkinson 
(2013). "Transcriptome sequencing (RNA-seq) analysis of the effects of metal 
nanoparticle exposure on the transcriptome of Chlamydomonas reinhardtii." Applied 
and Environmental Microbiology 79(16): 4774-4785. 
Snyder, E. Y., D. L. Deitcher, C. Walsh, S. Arnold-Aldea, E. A. Hartwieg and C. L. Cepko 
(1992). "Multipotent neural cell lines can engraft and participate in development of 
mouse cerebellum." Cell 68(1): 33-51. 
Song, K. S., J. H. Sung, J. H. Ji, J. H. Lee, J. S. Lee, H. R. Ryu, J. K. Lee, Y. H. Chung, H. M. 
Park, B. S. Shin, H. K. Chang, B. Kelman and I. J. Yu (2013). "Recovery from silver-
nanoparticle-exposure-induced lung inflammation and lung function changes in 
Sprague Dawley rats." Nanotoxicology 7(2): 169-180. 
Sotiriou, G. A. and S. E. Pratsinis (2011). "Engineering nanosilver as an antibacterial, biosensor 
and bioimaging material." Current opinion in chemical engineering 1(1): 3-10. 
Stoehr, L. C., C. Endes, I. Radauer-Preiml, M. S. Boyles, E. Casals, S. Balog, M. Pesch, A. 
Petri-Fink, B. Rothen-Rutishauser, M. Himly, M. J. Clift and A. Duschl (2015). 
"Assessment of a panel of interleukin-8 reporter lung epithelial cell lines to monitor 
the pro-inflammatory response following zinc oxide nanoparticle exposure under 
different cell culture conditions." Particle and Fibre Toxicology 12: 29. 
Stoehr, L. C., E. Gonzalez, A. Stampfl, E. Casals, A. Duschl, V. Puntes and G. J. Oostingh 
(2011). "Shape matters: effects of silver nanospheres and wires on human alveolar 
epithelial cells." Particle and Fibre Toxicology 8(1): 1-15. 
Sturla, S. J., A. R. Boobis, R. E. FitzGerald, J. Hoeng, R. J. Kavlock, K. Schirmer, M. Whelan, 
M. F. Wilks and M. C. Peitsch (2014). "Systems toxicology: from basic research to 
risk assessment." Chemical Research in Toxicology 27(3): 314-329. 
Sun, H., H. A. Clancy, T. Kluz, J. Zavadil and M. Costa (2011). "Comparison of Gene 
Expression Profiles in Chromate Transformed BEAS-2B Cells." PLoS ONE 6(3): 
e17982. 
Sung, J. H., J. H. Ji, J. D. Park, J. U. Yoon, D. S. Kim, K. S. Jeon, M. Y. Song, J. Jeong, B. S. 
Han, J. H. Han, Y. H. Chung, H. K. Chang, J. H. Lee, M. H. Cho, B. J. Kelman and 
I. J. Yu (2009). "Subchronic Inhalation Toxicity of Silver Nanoparticles." 
Toxicological Sciences 108(2): 452-461. 
 
 80 
Sung, J. H., J. H. Ji, J. U. Yoon, D. S. Kim, M. Y. Song, J. Jeong, B. S. Han, J. H. Han, Y. H. 
Chung, J. Kim, T. S. Kim, H. K. Chang, E. J. Lee, J. H. Lee and I. J. Yu (2008). 
"Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure 
to silver nanoparticles." Inhalation Toxicology 20(6): 567-574. 
Suzuki, H., T. Toyooka and Y. Ibuki (2007). "Simple and easy method to evaluate uptake 
potential of nanoparticles in mammalian cells using a flow cytometric light scatter 
analysis." Environmental Science & Technology 41(8): 3018-3024. 
Teeguarden, J. G., V. B. Mikheev, K. R. Minard, W. C. Forsythe, W. Wang, G. Sharma, N. 
Karin, S. C. Tilton, K. M. Waters, B. Asgharian, O. R. Price, J. G. Pounds and B. D. 
Thrall (2014). "Comparative iron oxide nanoparticle cellular dosimetry and response 
in mice by the inhalation and liquid cell culture exposure routes." Particle and Fibre 
Toxicology 11(1): 1-18. 
Tenzer, S., D. Docter, J. Kuharev, A. Musyanovych, V. Fetz, R. Hecht, F. Schlenk, D. Fischer, 
K. Kiouptsi, C. Reinhardt, K. Landfester, H. Schild, M. Maskos, S. K. Knauer and 
R. H. Stauber (2013). "Rapid formation of plasma protein corona critically affects 
nanoparticle pathophysiology." Nature Nanotechnology 8(10): 772-781. 
Tice, R. R., E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, H. Kobayashi, Y. Miyamae, 
E. Rojas, J. C. Ryu and Y. F. Sasaki (2000). "Single cell gel/comet assay: guidelines 
for in vitro and in vivo genetic toxicology testing." Environmental and Molecular 
Mutagenesis 35(3): 206-221. 
Tofighi, R., M. Moors, R. Bose, W. N. W. Ibrahim and S. Ceccatelli (2011). Chapter 5. Neural 
Stem Cells for Developmental Neurotoxicity Studies. In: "In Vitro Neurotoxicology: 
Methods and Protocols". (G. L. Costa, G. Giordano and M. Guizzetti Eds.) pp 67-
80, Humana Press, New Jersey.  
Tomaszewska, E., K. Soliwoda, K. Kadziola, B. Tkacz-Szczesna, G. Celichowski, M. 
Cichomski, W. Szmaja and J. Grobelny (2013). "Detection Limits of DLS and UV-
Vis Spectroscopy in Characterization of Polydisperse Nanoparticles Colloids." 
Journal of Nanomaterials Article ID 313081. 
Tran, C. L., R. Tantra, K. Donaldson, V. Stone, S. M. Hankin, B. Ross, R. J. Aitken and A. D. 
Jones (2011). "A hypothetical model for predicting the toxicity of high aspect ratio 
nanoparticles (HARN)." Journal of Nanoparticle Research 13(12): 6683-6698. 
Tseng, M. T., Q. Fu, K. Lor, G. R. Fernandez-Botran, Z. B. Deng, U. Graham, D. A. Butterfield, 
E. A. Grulke and R. A. Yokel (2014). "Persistent hepatic structural alterations 
following nanoceria vascular infusion in the rat." Toxicologic Pathology 42(6): 984-
996. 
Tyler, G., Yvon, J. (2005). "ICP-OES, ICP-MS and AAS techniques compared.  Jobin Yvon 
Horiba ICP Optical Emission Spectroscopy Technical Note 05."   Accessed Sept 
2016, from:                                                                              
http://www.horiba.com/fileadmin/uploads/Scientific/Downloads/OpticalSchool_CN/TN/ICP/ICP-OES__ICP-
MS_and_AAS_Techniques_Compared.pdf   
Uttara, B., A. V. Singh, P. Zamboni and R. T. Mahajan (2009). "Oxidative Stress and 
Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant 
Therapeutic Options." Current Neuropharmacology 7(1): 65-74. 
Vales, G., L. Rubio and R. Marcos (2015). "Long-term exposures to low doses of titanium 
dioxide nanoparticles induce cell transformation, but not genotoxic damage in 
BEAS-2B cells." Nanotoxicology 9(5): 568-578. 
  81 
Vales, G., L. Rubio and R. Marcos (2016). "Genotoxic and cell-transformation effects of multi-
walled carbon nanotubes (MWCNT) following in vitro sub-chronic exposures." 
Journal of Hazardous Materials 306: 193-202. 
Walkey, C., S. Das, S. Seal, J. Erlichman, K. Heckman, L. Ghibelli, E. Traversa, J. F. McGinnis 
and W. T. Self (2015). "Catalytic Properties and Biomedical Applications of Cerium 
Oxide Nanoparticles." Environmental Science: Nano 2(1): 33-53. 
Vallyathan, V., S. Leonard, P. Kuppusamy, D. Pack, M. Chzhan, S. P. Sanders and J. L. Zweir 
(1997). "Oxidative stress in silicosis: evidence for the enhanced clearance of free 
radicals from whole lungs." Molecular and Cellular Biochemistry 168(1-2): 125-
132. 
Vance, M. E., T. Kuiken, E. P. Vejerano, S. P. McGinnis, M. F. Hochella, Jr., D. Rejeski and 
M. S. Hull (2015). "Nanotechnology in the real world: Redeveloping the 
nanomaterial consumer products inventory." Beilstein Journal of Nanotechnology 
6: 1769-1780. 
Wang, L., S. Luanpitpong, V. Castranova, W. Tse, Y. Lu, V. Pongrakhananon and Y. 
Rojanasakul (2011). "Carbon nanotubes induce malignant transformation and 
tumorigenesis of human lung epithelial cells." Nano Letters 11(7): 2796-2803. 
Wang, T., J. Bai, X. Jiang and G. U. Nienhaus (2012). "Cellular uptake of nanoparticles by 
membrane penetration: a study combining confocal microscopy with FTIR 
spectroelectrochemistry." ACS Nano 6(2): 1251-1259. 
Wang, X., Z. Ji, C. H. Chang, H. Zhang, M. Wang, Y.-P. Liao, S. Lin, H. Meng, R. Li, B. Sun, 
L. V. Winkle, K. E. Pinkerton, J. I. Zink, T. Xia and A. E. Nel (2014). "Use of coated 
silver nanoparticles to understand the relationship of particle dissolution and 
bioavailability to cell and lung toxicological potential." Small 10(2): 385-398. 
Wang, Z., M. Gerstein and M. Snyder (2009). "RNA-Seq: a revolutionary tool for 
transcriptomics." Nature Reviews Genetics 10(1): 57-63. 
Wei, L., J. Lu, H. Xu, A. Patel, Z.-S. Chen and G. Chen (2015). "Silver nanoparticles: synthesis, 
properties, and therapeutic applications." Drug Discovery Today 20(5): 595-601. 
Weir, A., P. Westerhoff, L. Fabricius and N. von Goetz (2012). "Titanium dioxide 
nanoparticles in food and personal care products." Environmental science & 
technology 46(4): 2242-2250. 
Weldon, B. A., M. F. E, G. Oberdörster, T. Workman, W. C. Griffith, C. Kneuer and I. J. Yu 
(2016). "Occupational exposure limit for silver nanoparticles: considerations on the 
derivation of a general health-based value." Nanotoxicology 10(7): 945-956. 
Wente, S. R. and M. P. Rout (2010). "The Nuclear Pore Complex and Nuclear Transport." Cold 
Spring Harbor Perspectives in Biology 2(10): a000562. 
Veranth, J. M., N. S. Cutler, E. G. Kaser, C. A. Reilly and G. S. Yost (2008). "Effects of cell 
type and culture media on Interleukin-6 secretion in response to environmental 
particles." Toxicology in Vitro 22(2): 498-509. 
Verspohl, E. J. and J. Podlogar (2012). "LPS-Induced Proliferation and Chemokine Secretion 
from BEAS-2B Cells,." Pharmacology & Pharmacy 3(2): 166-177. 
Westmeier, D., R. H. Stauber and D. Docter (2016). "The concept of bio-corona in modulating 
the toxicity of engineered nanomaterials (ENM)." Toxicology and Applied 
Pharmacology 299: 53-57. 
 82 
Wichmann, H. E. (2007). "Diesel exhaust particles." Inhalation Toxicol 19 (Suppl 1):241-244. 
Vogel, C. and E. M. Marcotte (2012). "Insights into the regulation of protein abundance from 
proteomic and transcriptomic analyses." Nature Reviews Genetics 13(4): 227-232. 
Xia, T., M. Kovochich, J. Brant, M. Hotze, J. Sempf, T. Oberley, C. Sioutas, J. I. Yeh, M. R. 
Wiesner and A. E. Nel (2006). "Comparison of the abilities of ambient and 
manufactured nanoparticles to induce cellular toxicity according to an oxidative 
stress paradigm." Nano Letters 6(8): 1794-1807. 
Xia, T., M. Kovochich, M. Liong, L. Mädler, B. Gilbert, H. Shi, J. I. Yeh, J. I. Zink and A. E. 
Nel (2008). "Comparison of the mechanism of toxicity of zinc oxide and cerium 
oxide nanoparticles based on dissolution and oxidative stress properties." ACS Nano 
2(10): 2121-2134. 
Xu, R. (2008). "Progress in nanoparticles characterization: Sizing and zeta potential 
measurement." Particuology 6(2): 112-115. 
Xue, Y., Q. Luan, D. Yang, X. Yao and K. Zhou (2011). "Direct evidence for hydroxyl radical 
scavenging activity of cerium oxide nanoparticles." The Journal of Physical 
Chemistry C 115(11): 4433-4438. 
Yokel, R. A., M. T. Tseng, M. Dan, J. M. Unrine, U. M. Graham, P. Wu and E. A. Grulke 
(2013). "Biodistribution and biopersistence of ceria engineered nanomaterials: size 
dependence." Nanomedicine 9(3): 398-407. 
Yu, S. J., J. B. Chao, J. Sun, Y. G. Yin, J. F. Liu and G. B. Jiang (2013). "Quantification of the 
uptake of silver nanoparticles and ions to HepG2 cells." Environmental Science & 
Technology 47(7): 3268-3274. 
Zhang, H., Z. Ji, T. Xia, H. Meng, C. Low-Kam, R. Liu, S. Pokhrel, S. Lin, X. Wang, Y.-P. 
Liao, M. Wang, L. Li, R. Rallo, R. Damoiseaux, D. Telesca, L. Mädler, Y. Cohen, 
J. I. Zink and A. E. Nel (2012). "Use of metal oxide nanoparticle band gap to develop 
a predictive paradigm for oxidative stress and acute pulmonary inflammation." 
ACS Nano 6(5): 4349-4368. 
Zhang, J., Y. Nazarenko, L. Zhang, L. Calderon, K.-B. Lee, E. Garfunkel, S. Schwander, T. D. 
Tetley, K. F. Chung, A. E. Porter, M. Ryan, H. Kipen, P. J. Lioy and G. Mainelis 
(2013). "Impacts of a nanosized ceria additive on diesel engine emissions of 
particulate and gaseous." Environmental science & technology 47(22): 13077-
13085. 
Zhao, F. and W. T. Klimecki (2015). "Culture conditions profoundly impact phenotype in 
BEAS-2B, a human pulmonary epithelial model." Journal of Applied Toxicology 
35(8): 945-951. 
Zheng, Q. and X. J. Wang (2008). "GOEAST: a web-based software toolkit for Gene Ontology 
enrichment analysis." Nucleic Acids Research 36(Web Server issue): 358-363. 
 
 
 
 
